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Abstract 
Gene trapping in mouse embryonic stem cells has been used to identify and 
characterise the function of novel genes. Introduction of a gene trap vector into the genome 
results in the generation of a fusion between the lacZ reporter gene and the endogenous 
trapped gene. The consequences of this are predicted to be threefold: (i) expression of the 
reporter gene will be controlled by the promoter and enhancer elements of the endogenous 
gene and will therefore mirror endogenous gene expression; (ii) the generation of a fusion 
transcript allows endogenous gene sequence to be cloned by 5'RACE-PCR and (iii) the 
insertion of the gene trap vector can disrupt the function of the endogenous gene. 
This work describes the characterisation of one specific gene trap integration, 1114 
that has not behaved entirely as predicted but has none-the-less identified an early marker of 
hepatic specification. The reporter activity profile associated with the 1114 gene trap 
integration is restricted to the definintive endoderm marking the ontogeny of the foetal 
liver. Reporter activity is observed as early as the 9 somite stage (8.0-8.5dpc) in 
endodermal cells of the foregut in the region destined to form the liver diverticulum and is 
restricted to the hepatic lineage until late gestation. Comparison of 1114 reporter activity 
with AFP identifies 1114 reporter activity as being the earliest, most specific marker of liver 
organogenesis identified to date. 
Breeding of the gene trap integration to homozygosity reveals no overt phenotype 
but its unique pattern of expression prompted us to clone the endogenous sequence. This 
has proven to be more complex than predicted as integration of the gene trap vector results 
in the production of two fusion transcripts. The most abundant (Group I) fusion transcript 
is ubiquitously expressed. No reporter activity is produced from this fusion transcript as 
gene trap vector splicing to this sequence places translation of the lacZ gene out-of-frame. 
The second, less abundant (Group II) fusion transcript is expressed exclusively in the liver 
during embryogenesis and is predicted to produce reporter activity. The cloning and 
sequencing of both the genomic sequence and the endogenous gene (gtar - gene trap 
nkyrin repeat) associated with the Group I and II fusion sequences has revealed that they 
represent different exons of gtar. Expression of the Group I and Group II sequences 
independent of the gene trap vector mimics that of the 1114 fusion transcripts. 
Furthermore, expression of these sequences in 1114 homozygous tissues indicates that the 
insertion of the gene trap vector has failed to disrupt the expression of gtar. Expression of 
the liver specific exon of gtar is postulated to be a consequence of either a separate 
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Chapter 1 
INTRODUCTION 
1.1. MUTATIONAL ANALYSIS OF THE MOUSE 
Mutational analysis has revolutionised our understanding of the processes 
involved in embryonic development. Phenotype driven screens in invertebrate systems 
such as Drosophila melanogaster (Nüsslein-Volhard, 1984) and Caenorhabditis elegans 
(Kempheus, 1988) have been successful in identifying many of the molecules and 
pathways essential for correct embryonic patterning in these organisms. Comparable 
saturation scale mutagenesis has been performed in the Zebrafish Danio rerio, providing 
an excellent resource for the analysis of vertebrate embryogenesis (Driever et al., 1996; 
Haffter et al., 1996). However, the identification of the genes associated with the 
phenotypes is hindered by the relatively poorly characterised Zebrafish genome. The 
mouse provides the ideal mammalian system for mutational analysis with well 
characterised inbred strains, over 1000 existing mutant loci and an increasingly well 
defined genome. Furthermore, transgenic technology allows for a vast range of 
modifications to the mouse genome. 
1.1.1. Random Mutagenesis 
The mouse has an existing pool of over 1000 spontaneous, chemical or 
irradiation induced mutants (Doolittle et al., 1996). Moreover, mutagenic screens to 
identify additional mutants for study have been undertaken in mice using X-rays or 
chemical mutagens such as ENU and chiorambucil (Rinchik, 1991). Initially these 
screens have focused on the identification of novel mutants within small, phenotypically 
defined genomic regions (Shedlovsky et al., 1988; Rinchik, 199 1) or to the isolation of 
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mutations with specific phenotypes (Shedlovsky et al., 1993; Hotz Vitaterna et al., 
1994). Currently the MRC Mammalian Genetics Unit at Harwell is undertaking a large 
scale ENU mutagenesis programme in the mouse (http://www.mgu.har.mrc.ac.ukl 
mutabase/). Two approaches are being used; a genome wide screen for dominant 
mutations and a targeted screen for recessive mutations within a deletion region on 
chromosome 13. Essential to both of these approaches is that phenotype screening of 
each mutant will be performed using a defined protocol of tests which will identify 
abnormalities ranging from embryonic lethality through to subtle behavioural 
abnormalities (Rogers et al., 1997). 	Increasingly refined mapping and gene 
identification techniques are aiding the significant task of isolating the mutated gene 
responsible for individual phenotypes. Interspecific backcross panels and the use of 
simple sequence length polymorphisms (SSLP) are defining a high resolution linkage 
map of the mouse genome allowing for more accurate mapping of mutant loci (Dietrich 
et al., 1996; Avner et al., 1988; Bedell et al., 1997). Positional cloning and the 
candidate gene approach have subsequently been successful strategies for the 
identification of the mutated gene. The genes responsible for many developmentally 
significant mutants have been isolated using these techniques, including T, mv, and sm 
by positional cloning (Hermann et al., 1990; Morgan et al., 1998; Sidow et al., 1997) 
and W, Steel, and un by identifying candidate genes (Reith et al., 1990; Huang et al., 
1990; Balling et al., 1988). 
A significant limitation of the random mutagenesis approach in the mouse 
compared to non-mammalian systems is the considerable resources needed to maintain 
the breeding numbers necessary to define and map mutations. 
1.1.2. Directed Mutagenesis 
The development of transgenic technology, in particular targeted homologous 
recombination in ES cells (Capecchi, 1989) provides a complementary approach to 
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phenotype driven screens with studies orientated towards gene identification and 
targeted mutational analysis. 
Diverse approaches have been employed to identify novel genes that play 
important roles in murine development. For example, the identification of homologues 
of pattern formation genes discovered in genetically more accessible organisms such as 
Drosophila has been hugely influential in isolating gene families essential in murine 
embryogenesis (Kessel and Gruss, 1990). However, such approaches will not identify 
genes that are mammalian specific. 
Many genes involved in mammalian signalling cascades initially identified, for 
example, by their oncogenic potential or effects in vitro, have shown restricted 
developmental expression patterns and subsequently displayed developmental 
phenotypes when disrupted in vivo (McMahon, 1992; Sanford et al., 1997; Yamaguchi 
et a!, 1994; Schmidt et al., 1995). 
Strategies for the de novo isolation of developmental genes based on expression 
profile include subtractive hybridisation (Lee et al.,1991; Harrison et al., 1995), 
differential display (Liang and Pardee, 1992; Welsh et al., 1992) and the identification 
of factors binding upstream of tissue specific genes (Costa et al., 1989). These 
technologies allow for more focused searches, enriching for genes with desired 
expression patterns and has been successful at identifying developmentally important 
genes (Dunwoodie et al., 1998; Chen et al., 1994a; Lai et al., 1993). 
Expressed sequence tag (EST) databases of randomly sequenced cDNA clones 
from a wide spectrum of developmental stages and tissues provides another potentially 
important de novo source of developmental genes (Adams et al., 1995; Boguski et al., 
1993). 
ES cell mediated gene knock-out studies have allowed for the function of many 
of the genes isolated by these techniques to be examined in vivo. A catalogue of 327 
individual gene knock-outs was first published by Brandon et al., (1995). From the 
beginning of 1999 this has grown into a database of over 1400 single and double 
knockouts as well as a number of insertional and classical mutants (http://www. 
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biomednet.comldb/mkind). 	The targeted disruption of individual genes has 
revolutionised our ability to assess gene function during embryogenesis. However, 
information regarding genomic gene structure is needed to construct targeting vectors 
and there is no guarantee that individual gene knock-outs will produce a 
developmentally relevant phenotype if gene function is redundant among family 
members. 
1.1.3. Insertional Mtitagenesis 
Another source of informative developmental mutants has arisen from the large 
numbers of transgenic mouse strains produced over the last 15 years. Around 5% of 
transgenic and retroviral insertions are believed to be mutagenic. These phenotypes are 
not attributable to the transgene itself, but due to the insertion of the exogenous DNA 
interfering with normal gene function either directly or by inducing chromosomal 
rearrangements and deletions (Rijkers et al., 1994; Gridley et al., 1987). The potential 
benefit in studying phenotypes arising from insertional mutants is that the exogenous 
DNA provides a molecular handle on the mutated locus eliminating extensive breeding 
strategies and potentiating identification of the effected gene. An excellent example of 
an insertional mutant leading to the isolation of a developmentally important molecule is 
from the retrovirally induced 413-d transgenic line. Mice homozygous for the retroviral 
insertion fall to gastrulate correctly showing impairment of embryonic mesoderm 
formation (Tannaconne et al., 1992; Conlon et al., 1991). The phenotype was 
subsequently shown to be associated with the disruption of nodal a member of the 
transforming growth factor -13  (TGF-13) superfamily of secreted molecules (Zhou et al., 
1993). However, identification of the disrupted transcript in insertional mutants has 
proven a laborious process borne out by how few genes associated with insertional 
mutants have been identified to date (Rijkers et al., 1994). The high copy number of 
transgene insertions and transgene induced rearrangements and deletions of endogenous 
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DNA at the insertion site all complicate the molecular analysis of the mutant 
locus.(Gridley et al., 1987; Jaenisch, 1988). 
1.2. ENTRAPMENT TECHNOLOGY 
This section will focus on gene entrapment technology as a means of inducing 
and identifying developmental mutants. The overall principles of gene entrapment and 
its use in various experimental systems will serve as an introduction to entrapment in 
murine ES cells. 
Gene entrapment uses insertional mutagenesis in a systematic and reproducible 
manner to identify genes and their transcriptional control elements. Entrapment vectors 
consist of a reporter gene which is introduced into the genome where its expression is 
dependent on insertion either adjacent to cis-acting transcriptional control elements 
(enhancer traps) or into a gene (promoter traps) (Figure 1.1; Skarnes, 1990). Enhancer 
trap vectors consist of a reporter gene driven by a minimal promoter. Expression of the 
reporter gene requires the activity of the endogenous enhancer elements (Figure 1.1 A; 
Bellen et al., 1990; Allen et al., 1988). In promoter trap constructs the reporter gene 
lacks a promoter with its expression dependent on vector insertion into a transcriptional 
unit for endogenous promoter activity (Figure 1.1B; Brenner et al., 1989; Gossler et 
al., 1989). Entrapment vectors therefore, although potentially mutagenic, can identify 
genes based solely on reporter expression. This allows non-essential genes to be 
isolated, a class of gene not accessible to phenotype driven screens. 
1.2.1. Entrapment In A Variety Of Model Systems 
The principles of entrapment technology have been applied to many different 
model systems. The first entrapment vectors were used in Escherichia coli and were 
based on the bacteriophage Mu which contained ampicillin and lacZ as reporter genes. 
Random integration of the promoter trap vectors into the bacterial genome tagged 
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Enhancer trapping 













reporter 	fusion protein 
Figure 1.1 Mode of action of the two basic entrapment vector systems 
Enhancer trapping 
Enhancer trap vectors consist of a reporter gene under the control of a minimal 
promoter. Insertion adjacent to endogenous enhancer elements drives expression of the 
reporter gene. 
Promoter trapping 
Promoter trap vectors essentially consist of a reporter gene. Insertion into endogenous 
transcription units is necessary for reporter activity. Reporter expression is driven by 
the endogenous promoter and enhancer elements and therefore mimics endogenous gene 
expression. 
E, enhancer elements; P, promoter element; pA, polyadenylation signal. 
transcriptional promoters for functional and mutational studies (Casabadan et at., 1979; 
Bellafato et at., 1984). Similar screens have been carried out using mouse embyronic 
fibroblasts and embryonic carcinoma (EC) cells using both enhancer and promoter traps 
to identify transcriptionally active loci in culture (Bhat et at., 1988; Brenner et at., 1989; 
Von Meichner et at., 1990). Functional studies on cell lines from these screens have 
isolated genomic regions modulating reporter expression in response to differentiation 
(Bhat et al., 1988) or cell cycle arrest (Brenner et at., 1989). 
The application of entrapment technology to developmental biology has been 
most successful in the fruit fly Drosophila melanogaster, with limited studies having 
been undertaken in the nematode Caenorhabditis elegans (Hope, 1991) and in slime 
moulds (Fey and Cox, 1997). In Drosophila, large scale screens have been carried out 
to identify and mutate genetic elements conferring temporally or spatially restricted 
expression patterns on the reporter gene during embryogenesis (Bellen et at., 1990). 
The rationale that tissue restricted gene expression is a prerequisite of embryonic 
patterning makes the reporter expression conferred by endogenous elements an 
important factor in assessing potential gene function. Enhancer traps are based on 
element transposons which lack transposase activity but contain the lacZ reporter gene 
that encodes for f3-galactosidase (P-gal), controlled by a ubiquitous minimal promoter. 
3-gal activity provides an excellent reporter for these studies as it can be easily 
monitored in the embryo using the chromogenic substrate X-gal (O'Kane and Gehring, 
1987). The transposons randomly integrate into the fly genome when transposase is 
provided in trans. Heritable, potentially mutagenic insertions are generated where 13-
gal activity in the embryo is regulated by adjacent regulatory elements (OKane and 
Gehring, 1987). In parallel large scale studies, 60-65% of insertional lines generated 
showed restricted reporter expression during development in an extensive range of 
tissues with 10-20% of transposon insertions being lethal when bred to homozygosity 
(Bier et al., 1989; Bellen et al., 1989). In a sub-set of these lines examined, the reporter 
expression correlated exactly with that of the endogenous transcripts found adjacent to 
the insertion sites (Wilson et at., 1989). Enhancer trapping therefore provides a 
powerful tool for identifying and mutating genes involved in Drosophila development. 
In addition, these lines provide a variety of cell-type and position dependent markers 
with which to further study Drosophila embryogenesis. Thousands of mutagenic P-
element insertions are maintained within the Berkeley Drosophila Genome Project 
(BDGP) as a means of linking the large amount of gene sequence data being produced 
to gene function (Spradling et al., 1995). 
1.2.2. Entrapment In The Mouse 
The production of transgenic animals via the pronuclear injection of exogenous 
DNA into fetilised mouse eggs was used to assess the feasibility of using entrapment 
technology in vivo. Injection of an enhancer trap vector with lacZ driven by the Herpes 
.imp1ex Virus Thymidine Kinase promoter (HSV-tk) produced 52 embryos with an 
integrated transgene of which 11 gave a range of distinct reporter expression patterns. 
In addition, from 20 transgenic lines containing this construct, 5 showed unique, 
heritable reporter expression profiles (Allen et al., 1988). However, the laborious 
nature of producing transgenic mice with enhancer trap events (only 11 embryos from 
200 pronuclear injections showed reporter expression (Allen et al., 1988)) coupled with 
the problems associated with identifying adjacent DNA from transgenic insertion sites 
(Gridley et al., 1987) makes it impractical to use this as a routine entrapment system in 
the mouse. 
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1.3. ENTRAPMENT IN ES CELLS 
The viability of routinely performing developmental entrapment screens in the 
mouse improved with the development of embryonic stem (ES) cell technology. ES 
cells are cultured from the inner cell mass of blastocysts stage embryos (Martin, 1981; 
Evans and Kaufman, 1981). In culture, ES cells are amenable to a range of genetic 
manipulations and can be reintroduced into intact blastocysts where they can contribute 
to all cell lineages in chimaeric embryos including the gem-dine (Bradley et al., 1984; 
Robertson et al., 1986; Thomson et al., 1989). Therefore, ES cells allow for the genetic 
alteration of the mouse genome in culture and the consequences can be examined in 
vivo. Entrapment constructs can be introduced into the mouse genome using ES cells 
and rare integration events into transcriptionally active loci can be screened in vitro 
(Gossler et al., 1989; Friedrich and Soriano, 1991). ES cell lines with selected 
entrapment events can be produced in high numbers and subsequently used to produce 
chimaeric and eventually transgenic animals in which reporter expression is monitored 
to identify loci which are transcriptionally active during embryogenesis (Gossler et al., 
1989; Friedrich and Soriano, 1991). 
1.3.1. Enhancer Trapping 
The principles underlying enhancer trapping in other systems have been applied 
successfully in ES cells (Gossler et al., 1989; Korn et al., 1992). The vector p3LSN 
consisting of a minimal hsp68 promoter driving lacZ and the HSV-tk promoter driving 
expression of the neomycin phosphotransferase gene (neoR)  was electroporated into ES 
cells and transformed cell lines selected for using G418. 3-gal activity was observed in 
30/66 cell lines, either in undifferentiated ES cells or in chimaeric embryos derived from 
individual cell lines. This indicates that around 45% of enhancer trap integrations are 
accessing cellular enhancers. Each cell line showing reporter expression in chimaeric 
embryos 22/66 (33%) gave a unique LacZ expression profile between 7.5 d.p.c. and 
10.5 d.p.c. in a range of regional and tissue specific expression patterns (Gossler et al., 
1989; Korn et al., 1992). 
Enhancer trapping therefore appears an efficient means of accessing cellular 
enhancers active during embryogenesis. Further analysis of the enhancer trap lines, 
however, has highlighted limitations in using enhancer trapping as a routine 
developmental screen in the mouse. Firstly, the mouse genome is not as well 
characterised as Drosophila, making it more difficult to clone the gene associated with 
the enhancer activity. As a result, endogenous transcripts have been isolated from the 
vector integration sites from only three enhancer trap lines to date (Korn et al., 1992). 
Secondly, two of these lines showed more widespread expression of the endogenous 
transcript when compared to reporter gene activity. This suggests that the vector is 
incompletely accessing the regulatory elements necessary for the correct expression of 
the endogenous gene (Soininen et al., 1992; Neuhaus et al., 1994). Finally, no 
phenotype was observed when two enhancer trap integrations were bred to 
homozygosity (Korn et al., 1992). Although only two lines were analysed in this 
study, one would expect relatively few enhancer trap integrations to be mutagenic 
because entrapment is not dependent on insertion directly into the endogenous gene. 
1.3.2. Promoter Trapping 
The ability to screen large numbers of ES cells allows for the identification of 
relatively rare entrapment events. This has made possible the use of promoter trap 
constructs to overcome the problems inherent in the enhancer trapping strategy. 
Promoter trap vectors can be divided into three groups; exon, gene, and polyA trap 
vectors. Exon trap constructs contain a reporter gene without any promoter elements. 
Reporter activity is dependent on insertion into the exon of an endogenous gene in the 
correct orientation and reading frame (Figure 1.2A; von Melcher et al., 1992; Friedrich 
and Soriano, 1991; Macleod et al., 1991). Gene trap vectors differ from exon traps in 
that they contain a consensus splice acceptor site upstream of the reporter gene. 
Exon trapping 




> fusion transcript 
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Gene trapping 
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Figure 1.2: Promoter trapping 
Exon trapping 
Exon trap vectors consist only of a reporter gene. Reporter activity is dependent on 
vector insertion into the exon of a transcription unit in the correct orientation and 
reading frame. If the reporter has its own translational start codon, vector insertions 
into untranslated exons can be recovered. 
Gene trapping 
Gene trap vectors contain a splice acceptor sequence upstream of the reporter gene. 
Vector insertion into the intron of a transcription unit in the correct orientation will 
result in splicing between the reporter gene and the endogenous upstream exon. 
Translation of this fusion transcript in the correct reading frame will produce reporter 
activity. Vector insertions splicing to untranslated exons will be detected if the reporter 
gene contains its own start codon. 
Insertion of the vector, in the correct orientation, into the intron of the endogenous gene 
will induce splicing from the endogenous upstream splice donor to the vector splice 
acceptor (Figure 1.2B; Gossler et al., 1989; Friedrich and Soriano, 1991). An active 
reporter gene will be produced if the reporter is in-frame with the endogenous gene 
(Skarnes et al., 1992). PolyA trap vectors consist of a reporter gene lacking a 
polyadenylation (polyA) signal. Insertion of the vector upstream of an endogenous 
polyA signal produces a functional reporter transcript (Niwa et al., 1993; Figure 1.3; 
Section 1.3.2.4(v)). 
The fact that a promoter trap vector has to integrate into a transcription unit and 
the subsequent production of a fusion transcript provides three potential benefits for its 
use in entrapment screens over enhancer traps. Firstly, identification of the endogenous 
gene should be more straightforward. Secondly, as the reporter is expressed directly 
from the endogenous promoter, expression should accurately reflect endogenous gene 
expression. Finally, the integration of the vector is more likely to be mutagenic. 
The work reviewed in the next section provides evidence for the above predictions, 
especially in the context of gene trapping which has been the prevalent system used for 
ES cell entrapment of developmentally important molecules. 
1.3.2.1. Entrapment Aids Gene Identification 
The correct insertion of both exon and gene trap vectors induces the production 
of a transcript consisting of upstream endogenous sequence fused to the reporter gene 
(Skarnes et al., 1992; Figure 1.2B). 	This fusion transcript should make the 
identification of the endogenous gene relatively straightforward using PCR based 
cloning strategies such as 5'Rapid Amplification of cDNA Ends-PCR (5'RACE-PCR) 
using primers complementary to vector sequences (Frohman et al., 1988; Skarnes et 
al., 1992). Refinements to the 5'RACE-PCR protocol by direct sequencing (Townley 
et al., 1997) has greatly enhanced gene identification and is amenable to automation 
(Zambrowicz et al., 1998). Endogenous transcripts have also been isolated from 
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cellular sequences flanking the vector insertion site using inverse PCR, ligation 
mediated PCR and plasmid rescue protocols (von Meicher et at., 1990,1992; Hicks et 
at., 1997; Brennan, 1997). The relative ease of gene identification using these 
techniques has lead to the large scale screening of entrapment events based solely on 
trapped gene sequence (Zambrowicz et at., 1998; Chowdhury et al., 1997; see Section 
1.3.2.5(i)). From these studies and from the individual cell lines characterised (Table 
1. 1), genes involved in functionally diverse processes are proving susceptible to 
entrapment (Chowdhuiy et at., 1997). 
1.3.2.2. Reporter Activity Reflects Endogenous Gene Expression 
Entrapment screens based on reporter expression during embryogenesis rely on 
reporter expression correlating well with that of the cellular transcript. From the gene 
trap lines analysed to date, reporter activity and endogenous transcript expression has 
been shown to be comparable in most instances (Table 1.1). Increasingly, however, 
examples where this is not the case are being uncovered (Voss et at., 1998a; Deng and 
Behringer, 1995; Schuster-Gossler et at., 1998). The transcription factor BTF-3 is 
expressed ubiquitously throughout the embryo and in the adult. However, a gene trap 
integration into this gene shows restricted 3-gal activity in the heart, limbs and brain 
(Deng and Behringer, 1995; Table 1.1). Insertion into Gt12 provides another example 
where expression of the endogenous transcript is more widespread than reporter activity 
(Schuster-Gossler et at., 1994; Table 1.1). Possible explanations for this are vector 
integrations either into exons alternatively spliced out in certain tissues or affecting 
enhancer elements altering the transcriptional control of the endogenous gene (Voss et 
al., 1998a; Deng and Behringer, 1995). 
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Table 1.1: Characterised Entrapment Events 




Phenotype (defect) Reference 
ROSA-geo 	TEF-1 widespread ND yes lethal-Eli (heart) Chen etal., 1994b 
BTF-3 restricted (heart, limbs, brain) no nd lethal-E6.5 Deng and Behringer, 1995 
ROSA26 ubiquitous ND yes possibly Zambrowicz etal., 1997 
a-enolase restricted ND ND lethal -.E6.5 Couldrey et al., 1998 
dystrophin 
U3-geo 	ECK 
restricted (somites, limbs) yes no (h) muscle degeneration Wertz and Fuchtbauer, 1998 
restricted (ps, node, hindbrain) yes yes none Chen et al., 1996 
ArMT restricted (brain, neural tube) ND ND embryonic lethal Scherer et al., 1996 
U3neo 	fugl widespread NA yes lethal-E6.0 DeGregori et al., 1994 
U3tkneo XVffl-1 NA NA yes viable Muth et al., 1998 
pGT4.5 	Gt2 widespread ND ND viable Skarnes etal., 1992 
Gt4-1 restricted (neural) ND yes perinatal lethal 
Gt4-2 widespread yes yes growth retarded! lethal 
GOO restricted (otocyst, by, gut, bladder) yes yes ND 
cordon bleu restricted (node, fp, notochord, gut, liver) yes no (r) viable Gasca etal., 1995 
PTI-ATG 	1.23 restricted (dorsal midbrain) ND ND viable Forrester et al., 1996 
1.114 restricted (liver) ND ND viable 
1.163 restricted (ys, somites, spinal cord) ND ND viable 
R. 140 restricted (lb) ND ND embryonic lethal 
aquarius restricted (lb, somites, branchial arches) yes no viable Sam etal., 1998 
TFEB restricted (ys, heart, liver) yes no viable McClive etal., 1998 
R.108 resricted (heart, neural tube, lb) ND ND viable 
R.124 restricted (heart) ND ND postnatal lethal (heart) 
pGT1 .8-geo 	E-catenin restricted (epithelia) yes yes lethal.-E3.5-4.0 (trophoblast) Tones et al., 1997 
MAP-4 widespread yes no viable Voss etal., 1998b 
PTP-BL restricted (epithelia, PNS) yes ND viable Thomas etal., 1998b 
SA-IRESf3-geo 	bodenin restricted (head, heart) yes § no viable Faisst and Gruss, 1998 
paddy restricted (lb) yes § ND viable Pires-DaSilva and Gruss, 1998 
pGT1.8TM 	LAR widepread yes yes viable Skarnes et al., 1995 
PTPic restricted (endoderm, pm, somites) yes yes viable 11 
netrin restricted (spinal cord, fp, somites) yes no (h) postnatal lethal Serafini etal., 1996 
HS2ST restricted yes yes perinatal lethal (renal agenesis) Bullock etal., 1998 
TV2 	 jumonji restricted (mid-hindbrain, cerebellum) ND yes lethal-E15.5 (neural tube) Yoshida etal., 1995 
pGTi Gt12 restricted (myogenic lineage) no no (h) dwarfism Schuster-Gossler etal., 1996+1998 
pPAT 	PAT12 none no yes viable Yoshida etal., 1995 
SEE ALSO: Stoykova etal. (1998) 
ND. analysis not done. NA. not applicable. 
*, does the expression of the reporter gene accurately reflect the expression pattern of the endogenous gene? 
**, judged by the absence of endogenous gene sequence 3 of vector insertion site in animals homozygous for the entrapment event. 
§, very limited examination of reporter versus endogenous transcript expression; r, reduced level of endogenous transcript; h, hypomorphic allele 
ps, primitive streak; by, blood vessels; fp. floor plate; ys, yolk sac; lb, limb bud; 
1.3.2.3. Vector Insertion Is Mutagenic 
The mutagenicity of exon and gene trap constructs relies on the production of a 
fusion transcript terminating at the reporter polyA signal effectively ablating the cellular 
transcript downstream of the insertion site (Figure 1.2). 
Data from exon and gene trap screens carried out to date indicates that vector 
integration produces recessive lethal phenotypes in 39/104 (37%) of lines examined 
(Camus et al., 1996; Skarnes ci' al., 1992; Hicks et al., 1997, Friedrich and Soriano, 
1991; Forrester et al., 1996; Stoykova et al., 1998; Voss et al., 1998a) correlating well 
with the percentage of phenotypically lethal loci identified during random mutational 
screens in other model systems (Miklos and Rubin, 1996). 
More directly, the detailed characterisation of promoter trap lines confirms that 
in the majority of cases, vector integration disrupts the endogenous transcript 3' of the 
vector integration site (Table 1.1). In four lines vector integration has resulted in 
reduced but detectable levels of endogenous transcript in animals homozygous for the 
promoter trap integration. Gene trap integrations into netrin (Serafini et al., 1996), 
dystrophin (Wertz and Fuchtbauer, 1998) and Gt12 (Schuster-Gossler et al., 1998) 
result in hypomorphic alleles of these genes, whereas insertion into the fourth gene, 
cordon bleu (Gasca et al., 1995) reveals no obvious phenotype (Table l.1). It remains 
to be seen whether a lack of phenotype in the last line is due to sufficient production of 
endogenous message or redundant gene function. Most interestingly, in a further four 
gene trap lines, TFEB (McClive et al.,1998), bodenin (Faisst and Gruss, 1998), 
aquarius (Sam et al., 1998), and MAP-4 (Voss et al., 1998b) endogenous expression 
levels approaching wild type are observed in animals homozygous for the gene trap 
integration. These lines are thought to reflect instances where mRNA processing 
splices around the integrated vector due to inefficient use of the vector polyA signal 
(Sam et al., 1998; Voss et al., 1998b). 
Promoter trapping in ES cells therefore provides a practical, single route to 
identify and mutate developmentally significant molecules in the mouse (Table 1.1). 
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Insertional mutants have been produced, affecting a range of developmental processes 
including heart formation (Chen et at., 1994b), neural tube closure (Takeuchi et al., 
1995) and axon guidance (Serafini et at., 1996). Promoter trap integrations are also 
producing excellent tissue specific and cell lineage markers with which to further study 
development. Markers specific for cardiac tissue (McClive et at., 1998) and neuronal 
cells (Stoykova et at., 1998) are just two examples of studies producing potentially 
useful cell lines. One particularly well characterised gene trap line, ROSA-geo 26, 
displays reporter activity in all cell types examined making it an excellent marker for 
chimaera experiments such as haematopoetic cell transplantation studies (Zambrowicz et 
at., 1997). 
1.3.2.4. Promoter Trapping Technology 
The data outlined above, highlighting the potential of promoter trapping, has 
been achieved using widely varying entrapment technologies. This next section 
reviews the different vector designs and vector delivery systems which have been 
developed to increase the efficiency of, and eliminate any biases in, promoter trapping 
in ES cells. 
iJ Vector design 
The application of promoter trap technology to the mouse, both in vitro or in 
vivo, has spawned many variations on the basic promoter trap structure. The inclusion 
of the translational start site for the reporter gene allows for the recovery of promoter 
trap insertions into untranslated regions of genes. Subsequently, an improvement in the 
efficiency of these promoter trap vectors to access true entrapment events is observed, 
that is, an increase in the proportion of neomycin expressing (G418 resistant) 
transformants displaying 3-gal activity (Brenner et al., 1989; Hill and Wurst, 1993). 
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In the production of gene trap vectors, the inclusion of the splice acceptor site 
upstream of the lacZ gene was shown to increase gene trap efficiency when compared 
directly to exon trap vectors (Gossler et al., 1989; Friedrich and Soriano, 1991). This 
greater efficiency reflects the larger genomic target that introns provide for vector 
insertions compared to the smaller potential sites available to exon trap vectors 
(Friedrich and Soriano, 1991). It is of interest to note that gene trap vectors inserting 
into exons in frame with the reporter gene will also produce a functional reporter protein 
using cryptic splice donor sites within the vector intron sequence (McClive et al., 1998; 
Brennan, 1997). 
A feature in several gene trap vectors is the inclusion of a viral internal 
ribosomal entry site (IRES) between the splice acceptor and reporter gene (Chowdhury 
et al., 1997; Takeuchi et al., 1995; Zambrowicz et al., 1998). The presence of the IRES 
is predicted to produce the independent translation of the endogenous gene and the 
reporter gene from a single dicistronic message (Mountford and Smith, 1995). 
Chowdhury et al. (1997) showed that the inclusion of an IRES increased both the 
number of G418 resistant transformants and proportion of these transformants with f3-
gal activity. In using an IRES, reporter expression will be independent of the 
endogenous reading frame into which the vector has inserted. Furthermore, any 
potential steric hinderance of reporter or selection activity by endogenous N-terminal 
protein fusion should be eliminated. The design of the secretory trap vector pGT1.8TM 
features the CD4 transmembrane domain between the splice acceptor and reporter gene, 
preselecting for the entrapment of genes producing secreted or membrane bound 
proteins (Skarnes et al., 1995). This vector is reviewed as a preselection strategy in 
Section 1.3.2.5(u). 
ii! Reporter gene 
Several different reporter genes have been used for trapping in ES cells. The 
drug resistance genes histidine dehydrogenase and neomycin phosphotransferase have 
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been used, providing excellent selection in vitro (von Meicher et al., 1990, 1992). 
However, large N-terminal fusions may compromise the activity of these reporters 
(Macleod et al., 1991) and activity cannot be assayed for, temporally or spatially. 
Accordingly, these reporters, in particular neomycin, have been used in more general 
entrapment screens (von Meicher et al., 1992; Hicks et al., 1997). 
In gene trap screens designed to identify developmentally regulated genes, a 
readily assayable reporter is a prerequisite. Consequently, promoter driven neomycin 
expression has been used as selection for transformants with the subsequent selection 
of entrapment events relying on the expression of the lacZ reporter gene (Gossler et al., 
1989; Friedrich and Soriano, 1991). As alluded to earlier, 3-gal activity is easily 
assayed for in ES cells as well as embryos and can tolerate large N-terminal fusions 
(Friedrich and Soriano, 1991; Casabadan, 1980). Nevertheless, in having promoter 
driven selection independent of reporter expression it is necessary to screen out 
integrations outwith transcription units. 
The 13-geo reporter gene, consisting of neomycin fused to the 3' end of 
galactosidase, was developed to eliminate this allowing for the direct selection of 
promoter trap events in ES cells (Friedrich and Soriano, 1991). Theoretically, all 
neomycin expressing clones will have f3-galactosidase activity. However, in practice, 
the greater sensitivity of G418 selection results in entrapment events into genes whose 
expression level is sufficient to confer drug resistance but below the threshold 
necessary for X-gal staining (Friedrich and Soriano, 1992; Skarnes et al.,1995). 
Depending on which allele of neomycin is used (Yenofsky et al., 1990), 95% of gene 
trap integrations show reporter activity using the hypoactive allele (Friedrich and 
Soriano, 1992) with 60% and 30% observed using the wild type allele in the vectors 
pGT1.83-geo (Skarnes et al.,1995) and pSA3-geo (Chowdhury et al., 1997) 
respectively. In using the hypoactive allele, a preselection is observed for cell lines 
with high levels of n-gal activity mirroring the high level of neomycin expression 
needed for G418 resistance. By contrast, use of the wild type allele resulted in more 
varied levels of 3-gal activity which highlights the greater difference in sensitivity 
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between f3-gal activity and wild type neomycin (Skarnes et al., 1995). This allows for 
the trapping of genes expressed at lower levels and increases the potential number of 
genes accessible to entrapment when compared to the hypoactive allele (Skarnes et al., 
1995). 
Alkaline phophatase (AP) has also been used as a reporter gene in exon and 
gene trap vectors as an alternative to 3-gal activity for the monitoring of expression 
during development (Xiong et al., 1998). The efficiency of entrapment using the AP 
reporter was comparable to using the lacZ reporter gene. Moreover, AP activity could 
be monitored during in vitro differentiation prototcols and in vivo providing excellent 
spatio-temporal reporting of endogenous gene expression (Xiong et al., 1998). 
It is of interest to note recent work in the development of green flourescent 
protein (GFP) as a reporter gene in mammalian systems. GFP has been used 
successfully for entrapment protocols in slime moulds (Fey and Cox, 1997) and 
benefits over other reporters in that its expression can be monitored non-destructively in 
living cells (Heim et al., 1994). In the mouse, GFP is efficiently detected in vivo and 
in vitro and can be transmitted through the germline (Hadjantonakis et al., 1998). 
Moreover, the detection of GFP-Hox gene fusions during mouse embryogenesis has 
recently been reported by Godwin et al. (1998). These studies provide the foundation 
for the application of GFP technology to produce more refined and powerful 
entrapment screens in the mouse. 
iii! Vector delivery 
Entrapment vectors have been introduced into ES cells either via electroporation 
or retroviral infection (Gossler et al., 1989; Friedrich and Soriano, 1991; von Meicher 
et al., 1992). The use of either technique can have a direct bearing on the resulting 
vector integrations. 
Electroporation of entrapment vectors is an attractive procedure due to its 
relative simplicity, the relative inefficiency of which can be overcome by using larger 
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numbers of ES cells (Skarnes et al., 1992). However, the electroporation of 
entrapment vectors has been shown to induce insertional artefacts (Friedrich and 
Soriano, 1991; Niwa et al., 1993; Takeuchi et al., 1995; Skarnes et al., 1992). The 
deletion of extreme sequences from plasmid entrapment vectors has been observed in a 
number of lines (Niwa etal., 1993; Takeuchi etal., 1995; Torres et al., 1997). Despite 
this, vector function is generally uncompromised as the deletion affects non-essential 
external sequences. 
From the limited number of plasmid vector integration sites examined, two 
integrations induced uncharacterised rearrangements in the cellular DNA (Niwa et al., 
1993) while another three insertions caused no obvious effects (Soininen et al., 1992; 
Macleod et al., 1991). How common these rearrangements are is unknown but 
rearrangements perturbing the transcriptional control of the endogenous gene are 
relatively rare because in the majority of plasmid integrations analysed to date reporter 
expression correlates well with the endogenous gene (Table 1.1). 
Another characteristic of electroporation is the integration of mutiple copies of 
the plasmid vector (Friedrich and Soriano, 1991; Forrester etal., 1996; Takeuchi et al., 
1995; Skarnes et al., 1992). The majority of multiple vector insertions characterised 
appear to be in concatemeric arrays ranging from 2-5 vector copies at a single 
chromosomal site (Friedrich and Soriano, 1991; Skarnes et al., 1992; Takeuchi et al., 
1995). However, backcrossing mice from three independently derived gene trap lines 
segregated individual vector copies suggesting that vectors had inserted at 2 distinct 
chromosomal loci in these lines (Forrester et al., 1996, Voss et al., 1998a). As with 
deletion of vector sequences, integration of multiple vectors is predicted not to interfere 
with entrapment function as only the vector at the extreme of the tandem repeat should 
be active. Indeed in the majority of cases examined to date single fusion transcripts are 
produced, the vector is mutagenic and reporter activity mimics the endogenous gene 
(Forrester etal., 1996; Takeuchi et al., 1995; Skames etal., 1992). Nevertheless, it is 
noteworthy that reporter expression level from concatemeric transgene arrays is 
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negatively affected by an increased number of transgene copies integrated (Garrick et 
al., 1998; Wolffe, 1998). 
Retroviral entrapment vectors typically contain the reporter gene within the body 
of the virus if it has a splice acceptor sequence upstream (Friedrich and Soriano, 1991; 
Brenner et al., 1989) or within the U3 region of the LTR if the reporter lacks a splice 
acceptor (von Meicher et al., 1992). The mechanism of retroviral infection of ES cells is 
very precise so that at low multiplicities of infection a single proviral entrapment vector 
integrates into the genome while the structure of the vector and cellular DNA is 
preserved (von Meicher et al., 1992; Chen et al., 1996; Scherer et al., 1996). 
Retroviruses and their entrapment derivatives have preferential intragenic and 
possibly intergenic insertion sites (Jaenisch, 1988). Retroviruses have been shown to 
integrate close to DNaseI hypersensitive sites (Vijaya et al., 1986, Rhodewold et al., 
1987) and transcriptionally active regions of the genome (Mooslehner et al., 1990; 
Scherdin et al., 1990). Moreover, retroviral entrapment vectors preferentially integrate 
close to the 5' end of transcription units as judged by the length of the resulting fusion 
transcript and promoter activity associated with genomic regions immediately 5' of the 
insertion site (von Melcher et al., 1990; Friedrich and Soriano, 1991). Consequently, 
5' retroviral insertions are more likely to interfere with cis-acting transcriptional control 
elements as observed in the transgenic retroviral line Movl3 (Hartung et al., 1986; 
Barker etal., 1991). As alluded to previously, this may be the case with the retroviral 
gene trap insertion into the transcription factor BTF-3 where reporter expression does 
not correlate with the endogenous transcript (Deng and Behringer, 1995). 
Interestingly, a study of integrations into known genes suggests that no such bias 
occurs with plasmid vectors (Chowdhury et al., 1997). 
On a genome wide scale, studies on avian retroviruses reveals that insertions 
occur at specific genomic sites at a very high frequency (Shih et al., 1988; Withers-
Ward et al., 1994). However, this doesn't exclude other sites from insertion as most 
regions of the genome are predicted to be accessible to retroviral integration at varying 
frequencies (Withers-Ward et al., 1994). 
iv/ Entrapment is a random event 
An important issue raised by retroviral integration is whether there are any 
potential biases in the insertion of entrapment vectors. As larger, saturation level 
entrapment screens are undertaken, it is important to know the number of gene loci 
accessible to entrapment and whether certain genes are resistant or more susceptible to 
entrapment. 
In Drosophila , an entrapment screen designed to isolate nervous system 
phenotypes, identified repeated P-element insertions within individual genes (Bier et 
al., 1989). Moreover, certain chromosomal regions appear to be resistant to P-element 
insertion (Smith et al., 1993). 
In ES cells, the analysis of promoter trap insertions into 400 loci revealed 3 
insertions each into L29 and a-NAC (Hicks et al., 1997) and from 6 secretory trap 
lines, integration had occurred into two distinct sites of the LAR gene (Skarnes et al., 
1995). Moreover, entrapment events have been repeated by different vectors. Jumonji 
was initially identified by Takeuchi et al. (1995) using the TV2 gene trap vector and has 
since been trapped using the retroviral ROSA3-geo and plasmid pGT1.8TM and 
pGT1.83geo gene trap vectors (Baker et al., 1997; Voss et al., 1998a; W. C. Skarnes, 
personal communication). Similarly, insertions into both enolase and R-PTP1< have 
been reported, again by different vectors (Chowdhury et al., 1997; Skarnes et al., 
1995; Couldrey et al., 1998). Even with the relatively small number of integrations 
analysed to date it is apparent that certain genes are more frequently identified during 
entrapment. The precise nature of this bias in unknown but may reflect a number of 
different factors. Genes comprising of large intronic regions are predicted to be more 
accessible to gene trap vectors (Skarnes et al., 1995). A more open chromatin structure 
associated with transcriptionally active loci is known to influence retroviral integration 
(Jaenisch, 1988) and could potentially affect plasmid vector insertion. It could also 
reflect the high expression level of the genes facilitating their identification by different 
entrapment protocols. Despite this, a small percentage of over-represented loci is not 
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predicted to interfere significantly with the number of total loci accessible to entrapment 
(Evans, 1998). 
vi PoIyA trapping 
A significant limitation of exon and gene trapping is that identification of true 
entrapment events is reliant on reporter activity which in turn is reliant on expression of 
the trapped endogenous gene in ES cells. Given that certain developmentally important 
genes are not expressed in ES cells, for example MyoD and Myf5 (Rohwedel et al., 
1994), exon and gene trapping will fail to access such genes. PolyA trap vectors 
overcome these limitations. The first polyA trap vectors to be developed contained a 
phosphoglycerate kinase (PGK) promoter-neomycin cassette lacking a polyA addition 
signal (Niwa et al., 1993). In ES cells, promoter driven neomycin is dependent on a 
downstream endogenous polyA signal to be stably expressed and is therefore 
independent of the expression status of the endogenous gene. In addition, a lacZ 
reporter fused to a consensus splice acceptor site was located upstream of PGK-
neomycin allowing for endogenous gene expression to be monitored (Niwa et al., 
1993). However, inefficient vector splicing caused by deletions of vector sequences 
resulted in the preference for vector integrations into the 5' end of genes. The 
subsequent difficulties in isolating definitive polyA addition signals using 3' RACE-
PCR made it difficult to appraise the effectiveness of this polyA trap vector (Niwa et 
al., 1993). 
A more robust polyA trap vector (pPAT) was developed by Yoshida et al. 
(1995). This vector has two modifications; intronic sequence upstream of the splice 
acceptor site to insulate the splicing activity from vector deletions and a splice donor 
sequence downstream of the neomycin gene for more efficient polyA trapping (Figure 
1.3; Yoshida et al., 1995). Using pPAT, 49 G418 resistant lines (polyA trap events) 
were produced of which 12 (25%) gave amplification products after 3'RACE, 
substantiating that vector insertions are more common towards the 5' end of genes 
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Figure1.3: PolyA trapping 
PolyA trap vectors contains a promoter driven selectable marker (neo) lacking 
a polyadenylation signal downstream of a reporter gene. The recovery of 
vector insertion into a transcription unit is dependent on the selectable marker 
acquiring an endogenous polyA signal via the splice donor site (SD). The 
upstream reporter gene acts as a gene trap and allows for the monitoring of 
endogenous gene expression. 
SA, splice acceptor; pA, polyadenylation signal 
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which are less likely to be amplified using 3'RACE. From 6 of these amplifiable cell 
lines, 5 contained polyA addition signals, 4 of which were from novel transcripts. 
Furthermore, -galactosidase activity was observed in chimaeric embryos derived from 
3 of the 4 novel sequence producing lines. The vector was also shown to be 
mutagenic, disrupting the endogenous transcript of a single line (Yoshida et al., 1995). 
Recently, polyA trapping in ES cells has been used to produce a library of 
sequence tags from 2000 genes potentially mutated by vector insertion (Zambrowiscz et 
al., 1998; see Section 1.3.2.5(i)). PolyA trapping therefore provides an efficient 
method of identifying and mutating genes independently of expression state in ES cells. 
vu Gene trapping and site specific recombination 
A novel promoter trap strategy involving site-specific recombination was 
initially developed using an IL-3 dependent haematopoietic cell line to identify genes 
activated during programmed cell death (Russ et al., 1996). A similar strategy has 
since been applied to identify transcripts transiently induced during development 
(Thorey et al., 1998). A stable ES cell line was produced containing a reporter cassette 
comprising a PGK promoter driving a loxP flanked neomycin cassette upstream of a 
lacZ reporter (Figure 1.4). A novel gene trap vector comprising Cre recombinase was 
introduced into this cell line. Insertion of the gene trap vector into an active gene 
produces Cre activity, excising neomycin from the reporter cassette, resulting in a 
permanent switch to LacZ expression (Figure 1.4). Using this strategy a total of 5 gene 
trap cell lines not expressing Cre (neomycin expressing) were differentiated in vitro, 
with two of these lines subsequently used to produce transgenic mice. In both 
differentiating ES cells and transgenic embryos, [3-gal activity was observed indicating 
that initial neomycin expression had switched to lacZ via Cre recombination activated 
from expressed cellular transcripts. Confirming the ability of this system to detect 
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Figure 1.4: Gene trapping using site specific recombination 
The Cre recombinase gene is introduced into a transgenic ES cell line containing a 
reporter cassette with promoter driven neomycin expression upstream of a silent lacZ 
gene. Insertion of the Cre gene into a endogenous transcription unit has no effect on 
neomycin expression when the endogenous gene is inactive. Activation of the 
endogenous gene produces Cre under the control of the promoter of the endogenous 
gene. Cre mediated excision of the neomycin gene via flanking loxP sites places the 
lacZ gene under the control of the neomycin promoter. Expression of lacZ is 
maintained even if the endogenous locus stops expressing Cre. 
(Adapted from Thorey et al., 1998) 
were shown to be only transiently induced upon ES cell differentiation (Thorey et al., 
1998). 
Consequently, conditional entrapment provides a complementary system to 
promoter trapping, as entrapment using this strategy does not rely on expression of the 
trapped gene in ES cells. Indeed genes expressed in ES cells are selected against. 
Furthermore, the permanent switch in reporter expression by Cre activation can be 
induced by genes only transiently expressed during development although the spatial 
and temporal expression of individual genes will be impossible to monitor. 
1.3.2.5. Prescreening Gene Trap Events 
With potentially every gene in mice accessible to entrapment by existing vectors 
(Hicks et al., 1997; Gossler et al., 1989; Friedrich and Soriano, 1991, von Melcher et 
al., 1992), the criteria by which cell lines are selected for further study depends on the 
individual investigators interests. Using ES cells, however, allows for the pre-selection 
of cell lines before attempting germ line transmission of the integration for phenotype 
analysis. This section examines techniques which have been used to pre-screen gene 
trap cell lines. Comparative analysis of endogenous gene sequence, biases introduced 
by vector design and monitoring reporter gene expression in vivo or during in vitro 
differentiation protocols have been used to pre-select integration events for further 
analysis. 
iJ Sequence 
As mentioned previously in Section 1.3.2.1, improvements in identifying 
endogenous gene sequence have made possible the large scale screening of integration 
events. Comparative sequence analysis to cDNA databases of sequences from three 
such screens is shown in Table 1.2. Promoter proximal sequence tags (PST's) 
represent upstream genomic sequences from retroviral vector insertion sites and, as 
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Table 1.2: Sequence data from 3 large scale entrapment screens 
VECTOR TARGET! 
SEQUENCE DATA  
TOTAL HOMOLOGY (%total) 
known EST's novel 
Plasmid gene-trap genes 
pSAl3geo/pSAIRES3geo (1) exonl5'RACE-PCR 56 17(30%)i 11(20%) 28(50%) 
pGT1.8TM (2) exon/Direct Sequence 57 29(51 %)Y 11(19%) 17(30%) 
Retroviral Promoter Trap 
PST*/plasmid rescue 400 42(11%) 2 1(5%) 337(84%) U3neo SVJ (3) 
Chowdhury et al., 1997 
Townley et al., 1997 
Hicks et al., 1997 
*PST= Promoter Proximal sequence Tag 
- The larger proportion of known genes identified using pGTI .8TM reflects the limited type of 
genes (secretory/membrane spanning) this vector can access (Skarnes et al., 1995). 
such, potentially include promoter or intronic sequences because a retroviral promoter 
trap event is not dependent on insertion into an exon (Hicks et al., 1997; von Meicher et 
al., 1992). RACE-PCR based techniques identify exon sequences only and therefore 
gives a more accurate prediction of the proportion of known genes, ESTs and novel 
genes accessed in these screens (Chowdhury et al., 1997). Pre-screening using gene 
sequence allows for the selection of integrations into genes with, for example, structural 
homology to important developmental genes or candidate disease genes. It also allows 
for the exclusion of previously characterised genes from further study. 
Perhaps more significantly, given the massive amounts of EST sequence data 
available (Boguski et al., 1993), these screens provide a valuable resource for 
attributing gene sequence data to biological function on a large scale. This is 
highlighted by the recent characterisation of sequence from over 2000 gene trap 
insertions (Zambrowicz et al., 1998). The systematic application of these techniques 
has the potential to produce mutations in every gene expressed in the mouse. 
ii! Secretory trap vectors 
The secretory trap vector was developed as a means of identifying the secreted 
and transmembrane proteins important for cell signalling in the developing embryo 
(Skarnes et al., 1995). The secretory trap vector (pGT1.8TM) contains the CD4 
transmembrane (TM) domain between the splice acceptor and 3-geo. Insertion of the 
vector immediately downstream of an endogenous signal sequence or downstream of a 
signal sequence and an even number of transmembrane domains is predicted to place 
I3geo in a typel orientation, maintaining reporter activity in the cytosol (Figure 1.5). 
Integration of the secretory trap vector into a gene either lacking a signal sequence or 
downstream of a signal sequence and an odd number of transmembrane domains places 
3-geo into the endoplasmic reticulum (ER) lumen abolishing activity (Figure 1.5). Data 
from six secretory trap lines characterised to date shows that vector insertion into 
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Figure 1.5: Model of secretory trap vector action 
Diagram showing the basis of secretory trap selection for vector insertions 
downstream of signal sequences 
Insertion of the secretory trap vector into genes containing a signal sequence (SS) 
produces a fusion protein that inserts into the endoplasmic reticulum (ER) membrane 
in a type I configuration. The vector transmembrane domain (TM) places the 3-geo 
reporter in the cytosol where 3-gal is active. 
Insertion of the secretory trap vector into a gene lacking a signal sequence 
produces a fusion protein which inserts in the ER membrane in a type II orientation. 
Consequently, J3-geo is exposed to lumen of the ER where 3-gal is inactive. 
(Figure adapted from Skarnes et al., 1995) 
membrane spanning molecules has occurred downstream of the endogenous signal 
sequences as predicted (Skarnes et al., 1995). 
iii/ Reporter expression 
The main driving force in gene entrapment technology thus far has been the 
potential to isolate novel genes with spatially and temporally restricted expression 
patterns during embryogenesis (Gossler et at., 1989). To this end Wurst et at. (1995) 
analysed reporter gene activity in chimaeric embryos derived from 279 independent 
gene trap cell lines. Chimaeric embryos were initially dissected at 8.5 d.p.c. From 279 
cell lines, 36 (13%) showed spatial variability in reporter activity, 88 (32%) produced 
widespread or ubiquitous activity and 155 (55%) gave no reporter gene activity. A 
quarter of the cell lines examined at 8.5 d.p.c. were also examined at 12.5 d.p.c. for 
reporter activity. Of the cell lines showing ubiquitous or no reporter activity, around 
30% showed alternative patterns of reporter activity at 12.5 d.p.c. Extrapolating these 
data infers that approximately 40% of gene trap integrations isolated in ES cells exhibit 
temporal or spatial variability in reporter activity during embryogenesis. In another 
study, Voss et al. (1998a) report slightly different proportions of chimaeric embryos 
showing ubiquitous (30%), restricted (32%) and no (38%) reporter activity in a study 
of 183 cell lines at El 1.5. The application of tetraploid aggregation chimaera 
technology, which allows for the almost complete derivation of embryos from ES cells 
(Nagy et al., 1990), would reduce the number of chimaeric embryos needed to be 
confident of an complete reporter gene expression profile, saving on time and animals. 
Despite the obvious benefits in screening gene trap lines in this manner, the 
routine production of chimaeras from each cell line is not a realistic proposition in terms 
of time and cost when pre-screening large numbers of cell lines for developmentally 
important genes. 
24 
iv! In vitro prescreening 
In order to enrich for gene trap events into developmentally regulated genes 
prior to chimaera production, several groups have studied the reporter gene activity of 
individual gene trap cell lines during in vitro differentiation protocols. 
Baker et al. (1997) examined reporter gene activity in embryoid bodies (EB) 
derived from 86 ROSA3geo cell lines. EB are aggregates of differentiated ES cells 
which are capable of producing various embryonic cell types prevalent in the early 
stages of embryonic development. Blood islands and blood vessels, cardiomyocytes, 
skeletal myocytes, chondrocytes, neurons and glia are produced spontaneously in EB. 
Analysis of the 86 gene trap lines revealed that 22% showed no reporter activity in EB, 
23% had ubiquitous activity and 55% gave varying degrees of restricted reporter 
activity. Co-expression of 13-galactosidase and lineage specific markers for skeletal 
myoblasts, cardiomyocytes, chondrocytes and neurons was observed in the subset of 
cell lines displaying restricted reporter expression. Furthermore, a good correlation 
was observed in these lines between in vitro reporter activity and in vivo expression of 
the trapped gene. This correlation was also observed in a study of 191 U3-geo lines 
differentiated to form EB. From this screen, 16% showed modulated reporter activity 
in EB of which seven lines transmitted through the germline displayed comparable 
alterations in reporter activity in the embryo (Scherer et al., 1996). More recently, two 
similar reports highlight the fact that even very limited in vitro pre-selection protocols 
can achieve a two-fold enrichment for genes with restricted expression during 
development by reducing the proportion of lines selected which result in ubiquitous 
reporter expression in the embryo (Voss et al., 1998a; Stoykova et al., 1998). 
Another strategy to enrich for developmentally expressed genes involves the 
pre-selection of gene trap integrations in which reporter activity was modulated by the 
differentiating factor retinoic acid (RA) (Forrester et al., 1996). Variations in the 
physiological levels of RA in the embryo induces a range of teratogenic effects (Linney, 
1992, Eichele 1989) which are recapitulated in embryos deficient in individual or 
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groups of retinoic acid receptors (Kastner et al., 1997). Moreover, the RA signalling 
pathway has been shown to modulate the expression of a number of developmentally 
important genes in vitro and in vivo (Pruitt, 1992; Simeone et al., 1990; Conlon and 
Rossant, 1992; Marshall et al., 1992). 
From 202 13-gal positive cell lines treated with RA, reporter activity was induced 
in 9 lines and repressed in 11. Tetraploid aggregation chimaeras derived from these 20 
lines showed spatially restricted reporter activity in all but one line from 8.5 -11.5 
d.p.cilate gastrulation to midgestation. Of the 11 repressed lines 8 showed reporter 
activity in the heart, 4 of which also displayed activity in the hindbrain, craniofacial 
region and branchial arches. From the 9 induced lines, 3 showed reporter activity in the 
region of the spinal cord and adjacent somites. These results, therefore, show a 
significant enrichment for developmentally restricted genes not seen using other 
protocols. A similar enrichment is seen when ES cells are differentiated into EB in the 
presence of RA (Gavojic et al., 1998). Interestingly, the majority of tissues with 
reporter activity in these embryos also display patterning defects induced by variations 
in RA levels suggesting that the trapped genes may be downstream of the RA signalling 
pathway (Forrester et al., 1996). Although this will ultimately limit the number of 
integrations into genes that are responsive to RA, this system can be applied to isolate 
genes modulated by other differentiating factors. Bonaldo et al. (1998) differentiated 
gene trap cell lines in the presence of the growth factors follistatin and nerve growth 
factor as well as RA. As with the previous screens, a modulation in reporter activity in 
vitro correlated well with developmentally restricted activity in vivo. 
1.3.2.6. Summary 
Promoter trapping in ES cells therefore provides a powerful means for the 
identification and functional analysis of individual genes. Random large scale 
entrapment mutagenesis programmes catalogued by gene sequence data as carried out 
by Zambrowiscz et al. (1998) complement existing expressed sequence databases and 
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genome sequencing projects and perhaps provide the most realistic means of achieving 
saturation level mutagenesis in the mouse. Lexicon Genetics provides these sequences 
and cell lines through OmnibankTM  as a commercial resource to investigators for the 
functional analysis of the trapped genes. The large scale functional screening of 
individual mutants from such a resource is financially and ethically prohibitive. The 
pre-screening of entrapment events provides a solution to this as it allows for more 
focused searches for genes of interest based on expression pattern or gene sequence 
structure (Forrester et al., 1996; Skarnes et al., 1995). 
Using retinoic acid pre-screening, the 1114 gene trap cell line was identified 
which showed restricted reporter activity in the liver of mid-gestation chimaeric 
embryos (Forrester et al., 1996). This thesis reports the characterisation of the 1114 
cell line. 
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1.4. LIVER DEVELOPMENT 
In contrast to the developing mesoderm and ectoderm, relatively little is known 
of the molecules mediating the patterning of the endodermal lineage. The liver is the 
earliest derivative of the gut endoderm providing an attractive system with which to 
investigate endodermal differentiation. The anatomy of liver development is relatively 
well characterised involving the interaction of a number of tissues, the nature of which 
parallel organogenesis in other tissues. Moreover, recent molecular analysis has 
highlighted potentially conserved mechanisms of gut endoderm differentiation between 
the mouse and other model systems such as Drosophila and C.elegans. Insights 
gleaned from the study of liver development may identify factors with functional 
overlap in hepatic regeneration and disease states such as cancer, as has already been 
seen for certain foetal markers. 
1.4.1. Overview Of Liver Development 
In the mouse, liver development commences at around 8.5 d.p.c. when the 
ventral floor of the foregut endoderm thickens forming the liver diverticulum. 
Subsequently, the epithelial cells of the liver diverticulum proliferate, forming cords 
which invade the loose mesenchyme of the ventral septum transversum (Le Douarin 
1975; Zaret 1996, 1998). As development proceeds the foetal liver becomes 
increasingly structured. The endodermal chords anastomose with the endodethelial 
capillary bed connected to the nearby vitteline veins. These mesenchymally derived 
tissues will go on to line the hepatic blood sinusoids (Severn, 1972). By 12 d.p.c., 
hepatocytes derived from the endodermal cells of the liver diverticulum contribute 
around 40% of the total cells of the foetal liver (Jones, 1970). 
From mid to late gestation, the liver becomes the major site of haematopoiesis in 
the mouse embryo. Cells of the erythroid lineage first colonise the foetal liver around 
10 d.p.c. and by 11.5 d.p.c. myeloid cells, macrophages, B cells and presumptive 
haematopoietic stem cells are also present (Medvinsky et al., 1993; Dzierzak and 
Medvinsky, 1995). The haematopoietic cells are mesodermal in origin deriving from 
progenitor cells migrating from both the yolk sac mesoderm and the aorta-gonad-
mesonephrous (AGM) region (Medvinsky et al., 1993). As development progresses, 
haematopoietic cells are more commonly found extravascularly in the foetal liver with 
numbers progressively decreasing as haematopoiesis switches to the bone marrow of 
the neonate. 
1.4.2. Tissue Interactions Mediating Liver Development 
Tissue explantation and transplantation studies, classically in the chick and more 
recently in the mouse, have uncovered a series of interactions between endodermally 
derived epithelia and ventral mesenchyme derived from mesoderm necessary for liver 
ontogeny (Zaret, 1996, 1998). Such mesenchymal-epithelial interactions driving 
organogenesis is a common developmental mechanism observed in a number of other 
organs including kidney, lung, and mammary gland (Birchmeier and Birchmeier, 
1993). 
In the chick, endoderm from the 5-somite stage onwards has the ability to 
differentiate into phenotypically distinct hepatocytes upon transplantation into host 
embryos. Prior to this stage, hepatogenesis is only observed if the endoderm is 
explanted with precardiac mesoderm suggesting that initial hepatic determination of 
endoderm is dependent on its interaction with precardiac mesoderm (Le Douarmn, 
1975). Differentiation of determined hepatic endoderm from the 5 somite stage 
onwards in vivo or in vitro is dependent on the hepatic mesenchyme. Interestingly, 
only hepatic endoderm is responsive to inductive mesenchyme but other mesenchymes 
derived from lateral plate mesoderm are capable of inducing hepatic endoderm 
differentiation (Le Douarmn, 1975). 
Presumptive hepatic endoderm isolated from the ventral foregut from different 
embryonic stages of the mouse was cultured with either chick hepatic or pulmonary 
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mesenchyme and then grafted into chick (Houssaint, 1980). From the 9 somite 
onwards, the murine foregut endoderm had the ability to differentiate into 
morphologically distinct hepatocytes expressing the hepatic marker c-foetoprotein 
(AFP). Moreover, these studies showed that both hepatic and pulmonary lateral plate 
mesenchyme could support the differentiation and proliferation of endodermally derived 
hepatocytes correlating well with the requirements of chick hepatic endoderm. In the 
absence of co-cultured mesenchyme mouse endoderm failed to differentiate (Houssaint, 
1980; Le Douarin, 1975). 
Gualdi et al., (1996) showed that ventral foregut endoderm explants from 4-6 
somite embryos would only express the hepatocyte specific markers AFP and serum 
albumin (alb) when cultured alongside cardiac mesoderm consistent with previous 
studies (Houssaint, 1980; Le Douarin, 1975). Perhaps more interesting was the 
finding that more posterior dorsal endoderm was capable of expressing AFP and alb 
when not in contact with adjacent dorsal mesoderm and ectoderm. Moreover, this 
posterior dorsal mesoderm and ectoderm was capable of inhibiting the expression of 
AFP and alb in explants of ventral endoderm and cardiac mesoderm (Gualdi et al., 
1996). This indicates that gut endoderm has the potential to differentiate along the 
hepatic lineage, an ability which is normally restricted by adjacent ectoderm and 
mesoderm. 
In a recent study by Jung et al. (1999), tissue explant studies similar to those 
performed by Gualdi et al., (1996) were used to determine the molecules mediating the 
inductive signals responsible for the specification of hepatic endoderm by the cardiac 
mesoderm. The treatment of isolated foregut endoderm with either fibroblast growth 
factor (FGF) 1 or FGF2 was sufficient to induce the liver specific gene expression 
effectively replacing the effect of cardiac mesoderm in comparable cultures. 
These studies allow us to postulate a programme of interactions necessary for 
the determination and early differentiation of the foetal liver in vivo (Figure 1.6). 
Hepatic determination occurs in the 4-8 somite embryo (8-8.5 d.p.c.) via interactions 
between the cardiac mesoderm and the epithelium of the ventral foregut endoderm 
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Figure 1.6: Inductive interactions during the formation of the foetal liver 
Between the 4 and 8 somite stage of embryogenesis, inductive signals from the cardiac mesoderm 
activate liver specific genes in the foregut endoderm specifying this region to differentiate along the 
hepatic lineage (shown as white blocks). 
From the 9 somite stage foregut closure proceeds posteriorly drawing the hepatic endoderm away from 
the developing heart (black arrow). During this process signals (white arrows) from the septum 
transversum (ST) induces the hepatic endoderm to proliferate within the endodermal layer. 
From 9.5d.p.c. the proliferating early hepatocytes migrate into the loose mesenchyme of the septum 
transversum where they anastomose with capillaries forming the liver bud (LB). 
(Figure 1.6A). After specification, foregut closure and extension pulls the hepatic 
endoderm more posteriorly as interactions with the adjacent mesenchyme of the septum 
transversum induces proliferation of the hepatic endoderm (Figure 1.613). At 9.5 d.p.c. 
continued mesenchymal-epithelial interactions drives the migration of endodermal 
chords into the septum transversum forming the liver bud (Figure 1.6Q. 
1.4.3. Hepatic Markers 
It is of interest to highlight at this stage the two related serum proteins AFP and 
alb which have been used as definitive markers of hepatocyte differentiation in recent 
studies (Gualdi et at., 1996; Houssaint, 1980; Cascio and Zaret, 1991; Shiojiri, 1981). 
From around 7 d.p.c., AFP is expressed at high levels in the endodermal cells of the 
visceral yolksac (Dziadek and Adamson, 1978; Dziadek and Andrews, 1983) with alb 
expression first detected at 13.5 d.p.c. in the same tissue (Meehan et al., 1984). Low 
levels of APP and alb transcripts can be first detected in the presumptive hepatic 
endoderm between 8.0-8.5 d.p.c. prior to formation of the liver diverticulum (Shiojiri, 
1981; Gualdi et at., 1996). From 9.5 d.p.c. onwards, high levels of AFP are observed 
in the liver (Shiojiri, 1981; Dziadek and Andrews, 1983) with additional expression in 
the developing gut (Tyner et al., 1990). AFP expression shuts down at birth with re-
expression in the adult associated with tumour formation (Abelev et at., 1971). 
Similarly a higher level of alb expression is seen at 9.5 d.p.c. in the liver diverticulum 
and by 12 d.p.c. around a 20 fold increase in expression is observed which is 
maintained throughout gestation and in the adult (Cascio and Zaret., 1991). Despite 
their extensive use as markers for both visceral endoderm and hepatic endoderm, the 
exact function of alb and APP is unknown although many functions have been 
postulated (Uriel et al., 1976; Brenner et at., 1980; Leffert et at., 1978). 
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1.4.4. Molecular Basis of Hepatic Determination 
With such a significant amount of work carried out defining the tissue 
interactions necessary for the transition of the foregut endoderm to the hepatic lineage, it 
is of great interest to characterise the molecular elements mediating these interactions. 
Although the expression of a number of factors in the definitive endoderm and liver 
primordia suggested roles in determination, gene knock-out analysis has failed to define 
functions for these factors in hepatic specification. Nevertheless, more recent studies 
are implicating two of these factors, HNF-33 and GATA-4, in potentiating hepatic 
determination. 
The transcription factors HNF-3 and HNF-4 were initially isolated as factors 
binding to the upstream regulatory elements of genes expressed in adult hepatocytes 
(Costa et al., 1989). 
HNF-4 is a member of the steroid hormone receptor superfamily (Sladek et al., 
1990). Expression of HNF-4 is first detected in the visceral endoderm of the yolk sac 
at 4.5 d.p.c. and is the sole site of expression until 8.5 d.p.c. when expression is seen 
in the liver diverticulum. From this stage, expression is seen at high levels in the 
proliferating hepatocytes with additional expression in the gut and nephrogenic tissue 
(Duncan et al., 1994). Mutational analysis of HNF-4 results in embryonic lethality 
around 7.5 d.p.c. with the mutant embryos displaying increased cell death in the 
embryonic ectoderm and impaired gastrulation (Chen et al., 1994a). Consequently, 
such an early phenotype, prior to liver determination, makes it impossible to assess the 
potential involvement of HNF-4 in liver ontogeny. 
HNF-3 is the defining member of the winged helix transcription factor gene 
family conserved throughout evolution which includes the forkhead gene in Drosophila 
(Lai et al., 1993). In the mouse embryo, expression of HNF-30 is first observed at 
gastrulation in the anterior portion of the primitive streak. At the headfold stage, HNF-
313 expression can be seen in the node, notochord as well as in the floorplate and 
definitive endoderm where its expression overlaps with the related gene HNF-3a (Ang 
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et al., 1993; Sasaki et al., 1993; Monaghan et al., 1993). At 8.5 d.p.c. HNF-3a and 
HNF-33 are expressed throughout the gut endoderm with high levels observed in the 
presumptive hepatic endoderm at 8.5 d.p.c. and in the liver diverticulum from 9.0 
d.p.c. (Ang et al., 1993). Disruption of HNF-3P causes embryonic lethality with 
defects in node and notochord formation which subsequently affects dorsal-ventral 
patterning. Furthermore, HNF-3P mutants form definitive endoderm but gut 
morphogenesis is disrupted with no invagination of the foregut pocket (Ang et al., 
1994). 
Defects in foregut morphogenesis are also observed in embryos deficient in the 
zinc finger transcription factor GATA-4 (Kuo et al., 1997; Molkentin et al.,1997). 
Expression of GATA-4 is seen in the visceral endoderm, developing heart and gut 
endoderm (Arceci et al., 1993; Molkentin et al., 1997). Inactivation of GATA-4 affects 
rostral-to caudal and lateral-to-ventral morphogenesis with the ventral closure of the 
yolk sac and the formation of the heart tube and foregut pocket disrupted (Kuo et al., 
1997; Molkentin et al.,1997). Following on from this study, Narite et al. (1997a, 
1997b) has shown that the ventral pattering defect is a result of GATA4 function, either 
in the visceral endoderm and/or definitive endoderm and is not intrinsic to cardiac 
tissue. 
Both HNF-3P and GATA-4, therefore, play a role in foregut morphogenesis, a 
function which is conserved between structural homologues in other metazoans. In 
Drosophila, the HNF-313 related gene forkhead and the GATA-like gene serpent are 
required for endodermal gut development (Weigel et al.,1989; Rehorn et al., 1996). 
C.elegans also possess a GATA factor end-] which is essential for endoderm formation 
(Zhu et al., 1997). 
Although both HNF-313 and GATA-4 mutants present phenotypes before 
hepatic specification, in vivo footprinting studies of the serum albumin enhancer 
element has suggested roles for both proteins in hepatic potentiation. HNF-30 and 
GATA-4 bind distinct sites in the alb enhancer element (which drives liver specific alb 
expression) in undifferentiated gut endoderm with the potential to activate albumin 
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expression. Subsequently, the binding of other factors to additional enhancer sites is 
observed upon hepatic specification (Gualdi et al., 1996; Bossard and Zaret, 1998). 
From these observations it is postulated that these two factors act to potentiate the 
expression of hepatic specific genes (Zaret, 1998; Gualdi et al., 1996; Bossard and 
Zaret, 1998). 
Another candidate gene which may be involved in hepatic specification is the 
divergent homeobox gene Hex. Expression of this gene is observed in the visceral 
endoderm and then later in the earliest definitive endoderm and subsequently at high 
levels in the ventral foregut and the liver bud (Thomas et al.,1998a). 
1.4.5. Mutational Analysis of Liver Development 
The molecules and pathways underpinning the interactions between the hepatic 
endoderm and ventral mesenchyme after its specification are being illuminated by a 
number of gene mutation studies which are outlined below. 
The secreted glycoprotein scatter factor/ hepatocyte growth factor SF/HGF was 
predicted to be involved in mesenchymal-epithelial interactions by its defining effects on 
motility and morphology of a variety of epithelial cells in culture (Stoker et al., 1987; 
Gherardi et al., 1989, Montesano et al., 1991) and its expression in the mesenchyme of 
various developing organs (Sonnenberg et al., 1993). In addition, SF/HGF was 
shown to be a powerful mitogen of primary hepatocytes in culture (Nakamura et al., 
1989) and may have a role in vivo on the proliferation of hepatocytes in response to 
liver injury (Zarnegar et al., 1989). Targeted disruption of SF/HGF results in 
embryonic lethality from 14-16 d.p.c. Affected embryos have hypoplastic livers with 
disrupted architecture containing a reduced number of morphologically abnormal 
hepatocytes. The mesenchymally derived sinusoidal cells of the livers which express 
SF/HGF are unaffected (Schmidt et al., 1995). 
Complementing this study, animals lacking the receptor for SF/HGF, the 
receptor tyrosine kinase c-met, which is expressed at high levels in the hepatic 
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endoderm, display a strikingly similar phenotype to the SF/HGF mutant embryos 
(Bladt et al., 1995). 
The divergent homeobox gene Hix was identified from its expression in 
restricted haematopoietic lineages (Allen et at., 1991). During development Hix 
expression is restricted to mesodermally derived tissues including the mesenchyme of 
the liver, gall bladder and intestines during organogenesis (Lints et al., 1996). Targeted 
disruption of Hix results in a perturbation in the outgrowth of the endodermally derived 
liver diverticulum as well as in the elongation and looping of the intestines (Hentsch et 
at., 1996). 
The proto-oncogene c-jun is a component of the transcription factor AP-1, an 
effector of the protein kinase C signalling pathway which is widely expressed 
throughout the embryo and adult (Ransone and Verma, 1990; Angel et al., 1987; Lee et 
at., 1987). Mice deficient in c-jun die at mid to late gestation with a severely 
hypoplastic liver and impaired hepatic erythropoiesis (Hilberg et at., 1993). 
The four studies outlined above highlight similar phenotypes relating to the 
development of the liver, that is, defects intrinsic to the outgrowth of the hepatic 
endoderm. Significantly, both SF/HGF and Hix, are expressed in the mesenchyme of 
the septum transversum and represent factors which could mediate the dependency of 
the hepatic endoderm on adjacent mesenchyme for organogenesis. Moreover, the 
studies also implicate certain signalling cascades involved in hepatogenesis. SF/HGF 
has been shown to activate AP-1 (c-fun) via the JNK1 signalling pathway in cultured 
hepatocytes and fibroblasts (Auer et at., 1998; Rodrigues et al., 1997). Although this 
is not the sole pathway either activated by SF/HGF or activating c-fun, it does provide a 
link to the comparable phenotypes observed when these different molecules are 
mutated. By this rationale, it is not unreasonable to suggest that the transcription factor 
Htx may function to activate SF/HGF in the hepatic mesenchyme although there is no 
direct evidence for this (Hentsch et al., 199). 
NF-kB is a transcription factor which has been predicted to be involved in a 
wide range of cellular functions but shows a liver specific defect when mutated (not 
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unlike c-fun). This factor consists of the polypeptides RelAIp65 and p50 and is 
believed to regulate infection, inflammation and stress (Baeuerle and Henkel, 1994). 
Mice null for the ReIA subunit display a massive degeneration of the foetal liver 
mediated by the apoptosis of hepatocytes resulting in lethality around 15 d.p.c. (Beg et 
at., 1995). 
Similar phenotypes are observed in mice deficient in jumonji and N-myc. 
Jumonji, initially identified by gene trapping, is expressed in the stromal cells of the 
liver with mutant embryos displaying hypoplastic livers, thymus and spleen with 
increased hepatocyte apoptosis in the liver by 13.5 d.p.c. (Motoyama et at., 1997). N-
myc mutants show growth retardation in many tissues, most notably the heart, as well 
as increased apoptosis of hepatocytes by 11.5 d.p.c. (Giroux et at., 1998). 
Both jumonji and N-myc are not expresssed in hepatocytes and yet their 
functions are absolutely required for hepatocyte survival. The mutant phenotypes 
therefore are postulated to be a manifestation of the dependency the liver has to 
continued cellular interactions throughout its ontogeny (Zaret, 1998). 
1.4.6. Summary 
The pioneering studies of Le Douarin over 20 years ago are only now beginning 
to be compounded by gene knock-out studies identifying factors and pathways which 
may be involved in the tissue interactions mediating liver ontogeny. Most success has 
been in identifying factors involved in the proliferation of the liver after specification. 
Notably, however, there has been a failure to identify molecules specifying the hepatic 
endoderm. Consequently, it is important to identify molecules expressed early and 
exclusively in the hepatic lineage as potential affectors or effectors of specification. 
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1.5. Experimental Approach 
The aim of my project is to characterise the 1114 gene trap cell line. 1114 was 
initially selected after showing an induction in reporter activity using the RA pre-
screening strategy of Forrester et al., (1996) outlined in Section 1 .3.2.5(iv). In 1114 
chimaeric embryos reporter expression was identified in the foetal liver of between 9.5-
10.5d.p.c. (Forrester et al., 1996). The expression pattern of the reporter gene 
prompted the characterisation of the 1114 line as a means of identifying a gene with a 
potential role in liver development. Chapter 3 describes the exquisite reporter 
expression profile of the 1114 gene trap integration which exclusively marks the 
specification and proliferation of the foetal liver. Chapter 4 identifies a complex 
integration event associated with this reporter activity and Chapter 5 and 6 resolve the 




MATERIALS AND METHODS 
Unless otherwise stated, analytical grade chemicals were obtained from either 
Sigma or BDH Laboratory supplies (Merc Ltd) with the exception of absolute ethanol 
(Hayman Ltd, Litham, UK). Analytical grade agarose was supplied by GibcoBRL 
with NuSieve low melting point (LMP) agarose supplied by Flowgen (Sittingbourne, 
UK). All bacterial media components were supplied by DIFCO laboratories. Synthetic 
oligonucleotides were synthesised by OS WELL DNA Service (University of 
Southampton, UK). Radioisotopes were supplied by Amersham International plc 
(Little Chalfont, UK) or NEN and X-ray film (Kodak XOMAT XAR-5) supplied by 
IBI Ltd (Cambridge, UK). 
2.1. Molecular Biology Methods 
General molecular biology techniques and the preparation of standard solutions 
was carried out according to Sambrook et al. (1989) unless otherwise stated. 
Restriction enzyme digests were performed as recommended by the suppliers 
(Boehringer Mannheim). Digest products were routinely analysed by agarose gel 
electrophoresis with gels cast and ran in 1xTAE buffer at appropriate concentrations 
containing 0.5j.ig/ml ethidium bromide. 0.5j..tg of 1kb DNA ladder (GibcoBRL) was 
loaded on each gel as a size standard. 
2.1.1. General Cloning Techniques 
DNA fragments and RACE-PCR products (Protocol 2, Section 2.1.8.1.) were 
routinely subcloned by restriction digestion and cloning into the pilasmid pBluescript 
KS (Stratagene). The Zero BackgroundTM cloning kit (Invitrogen) was also used to 
clone certain restriction fragments. Pfu polymerase generated blunt end RACE-PCR 
products were subcloned using the Zero BluntTM  PCR cloning kit (Invitrogen) and Taq 
polymerase PCR products (which have a deoxyadenosine added to the end) were 
subcloned using the TOPO TA Cloning® kit (Invitrogen). All the kits were used as 
instructed by the manufacturers. 
2.1.1.1. Gel Purification of DNA 
Restriction fragments for subcloning and the pBluescript vector were digested 
and purified as follows: 
Restriction digest products were run on 1.0% low melt agarose gels until 
suitable separation had occurred to isolate a single band. Bands of interest were excised 
from the gel using a scalpel under long wavelength UV illumination. The gel slice was 
weighed and an equal volume of dH20 added. Sodium chloride was added to a final 
concentration of 0. 1M. The sample was heated to 700C for 5-10 minutes in a hot block 
(Techne) and vortexed to melt the agarose. An equal volume of Tris-saturated phenol 
(Fisons) prewarmed to 370C was added to the gel solution and the sample vortexed for 
1-2 minutes. The suspension was then centrifuged at 13,000 x g. for 3 minutes and the 
upper aqueous phase removed and extracted in an equal volume of 
phenol/chloroform/IAA (25:24:1) which was vortexed and centrifuged at 13,000 x g. 
for 1 minute. The aqueous phase was removed, extracted with an equal volume of 
chloroform and centrifuged at 13,000 x g. for 30 seconds. The aqueous phase was 
precipitated with 2 volumes of 100% ethanol at -200C for a minimum of 10 minutes 
and DNA pelleted by centrifugation at 13,000 x g. for 10 minutes. The pellet was 
washed with 70% ethanol, air dried and resuspended in 20p1 of T.E. (10mM Tris-HC1 
pH8.0; 1mM EDTA pH8.0) 
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2.1.1.2. 	Ligations 
For ligations, pBluescript was digested and gel purified (Section 2.1.1.1). 
Restriction fragments for subcloning into pBluescript were either gel purified or, after 
digestion, extracted with an equal volume of phenol/chloroform, precipitated with 0.1 
volume 3M NaOAc (pH5.2) / 2 volumes of 100% ethanol at -200C for a minimum of 
10 minutes and resuspended in appropriate volume of sterile water. 
Ligation reactions were set up with approximately a 1:3 vector to insert molarity 
ratio with 1il (lunit) of T4 DNA Ligase (Boehringer) and 1tl lOx ligation buffer 
(660mM Tris.HCI pH7.5; 50mM MgCl2; 10mM DTT; 10mM ATP; Boehringer) to a 
total volume of 10il. Cohesive-end ligations were performed at 160C for a minimum 
of 1 hour, blunt-end ligations were incubated overnight at 160C. To determine the 
background level of vector re-ligation, a control reaction containing vector alone was 
also set up. Ligation reactions were precipitated with 0.1 volume of 3M NaOAc 
(pH5.2)/ 2 volumes of 100% ethanol, washed in 70% ethanol and resuspended in 4tl 
of T.E prior to transformation. 
2.1.1.3. Transformation of Bacterial Cells 
Electroporation was routinely used to transform the bacterial strain DH5a which 
were prepared as follows. 
A single bacterial colony from a freshly streaked plate was used to inoculate 25 
mis Luria broth (LB) culture media (1% w/v Tryptone (Difco); 0.5% w/v yeast extract 
(Difco); 85mM NaCl) which was grown at 370C overnight with shaking. 5mls of this 
overnight culture was used to inoculate SOmls LB broth and the culture grown to 
0D600 = 0.3 to ensure the cells are in log phase. The cells were then chilled on ice for 
15 minutes, centrifuged at 4000 x g. for 10 minutes at 40C. In all subsequent steps, 
centrifuge bottles, tubes, pipettes and strerile water are all kept at 40C. The bacterial 
pellet was resuspended in SOOmls of ice cold water, re-centrifuged as before and 
resusupended in 250m1 of ice cold water. Centrifugation was repeated and the bacterial 
pellet resuspended in 40m1 of ice cold 10% glycerol. After a final centrifugation the 
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pellet was resusupended in imI of ice cold 10% glycerol. The electrocompetent 
bacterial cells were dispensed into 100.tl aliquots in prechilled eppendorf tubes and 
snap frozen in liquid nitrogen before storage at 800C. 
Unless using fresh, aliquots of electrocompetent cells were thawed on ice for 
—30 minutes. 40 jil of electrocompetent cells were mixed with 4il of the precipitated 
and resuspended ligation reaction in an eppendorf tube on ice. The sample was 
transferred to a prechilled cuvette with a 1mm electrode gap (Biorad) and the cells were 
electroporated (25 mFD, 200 ohm and 1.8 kV using Biorad's Gene Pulser) which 
would typically produce a time constant of 4.5. 1 .Oml of LB broth at room temperature 
was immediately added to the cells and the culture transferred to an eppendorf tube 
which was incubated at 370C for 45-60 minutes to allow the cells to recover. 
Appropriate dilutions were plated onto LB agar plates (1.5% w/v agar in LB) with 
100tg/m1 Ampicillin as selection. When blue/white selection was also required, 
standard 9cm agar plates were treated with 40t1 of 25mg/mi X-gal (5-bromo-4-chloro-
3-indoly1-3-D-galactopyranoside) in dimethyl formamide (DMF) and 4tl of 0.2mg/ml 
IPTG (isopropylthio-3-D-galactoside) prior to plating. 
2.1.1.4. Screening Transformants 
(a) Colony Lifts 
Analysis of a large numbers of recombinant clones on agar plates prior to 
plasmid preparation was carried out by taking colony lifts onto nylon membranes, 
lysing the colonies and hybridising to a radiolabelled probe. 
A 9cm diameter Hybond N+ nylon membrane (Amersham) was placed on top 
of the agar plate and asymmetric orientation marks made using a needle. The membrane 
was removed from the plate and placed, colony side up into a imi puddle of denaturing 
solution (1.5M NaCl; 0.5M NaOH) on SaranWrap for 2 minutes. The membrane was 
removed and placed colony side up in a lml puddle of neutralising solution (0.5M 
Tris.HC1 pH8.0; 1.5M NaCl) for 5 minutes. The membrane was then rinsed 
41 
(submerged) in 2xSSC. The membrane was then air dried briefly and baked at 1200C 
for 30 minutes after which it hybridised to the appropriate probe. 
(b) Colony Screening by PCR 
Large numbers of recombinant bacterial clones were screened for inserts by 
PCR primers flanking the insertion site of the cloning plasmid (T3 and T7 for 
pBluescript and SP6 and T7 for pCR®-Blunt and pZErOTM2). 
Bacterial colonies were picked using a yellow pipette tip into 20j.tl of water. 7jil 
of the culture was stored at 40C and the remaining 1 3t1 of the culture was added to 2t1 
lOx PCR Buffer buffer (50mM KCl/lOmM Tris (pH8.3)); 2jil 25mM MgC12; 0.4pi 
10mM dNTPs; 1.il lOOng primer x; lil lOOng primer y; 0.2p1 (1 unit) Taq DNA 
polymerase (Promega). The samples were overlaid with mineral oil and incubated at 
94°C for 5 minutes and taken through 25 PCR cycles of 94°C for 30 secs; 55°C for 30 
secs; 72°C for 45 secs. Half the PCR reaction was separated on an agarose gel, 
Southern blotted and hybridised to the relevant probe. Positive colonies were grown 
for plasmid preparation using the 7i1 of stock culture. 
2.1.2. Isolation of Nucleic Acids 
2.1.2.1. Plasmid Preparation 
Plasmid isolation was either performed using the Qiagen plasmid isolation kit 
according to the manufacturers instructions or using the following protocol. The 
amounts used are for minipreps of plasmids. The equivalent amounts used for 
midipreps and maxipreps are provided in parentheses. 
A single colony was picked with a sterile yellow Gilson tip into 2mls (MID-
25m1s; MAX- lOOmIs) of LB with the appropriate antibiotic and the culture incubated at 
370C overnight with shaking. In an eppendorf tube, 1.5mls of overnight culture 
centrifuged for 3 minutes at 13,000 x g. to pellet the cells (MID and MAX- 6,000 x g 
for 15 mins). The supernatant was discarded and the pellet resuspended in 200tl 
(MID- 4mls; MAX- 10mls) of resuspension buffer (50 mM Tris-HC1 (pH 8.0); 10 mM 
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EDTA; 1001g/m1 RNase A- stored at 40C). 200p1 (MILD- 4mls; MAX- lOmis) of the 
freshly prepared lysis buffer (0.2 M NaOH; 1% SDS) was added and the tube inverted 
gently several times and the left on ice for 5 minutes. 200t1 (MID- 4mls; MAX- lOmis) 
of ice cold neutralisation buffer (3M KAcetate pH4.8 with acetic acid) was added the 
tube inverted gently several times and then left on ice for 5 minutes. The samples were 
then centrifuged at 13,000 x g for 5 minutes to pellet the precipitate (MID and MAX-
13,000 x g in Sorval SS-34 rotor for 15 minutes using Oakridge tubes). The 
supernatant (6-700jil for miniprep) was removed and added to 0.7 volumes of 
isopropanol in a fresh eppendorf tube (MID and MAX- supernatant was mixed with 
isopropanol in Corex glass tubes. If the supernatant is not clear, it can be passed 
through a 0.45 gm syringe filter- Nalgene). The DNA is pelleted by centrifugation at 
13,000 x g for 10 minutes, washed in 70% ethanol, air dried and resuspended in 50jil 
of T.E. (MID and MAX- centrifugation at 11,000 x g in Sorval SS-34 rotor and 
resuspended in 500tl) 
DNA from this preparation was of sufficient quality for diagnostic digest 
analysis. If the miniprep DNA preparation was to be used in the automatic sequencing 
protocol (Section 2.1.7.2.) and for all midi and maxipreps, the DNA was purified 
further by adding an equal volume of 13% PEG-8000 (in 1.6M NaC1) to the DNA and 
incubated on ice for 1 hour. The DNA was pelleted by centrifugation at 13,000 x g for 
5 minutes, washed twice with 70% ethanol, air dried and resuspended in an appropriate 
amount of either TE or sterile water (if used for automatic sequencing). 
2.1.2.2. PAC Preparation 
PAC clones were provided by the UK HUMP Resource Centre 
(http://www.hgmp.mrc. ac.uk) after the screening of 7 gridded filters of the mouse 
genomic PAC library RPC 121 with the L-69 (Group H) fusion transcript. The PAC 
clones were streaked out to single colonies on LB with 251g/m1 kanamycin. PAC 
clones were prepared using the Qiagen Midiprep and Maxiprep Kits according to the 
manufacturers instructions with the following modifications: 
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For the midiprep protocol, lOOmls of overnight culture (LB + 254g/m1 
kanamycin) was used. 8mls (2x recommended amount) of each of the buffers P1, P2, 
P3 were added (steps 1-3). For the elution of the plasmid from the Qiagen column 
(step 9), the elution buffer (QF) was heated to 650C and added to the column imi at a 
time. 
For the maxiprep protocol, 250m1s of overnight culture (LB+ Kanamycin) was 
used. 20mls (2x recommended amount) of each of the buffers P1, P2, P3 were added 
(step 1-3). For the elution of the plasmid from the Qiagen column (step 9), the elution 
buffer (QF) was heated to 650C and added 2mls at a time. 
Restriction enzyme digestion of PAC clones was carried out as for plasmids. 
2.1.2.3. Isolation of Genomic DNA 
ES Cells: 
ES cells grown to confluency in 25cm2 flasks were rinsed twice with PBS 
(137mM NaCl, 2.7mM KC1, 4.3mM Na2HPO4 and 1.4mMKH2PO4) and lysed 
overnight at 550C in 5m1 of lysis buffer (100mM Tris.HC1 pH8.5; 5mM EDTA; 0.2% 
SDS; 200mM NaCl; 100ig/ml Proteinase K (Sigma)-added fresh). The lysate solution 
was extracted with equal volumes of phenollchloroform/isoamyl alcohol (25:24:1) and 
centrifuged at 6,000 x g or 10 minutes. The aqueous phase was decanted and the 
extraction repeated with chloroformlisoamyl alcohol (24:1). The aqueous phase was 
precipitated using an equal volume of isopropanol. The DNA was spooled out of the 
tube using a sterile gilson tip, rinsed in 70% ethanol, and resuspended in 50p1 of T.E. 
overnight at 4oC and the DNA concentration determined by measuring the OD at 
260nm. 
Tissue: 
Tail tips (0.5-1.0cm) from newly weaned animals was digested overnight at 
550C in 0.5ml lysis buffer (100mM Tris.HC1 pH8.5; 5mM EDTA; 0.2% SDS; 200mM 
NaCl; lOOjig/mi Proteinase K added fresh) with agitation. The lysate was vortexed and 
centrifuged at 13,000 x g for 10 minutes to remove bones and hair. The resulting 
supernatant was extracted and precipitated as described above for ES cells. 
2.1.2.4. Isolation of High Molecular Weight Genomic DNA 
ES cells were grown to confluency in a 175cm2 flask, medium removed and 
cells rinsed in PBS. Cells were trypsinised to a single cell suspension, centrifuged for 
5 minutes at 1,200 x g. and resuspended in PBS. The cells were counted in a 
haemocytometer, spun amd resuspended in PBS to a final concentration of 2.5x 10 
cells/nil. 2 volumes of cells were mixed with 3 volumes of 1% LMP agarose in PBS 
(kept at 370C). Immediately, 100tl of the cell suspension was dispensed into a perspex 
plug mold (Biorad) with approximately 6 x 2 x 10mm size wells on ice. Once the 
agarose plugs had set, the plugs were pushed out into 50m1 tube (Corning) containing 
NDS (0.5M EDTA; 1% sodium lauroyl sarcosine; 0.01M Tris pH 7.5) with 1mg/mi 
proteinase K and were incubated overnight at 500C. The plugs were then rinsed twice 
in NDS for 2 hours and stored in NDS at 40C. The plugs are stable for at least 1 year 
at 4°C. 
2.1.2.5. Isolation of RNA 
Total RNA was isolated using a protocol modified from Chomczynski and 
Sacchi, (1987). ES cells for RNA preparation were grown to confluency in either 
25cm2 flasks or 9cm plates. Cells were rinsed twice with PBS and then harvested by 
pipetting up and down with 5mls of Solution D (4.4M guanidinium isothiocynate; 
25mM sodium citrate; 0.6% sarcosyl; 100mM 3-mercaptoethanol). The lysate was 
transferred to a Falcon 2059 centrifuge tube. For RNA isolation from tissues, 
approximately 100-200mg of freshly dissected tissue was homogenised using a 
standard ground glass homogeniser in Smls of Solution D. The lysate was transferred 
to a Falcon 2059 tube. The following protocol was used to isolate RNA from ES cells 
and tissue. 
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To 5mls of the Solution D lysate, 0.5mls 2M Sodium Actetate (pH4.0), 5mls 
Phenol (T.E. or Tris-saturated-Fisons) and 2mls chloroform were sequentially added. 
The samples were put on ice for 15 minutes and then centrifuged at 6,000 x g for 15 
minutes at 40C (Sorval SS34 rotor). The upper aqueous phase containing the RNA 
was removed and precipitated in an equal volume of isopropanol (-6mls) at 40C  for 1 
hour. The RNA was pelleted by centrifugation at 8,000 x g for 20 minutes at 40C 
(Sorval SS34 rotor). The pellet was resuspended in 0.3m1 Solution D, reprecipitated 
with an equal volume of isopropanol at 40C for 1 hour. Late gestation or adult liver 
samples with a high glycogen content were precipitated at 40C overnight with an equal 
volume of 4M lithium chloride to prevent co-precipitation of glycogen (this was only if 
the RNA was not being used in reverse transcription as Cl- ions inhibit RT). The 
precipitates were pelleted by centrifugation at 13,000 x g for 10 minutes at 40C and the 
pellet washed with 70% ethanol, supernatant removed with a P2 Gilson tip and the 
pellet immediately resuspended in 50p1 of DEPC treated water and left at 40C 
overnight. The RNA concentration was determined by absorbance at 260nm. The ratio 
of 260nm1280nm was used to estimate the purity of the sample with a ratio close to 1.8 
indicative of low protein contamination. The samples were stored long term at -700C. 
2.1.3. Analysis of High Molecular Weight DNA 
2.1.3.1. Digestion of Genomic DNA Agarose Plugs 
High molecular weight agarose plugs (Section 2.1.2.4.) were cut into three 
sections each sufficient for an single restriction digest. Agarose plugs were rinsed 
twice in TE at 40C for a minimum of 30 minutes per wash (the first wash was normally 
performed overnight). The plugs were then washed at 40C for 30 minutes in TB 
containing 0. 1M phenylmethylsulfonyl fluoride (PMSF) and subsequently rinsed twice 
in TE for 30 minutes. The plugs were then rinsed in the appropriate lx concentration of 
restriction buffer for 30 minutes. Each plug was digested overnight at 370C in a 
volume of 70 .d containing lx restriction buffer, spermidine (2mM spermidine for 
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restriction buffers with 50-100mM salt and 5mM spermidine for buffers with over 
100m]\4 salt), 200tg/ml BSA and 2.il of 40u/pi restriction enzyme. A further ijil of 
restriction enzyme was added and the plugs digested for 2 hours to overnight. The 
restriction digests were stopped by adding lOOpJ of 0.5M EDTA and the samples were 
ready for analysis by pulse field gel electrophoresis (Section 2.1.3.2.). To control for 
degradation of genomic DNA, a control plug is taken through the same protocol with 
the omission of the restriction enzyme. 
2.1.3.2. Pulse Field Gel Electrophoresis (PFGE) 
Separation of high molecular weight genomic DNA fragments was carried out 
using Biorads CHEF-DR II pulse field nucleic acid electrophoresis system. 
A 0.8% agarose gel in 0.5xTBE was poured using the CHEF-DR II casting 
stand and wells. Digested genomic DNA and molecular weight marker agarose plugs 
were inserted into the wells of the gel and sealed with 1 %LMP agarose. Liquid 
samples (PAC restriction digests) were mixed in an equal volume of 1% LMP agarose 
and loaded into the wells. (Molecular Weight Markers- Mid range I PFG marker and ? 
ladder; New England Biolabs). Once the wells had set the gel was submerged in 2 
liters of 0.5% TBE in the electrophoresis cell at 140C. The gel was then subjected to a 
switch time ramp of 1-20 second pulses for 20-24 hours at a constant 6V/cm. The 
switch time ramp increases the mobility of the DNA fragments as a function of 
molecular weight by gradually changing the switch times through the course of a run. 
This provides a more linear separation of DNA fragments through a range of molecular 
sizes. After electrophoresis, the pulse field gel was stained with 10i1 of ethidlium 
bromide (25mg/mi) in 500m1 of 0.5x TBE for 30 minutes. The gel was rinsed twice in 
sterile water, photographed and Southern blotted (Section 2.1.4.1.) 
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2.1.4. Nucleic Acid Transfer to Membranes 
2.1.4.1. Southern Blotting 
Southern blotting as described in Sambrook et al., 1989 was carried out for the 
transfer of high molecular weight DNA from the PFGE of restriction digested genomic 
DNA and PAC DNA. Prior to blotting, PFGE gels were stained in ethidium bromide 
(-l.tg/ml), rinsed in water and photographed. 
High molecular weight DNA was depurinated (acid nicked) in 0.25M HC1 for 
20 minutes with gentle agitation. The gel was rinsed in water and then denatured in 
0.5M NaOH, 1.5M NaCl for 30 minutes and neutralised for 30 minutes in 1.5M NaCl, 
1mM EDTA, 0.5M Tris-HC1 (pH7.2). A toughened glass plate was placed across a 
Pyrex dish containing 20x SSC (3M NaCl, 0.3M trisodium citrate) and two strips of 
Whatman 3MM paper were placed on top of the glass plate with the ends submerged in 
20x SSC to act as a wick. The gel was placed on top of the paper and surrounded by 
parafilm to prevent evaporation of the buffer. Hybond N+ nylon membrane 
(Amersham) cut to the size of the gel was pre-soaked in water, lOx SSC and then 
placed on the gel and the air bubbles removed. Three pieces of Whatman 3MM paper 
cut to gel size were soaked in lOx SSC and placed on top of the membrane followed by 
paper towels (-I 	thick). A weight (Sigma catalogue x2) was placed on top of the 
paper towels and the gel blotted overnight (normal samples) or for 48 hours (PFGE 
samples). The membrane was removed after blotting, rinsed in 2x SSC and baked at 
1200C for 30 minutes. For PFGE samples, the gel was re-stained in lg/mi ethidium 
bromide to determine the efficiency of nucleic acid transfer. 
2.1.4.2. Dry Blotting 
Dry blotting and alkali blotting were used routinely for the transfer of plasmid 
DNA and smaller molecular weight genomic DNA. 
The gel was denatured (0.5M NaOH; 1.5MNaC1) for 30 minutes and 
neutralised (1.5M NaCl; 0.5M Tris.HC1 pH7.4) for 30 minutes. The gel was placed 
face down on Saran wrap and Hybond N+  membrane (pre-soaked in water then 
20xSSC) was placed on to the gel followed by 3 pieces of Whatman 3MM paper 
(soaked in 20xSSC). Paper towels and a weight was placed on top. After overnight 
blotting the membrane was rinsed in 2xSSC and baked at 1200C for 30 minutes. 
2.1.4 3. Alkali Blotting 
The gel was denatured in 0.4M NaOH for 20 minutes and dry blotted as above 
with the Hybond N+ membrane and the Whatman 3MM soaked in 0.4M NaOH 
2.1.4.4. Dot Blotting 
Dot blotting was used for the routine screening of tail genomic DNA for 
genotyping purposes. All dot blotting was done by Dianne Peddie using the following 
one tube method for preparing and blotting genomic DNA from tail biopsies. 
Tail biopsies were digested overnight in tail lysis buffer (100mM Tris.HC1 
pH8.5; 5mM EDTA; 0.2% SDS; 200mM NaCl; 100.ig/m1 Proteinase K added fresh). 
While the lysate was still warm, 0.1 ml SM NaCl was added and vortexed at high speed 
for 5-10 sec. 0.5 mis of chloroform was added and vortexed again for 5-10 seconds. 
Samples were spun in a microfuge for 5 minutes. From the aqueous phase, 50 p1 was 
transferred to a 96-well plate and the DNA denatured by adding 150 tl of 0.53 M 
NaOH and incubating at 37°C for 30 minutes. The dot blot apparatus (Biorad 96-well) 
was prepared by cutting a piece of Hybond N+  membrane and a piece of Whatman 
3MM paper to fit the apparatus. The membrane was pre-wet in sterile water then 
soaked in 0.4 M NaOH for 10 minutes. The Whatman paper was pre-wet in 0.4 M 
NaOH and placed underneath the membrane on the apparatus. Samples were applied to 
the dot blot apparatus and left for 30 minutes before applying a gentle vacuum to draw 
through the samples. The membrane was removed, washed with 30mM NaP 
buffer/0. 1% SDS buffer and baked at 1200C for 30 minutes. 
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2.1.4.5. Northern Blotting 
10- 15tg of total RNA was added to 3 volumes of sample buffer (66% 
deionised formamide; 22% formaldehyde; 1 .2xMOPS buffer) and denatured at 700C 
for 10 minutes. Samples were cooled on ice and 2tl of lOx RNA loading dye added 
(50% glycerol; 1mM EDTA; 0.4% bromophenol blue; 0.4% xylene cyanol; 2jig 
ethidium bromide) the samples were separated on a 1% denaturing agarose gel prepared 
in 1xMOPS buffer (20mM MOPS; 4m1\4 sodium acetate; 1mM EDTA- pH7.0) and 
17.5% formaldehyde (overnight at 25V or 5-6 hours at 70V). Molecular size standards 
were used (1pg of the 0.24- 9.5Kb RNA ladder - GibcoBRL). After electrophoresis, 
the RNA quality was determined by the examining the 28s and 18s rRNA bands. If 
necessary, the gel was stained with EtBr for 30 minutes and destained overnight. The 
gel was denatured in 50mM NaOH for 30 minutes followed by neutralisation in buffer 
(1.5M NaCl; Tris.HC1 pH 8.0; 1mM EDTA) for 30 minutes. Hybond N membrane 
was soaked in water and then 20xSSC and the RNA transferred using an overnight 
capillary dry blot (Section 2.1.4.2.). 
2.1.5. Radiolabelling Probes 
2.1.5.1. Random Priming Probes 
DNA fragments were gel purified as described in Section 2.1.1.1. and the 
concentration determined by visualisation on an agarose gel. Random priming was 
performed using the 'High Prime' kit (Boehringer) according to manufacturers 
instructions. 
25-50ng of DNA was added to sterile water to a volume of 12j.il, denatured at 
1000C for 10 minutes and snap cooled on ice for 5 minutes. To the denatured DNA 
was added 4il of high prime mix (lunit/mi Kienow polymerase; 0.125mM dATP; 
0.125mM dGTP; 0.125mM; 0.125mM dTTP; 50% v/v glycerol) and 441 of 
[&2P]dCTP (3000CiJmMol, Amersham) and the reaction incubated at 370C for 10 
minutes. The reaction was stopped by adding 1il 0.5M EDTA pH8.0 and 79m1 of 
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dH20 and unincorporated nucleotides were removed by centrifugation of the reaction 
through a G-50 Sephadex column at 2000 x g. for 2 minutes. An aliquot of 2j.tl from 
the labelled probe was used to determine [ct32P]dCTP incorporation. Prior to 
hybridisation, the probe fragments were denatured at 1000C for 10 minutes, snap 
cooled on ice and added directly into the hybridisation mix. 
2.1.5.2. End-labelling Oligonucleotide Probes 
In a screw cap tube on ice was added 50 ng of oligonucleotide, 2.5p1  lOx 
kinase buffer (Boehringer), 5jil 7-32P-ATP (Amersham), ltl polynucleotide kinase 
(Boehringer) and sterile water to a final volume of 25p1. The reaction was incubated at 
370C for 1 hour Unincorporated nucleotides were removed by spinning the reaction 
through Sephadex-G50 as for random labelled probes. The labelled oligonucleotide 
was added directly into the hybridisation solution. 
2.1.5.3. Table of Probes 




en2-intron pT 1 ATG* 
lacZ pT1ATG* 
Group I (LA-8) pLA8* 


















GC1O.fXb 	pGClOt 	 XbaI 	 0.35 
439-a23(fP).fXh 	p439-a23 .fP* 	XhoI 	 0.5 
UBT-1 oligonucleotide probe (Group I). Stock number 9. 
5 '-CAACAGCGAGGAAGAGGAGGACGACGACGACGAGGAAGAGGA-3 
(1 Appendix Ill; * Appendix IV) 
2.1.6. Hybridisation Conditions 
All hybridisations and washes were performed in Techne hybridisation bottles 
rotating in a Techne HB-1 oven using approximately lOmis of hybridisation buffer per 
filter. Hybridisation times varied from 3-hour (for high DNA copy number blots e.g. 
plasmids and PCR products) to overnight (for single copy DNA blots e.g. genomic 
DNA and RNA blots). Prehybridisation, hybridisation and washes were carried out at 
650C for DNA blots using double stranded probes, 420C for DNA blots using 
oligonucleotide probes and 600C for RNA blots. 
Filters were prehybridised for 1-2 hours in hybridisation buffer. For the 
hybridisation of genomic DNA blots, 0.5M Na2HPO4 (p117.1); 15% deionised 
formarnide (Sigma); 7% SDS; 1mM EDTA; 1% w/v BSA (fatty acid free - Sigma) was 
used. Church and Gilbert buffer (0.5M Na2HPO4  (pH7. 1); 7% SDS; 1mM EDTA; 
Church and Gilbert, 1984) was used for the hybridisation of random primed probes and 
oligonucleotide probes to high copy number blots including analysis of RACE-PCR 
and RT-PCR products, PAC clone digests, plasmid digests, secondary screening of 
cDNA libraries. Northern blots were hybridised in 350mM Na2HPO4 (pH7.1); 30% 
deionised formamide (Sigma); 7%SDS; 1mM EDTA; 1% BSA w/v (fatty acid free, 
Sigma). Radiolabelled probe was denatured at 1000C for lOminutes, snap cooled and 
added to fresh hybridisation buffer (.-106c.p.m./ml). Following hybridisation, blots 
were rinsed for 3 x 20 minutes in wash buffer (150mM Na2HPO4  (pH7. 1); 0.1% 
SDS). After washing, the blots were wrapped in Saran wrap and exposed to 
autoradiographic film at -700C for an appropriate length of time (1-7 days) for a signal 
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to appear. Blots were stripped of hybridised probe by pouring on a solution of boiling 
0.5% SDS and allowing to cool to room temperature. 
2.1.7. DNA Sequencing 
The manipulation of raw sequence data (e.g. contiguous sequence assembly and 
conceptual translation) was performed using DNAstar Lasergene 1.60 (Lasergene, 
London, UK). 
2.1.7.1. Manual Sequencing 
Sequencing of double stranded plasmids (Sanger et al., 1977) was carried out 
using the Sequenase Version 2.0 DNA Sequencing Kit (USB-Amersham) as per 
manufacturers instructions with the following modifications. The plasmid was alkali 
denatured in the presence of the sequencing primer to improve primer annealing and 
DMSO is added to the reaction to restrict annealing of the template strands (modified 
from Winship, 1989). 
1-5 jig of plasmid DNA was added to 1-5pmol of sequencing primer (Section 
2.1.7.4.) to a volume of 16p1 withT.E. 4jtl of NaOH was added and the plasmid 
denatured for 5 minutes. The plasmid/primer mix was precipitated with 4p1 of 2.5M 
ammonium acetate (pH4.6) and 55R1 of 100% ethanol. The samples were spun at 
13,000 x g in a microcentrifuge for 10 minutes, pellet washed in 70% ethanol and 
resuspended in 12.5jil of reaction buffer containing 10% DMSO. The reaction was 
subsequently carried out as manufacturers instructions except for the addition of DMSO 
to the termination mix to a final concentration of 10%. 
2.1.7.2. Automated Cycle Sequencing 
Automated cycle sequencing was performed using the Perkin-Elmer Taq 
DyeDeoxy Terminator Cycle Sequencing Kit (Applied Biosystems). The cycle 
sequencing reaction is a modificaton of the dideoxy-termination method of Sanger et 
al.,1977. The four 2!,3  '-dideoxynucleosideS'triphophates (ddNTPs) are covalently 
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linked to different fluorescent dyes allowing the sequencing reaction to be carried out in 
a single tube. 
Plasmid DNA was prepared by PEG precipitation or Qiagen extraction. The 
DyeDeoxy terminator cycle sequencing reactions were carried out in accordance with 
manufacturers instructions. To conserve reagents, half the amounts were used (200-
500ng of plasmid DNA, 1 .6pM of primer (Section 2.1.7.4.), 4j.tl terminator ready 
reaction mix and sterile water to 1 0tl volume). The reactions were overlaid with 40j.il 
of mineral oil and subjected to 25 PCR cycles of 960C for 30 secs; 500C for 15 secs; 
600C 4 mins. The reactions were precipitated with l!1l  3M sodium acetate (pH4.6) and 
2 volumes of 100% ethanol on ice for 15 minutes followed by centrifugation at 13,000 
x g for 25 minutes. The pellet was washed in 70% ethanol, air dried and resuspended 
in 4j.fl of loading buffer (5mM EDTA pH8.0; 10mg/mi Blue dextran in deionised 
formamide). The sequencing reactions were denatured at 950C for 2 minutes and 2p1 
run on a denaturing polyacrylamide gel (7M urea; 5% acrylamide (29:1 Biorad); 
1xTBE; 0.06% ammonium persulphate; 15j.il TEMED per 50ml mix) in 1xTBE on the 
ABI PRISM 377 DNA Sequencer. 
ABIPri5mTM377 Sequencing Software 2. 1.1 (Applied Biosystems) was used to 
analyse the sequencing reactions. Sequence traces were examined by eye to clear any 
ambiguous sequence. For example, a G nucleotide after an A nucleotide often 
produced a low signal intensity which resulted in inaccurate base calling. Routinely, 
each sequencing run produced 500-600 bases. 
2.1.7.3. Direct Sequencing of RACE-PCR Products 
The following procedure was used to sequence 5RACE-PCR products 
(Protocol 1) which had been amplified with the biotinylated primer 105 (Section 
2.1.8.1.) 
(a) Purification and denaturation of RACE-PCR products 
20 p1 (200 tg) of Streptavidin coated beads (Dynabeads M-280) were prepared 
for each template to be sequenced. The beads were immobilised using a magnetic tube 
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holder (Promega) and the supernatant removed. The beads were resuspended in 20 tl 
of lx B&W buffer and mixed gently (2x B&W buffer was made;lOmM Tris-HCJ pH 
7.5, 1.0 mM EDTA, 2.0 M NaCl). Supernatant was removed after immobilising the 
beads on the magnet and then the beads were resuspended in 40 41 of 2x B&W buffer. 
Biotinylated RACE-PCR products (5-40p1) were diluted to 40fl with sterile water and 
mixed with 40t1 of washed beads (in 2xB&W). Samples were incubated for 15 
minutes at room temperature with frequent mixing to keep beads suspended. Using a 
magnet, the supernatant was removed from the beads which were then washed with 
40jil of lx B&W (samples stable for several weeks at 40C). The supernatant was 
removed, the beads resuspended in 81.11  of fresh 0. 1MNaOH and the sample incubated 
for 10 minutes at room temperature. The supernatant was removed and the beads 
washed once with 50j.il 0.1MNaOH, once with 401.11 lxB&W buffer and then once 
with 501.11 T.E. The beads were resuspended in 25j.il of sterile water. 
End labelling of sequencing primer 
10 pmol of sequencing primer 98 (Section 2.1.7.4.) was added to 2 t1 lOX 
polynucleotide kinase buffer (Boehringer-Mannheim); 50 l.tCi  [g-32P] ATP (3000-6000 
CiJmM); 11.11(10  units) polynucleotide kinase (Boehringer-Mannheim) to a total volume 
of 20 .tl with sterile water. Samples were incubated at 37°C for 10 minutes, heat 
inactivated at 95°C for 2 minutes and then stored at -20°C. 
Sequencing reactions 
Sequencing reactions were carried out as per manufacturers instructions using 
the Amersham ThermoSequenase Kit (US 78500). To a 0.5mi PCR tube on ice was 
added 25fl of streptavidin bound RACE-PCR products; 2j.tl IN ThermoSequenase 
reaction buffer; ipi [32P] - end labelled primer (0.5 pmole); 2.tl ThermoSequenase. 
61.11  of the reaction mix was added to each of four 0.5 ml PCR tubes containing 2.tl of 
each termination mix (ddATP, ddCTP, ddGTP, ddGTP). The reactions were overlaid 
with 4Ojil mineral oil and placed in a preheated (95oC) thermal cycler for 2 minutes 
followed by 25 cycles of 950C for 30 secs; 600C for 30 secs; 720C for 1 mm. When 
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the reaction was complete 4pJ of STOP solution was added, the samples heated to 800C 
for 3 minutes and the samples visualised by electrophoresis on a 6%polyacryamide gel. 
2.1.7.4. Sequencing Primers 
Primer (Stock No.) Sequence 5' - 3' 
Vector 
T3 (20) AATTAACCCTCAACTAAAGGG 
T7(21) GTAATACGACTCACTATAGGGC 
SP6 (62) AGCTAITFAGGTGACACTATAG 
Endogenous cDNA 
SANK-2 (69) GAACTGGCAGCAAATFGG 
SANK-3 (70) CACCACCTTCACATGACC 
SANK-4 (7 1) GAAGGCTGGC1TTGGCTG 
SANK-5 (72) GTAAACTGGATGGCATGG 
1.5kb PstI PAC fragment (439-a23.fP) 
SPAC-1 (73) TFAGTATCGCGAGACGAG 
SPAC-2 (74) TGCGGTGGCTTCTTCTTC 
Direct Sequencing 
98 AGCAOTGAAGGCTGTGC 
2.1.8. Polymerase Chain Reaction (PCR) 
All PCR reactions were carried out using the Hybaid Omnigene Thermocycler. dNTP's 
were supplied by Boehringer. 
2.1.8.1. Rapid Amplification of eDNA Ends-PCR (5'RACE-PCR) 
The 5'RACE protocol was initially described by Frohman et at., 1988 with the 
modifications to that protocol as described by Townley et al., 1997 essentially 
providing both the protocols described below. 
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Protocols 1 and 2 are essentially the same except for the use of different primers 
(Section 2.1.8.1. Protocol 1(g); Section 2.1.8.1. Protocol 2(g)) and several procedural 
differences. Protocol 1 is described in detail with the corresponding primers used in 
Protocol 2 given in parentheses. Procedural differences between Protocol 1 and 
Protocol 2 are listed after protocol 1. 
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(a) Figure 2.1: Overview of 5'RACE-PCR (Protocol 1) 
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Protocol 1 (Figure 2.1) 
First Strand cDNA Synthesis 
To a 0.5m1 PCR tube on ice was added 10 .tg of total RNA; lOng primer 78 
(GSP1-protocol 2) with DEPC treated water added to a volume of 12j11. Samples were 
denatured at 70°C for 5 minutes followed by snap cooling on ice. The contents were 
collected by brief centrifugation. To the RNA was added 4jil 5x 1st strand buffer 
(520mM Tris-HC1 pH8.3; 375mM KC1; 15mM M902 - GibcoBRL); 2jil 10mM DTT; 
1t1 10mM dNTP. After heating at 37°C for 2 minutes, lpJ (200units) of Superscript 
II (GibcoBRL) was added to a total volume of 20t1 and the samples incubated at 37°C 
for 1 hour. 1M NaOH was added to 0. 1M final concentration (2.2tl) and the reactions 
incubated at 65°C for 20 minutes to hydrolyse RNA. Samples were neutralised with 
2.2tl 1M HC1. The first strand cDNA reaction was then dialysed against T.E. for 4 
hours using a 0.025.im microdialysis filter (Millipore) floating in a petri dish with 
-50m1s of T.E. Approximately, 5-10il was recovered after dialysis. Sterile dH20 was 
added to 20Rl 
Poly A Tall Addition 
To 20tI of 1st strand reaction was added 6jil 6xTdT buffer (0.1M Potassium 
cacodylate (pH7.2); 10111M C0C12; 1mM DTT); 2j.il 2mM dATP. Samples were 
incubated at 37°C for 2 minutes and then 2tl (20units) of terminal transferase (TdT-
GibcoBRL) was added and the reaction incubated at 37°C for 5 minutes. The reaction 
was heat inactivated at 70°C for 2 minutes and the samples collected by centrifugation 
2nd Strand Synthesis (not in protocol 2) 
To 15j.il of the tailing reaction was added 2pJ lOx restriction buffer M 
(Boehringer); 1.tl 10mM dNTPs; lOng primer 56; lpJ (2units) Klenow (Boehringer) 
The samples were incubated at room temperature for 30 minutes followed by 30 
minutes at 37°C. The reaction was heat inactivated for 5 minutes 70°C. The double 
stranded cDNA sample was microdialysed on 0.1I.Lm microdialysis filter against T.E. 
as above. dH20 was added to 37p1. 
59 
1St Round PCR Amplification 
To 37pl of the double stranded cDNA was added 5p1 lOx PCR buffer (50mM 
KC1I1OmM Tris (pH8.3)); 4jil 25mM M902; 1tl 10mM dNTP's; lOOng primer 59 
(anchor- protocol 2); lOOng primer 79 (GSP 2- protocol 2); ipi (5 units) Taq DNA 
polymerase (Promega). The reaction overlaid with 50jil of mineral oil. The PCR 
amplification was performed on a thermocycler through 30 cycles of 94°C for I min 30 
secs; 60°C for Imin 30 secs; 72°C for 3 mins. PCR products were dialysed against 
T.E. on 0. lJim filters as above. Approximately 15il was recovered after dialysis. 
dH20 was added to 40jil. 
2nd Round PCR Amplification 
If the products were to be taken through the direct sequencing protocol (Section 
2.1.7.3.) then 5p1 of 1st round PCR products; 5tl lOx PCR buffer; 4jil 25mM M902; 
ipi 10mM dNTPs; lOOng primer 105; lOOng primer 55; ilil  Taq DNA polymerase 
(Promega) were added to a 0.5ml PCR tube. 
If the PCR products were to be cloned (Section 2.1.8.1. Protocol 1(f)), the 
nested second round PCR amplification reactions were performed as follows using Pfu 
polymerase (GibcoBRL) to produce blunt ended PCR products for cloning using the 
Zero BluntTM PCR cloning kit (Invitrogen). 5tl 1st round PCR products; 5tl lOx Pfu 
buffer (Stratagene); ipi 10mM dNTPs; lOOng primer 59 (anchor- protocol 2); lOOng 
primer 55 (55- protocol 2); ipi Pfu polymerase (Stratagene). 
Both reaction volumes were made up to 50tl with sterile water. The same PCR 
cycle conditions and microdialysis conditions were carried out as for the 1st round PCR 
reactions. To assess the specificity of the PCR amplifications, 5 t1 of the 1st and 2nd 
round PCR products were ran on a agarose gel, Southern blotted and hybridised to the 
en-2 exon probe. 
Cloning of PCR Products 
The Pfu amplified 2nd round PCR products were run on a 1.0% LMP agarose 
gel and the amplification products between 1.0 and 0.5kb in size were purified from the 
gel by phenol extraction and precipitation (Section 2.1.1.1.). Half of the remaining 
PCR products were subsequently cloned into pCR®-Blunt using the Zero BluntTM 
cloning procedure (Section 2.1.1.). 
Primers used in Protocol 1 
Primer (Stock No.) Sequence 5' -> Y(homology) 
56 	 GGTFGTGAGCTCUCTAGATGG1TFT[TTTVFTY1TFTVF (anchor) 
59 (19) GGTTGTGAGCTCTTCTAGATGG (anchor) 
105 (17) 	GGTFGTGAGCTCTCTAGATGG (anchor, 5'biotinylated) 
78 (44)TAATGGGATAGGTFACG (LacZ) 
79 	 AGTATCGGCCTCAGGAAGATCG (LacZ) 
98 	 AGCAGTGAAGGCTGTGC (en-2) 
Protocol 2 
Is essentially the same as protocol 1 except for the following differences. 
(b) Poly C Tail Addition 
To 20j.tl of 1st strand reaction was added 6p1 6xTdT buffer; 2jfl 2mM dCTP 
and the samples incubated at 37°C for 2 minutes. 2j.il (20units) of terminal transferase 
(TdT- GibcoBRL) was added and the reaction incubated at 370C for 5 minutes followed 
by heat inactivation at 701C for 2 minutes. Samples were collected by centrifugation. 
The PolyC tailed cDNA products were used directly in the 1st round PCR amplification 
using the polyG anchor primer. No second strand synthesis was necessary. 
2nd Round PCR 
As for Protocol 1 for direct sequencing using Taq DNA polymerase except 
bOng of polyG anchor primer used. 
Cloning of PCR Products 
2nd round PCR products were gel purified, digested with SpeT and KpnI and 
directionally cloned into a SpeIJKpnI digested pBluescript H KS- (Section 2.1.1.2.). 
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(g) Primers used in Protocol 2 
Primer (Stock No.) 	Sequence 5' -> Y(homology) 
Anchor (4) 	GGCCACGCGTCGACTAGTACGGGIIGcjGILGGGIIG 
GSP1 (1) 	 GCAAGGCGATFAAGTTGGGT (LacZ) 
GSP2 (2) 	 CCGTCGACTCTGGCGCCGCT (en-2) 
55 (40) 	TGCTCTGTCAGGTACCTGTTG (en-2) 
Underlined nucleotides correspond to restriction sites Spel (anchor) and KpnI 
(55) used for cloning RACE-PCR products. 
2.1.8.2. Reverse transcriptase PCR (RT-PCR) 
cDNA Synthesis 
ling of total RNA was made up to a volume of 13g1 with DEPC treated water in 
a 0.5 ml PCR tube. Samples were incubated at 70°C for 5 minutes to denature any 
RNA secondary structure, chilled on ice for 2 minutes and the samples collected at the 
bottom of the tube by centrifugation. To each sample (on ice) was added 2p1 lOx PCR 
buffer (Promega); 2jil 25mM MgCl2; ljil (0.125 units) random hexamers 
(Boehringer); 2il 10mM dNTPs; 1 .Opi (200units) MMLV reverse transcriptase 
(GibcoBRL)and DEPC treated water to a final volume of 20.il. Samples were left at 
250C for 10 minutes, incubated at 420C for 1 hour then denatured at 950C for 10 
minutes. 
PCR 
To 4p1 of the first strand cDNA reaction was added: 1 .6j.tl IN PCR buffer; 
1.6jil 25mM MgCl2;  bOng primer x; bOng primer y; 0.2j.il (1 unit) Taq DNA 
polymerase (Promega) with water added to 20t1 final volume. Samples were overlayed 
with 30pJ of mineral oil (Sigma) and PCR amplification carried out using 30 cycles of 
960C for 5 secs; 530C for 15 secs; 720C for 1 mm. 
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(c) Primers used in RT-PCR 







Sequence 5' - 3' (homology) 
GGTAGTTTTCTGTCAGTGG (Group II) 
CCCCTCCACAACTGCTCC (Group II) 
CTGTGCTCTCAGCTCTCATC (endogenous cDNA) 
GAAGACTGTGCATTGACATC (endogenous cDNA) 
GCTGGTGAAAAGGACCTCT (HPRT) 
CACAGGACTAGAACACCTGC (HPRT) 
2.1.9. RNase Protection Assay 
The following plasmids were used for the generation of antisense riboprobes. 
Plasmids were linearised by restriction digest using the specified enzyme and the 
riboprobe generated using the appropriate RNA polymerase site. 
Riboprobe Plasmid Digest Polymerase 
Group I (LA-8) pLA8* XbaI T3 
Group II (L-69) pL69* HindHI T7 
5Aa.fP(150) p5Aa.fP(150)* XbaI T3 
GAPdH GAPdH* AccI SP6 
* Appendix IV 
The linearised plasmid was gel purified (Section 2.1.1.1.) and the concentration 
determined after separation of the purified fragment on an agarose gel. 
(a) Riboprobe Synthesis 
In a screw cap tube at room temperature was added 2.il (500ng) of template 
DNA; 0.751i1 200mM DTT; 0.75ji1 2mg/mi BSA; 2.25ji1 3.3mM ATP/UTP/GTP; 
O.Spi (20units) RNase inhibitor (GibcoBRL); 6.25p1 [a32P] CTP (250mCi);1.5t1 lOx 
transcription buffer (40mM Tris.HC1 pH8.0; 6mM MgC12;  10mM DTT; 2mM 
spermidine); 1 .Ojil RNA polymerase (T3, T7 or SP6- Boehringer). For the GAPdH 
loading control, 0.5j.il [a32P] CTP and 5.75 j.tl unlabelled 1mM CTP for GAPdH was 
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added in place of the 6.25p1 [a32P] CTP. The in vitro transcription reaction was 
incubated at 37°C for 1 hour and then treated with 2jil (20units) RNase-free DNase at 
37°C for 15 minutes to remove the DNA template. The reaction volume was made up 
to 50tl with sterile water. To remove protein and unincorporated nucleotides, the 
probe was either extracted once with an equal volume of phenol/chloroform and spun 
through a Sephadex G-50 column or centrifuged through a SpinX column (Sigma 
Costar) loaded with Sephadex G-50 at 13,000 x g for 5 seconds. The probe was either 
directly gel purified from this stage or stored overnight at -800C. 
Gel Purification of Riboprobe 
The riboprobe was mixed with loading dye (95% formaniide; 20mM EDTA; 
0.05% bromophenol blue; 0.05% xylene cyanol FF) at a ration of 3:2, denatured at 
800C for 2 minutes and run on a 6% denaturing polyacrylanilde sequencing gel (7M 
urea; 5.7% acrylamide; 0.3% bisacrylamide; 1xTBE; 0.06% ammonium persuiphate; 
35111 TEMED per lOOmi mix) in 1xTBE for —1 .5hours at 60W. After the 
electrophoresis the wet gel on the glass plate was wrapped in Saran wrap and exposed 
to autoradiographic film for 5 minutes (the film was aligned to the top left of the glass 
plate). The developed autoradiograph was aligned to the gel and the area of the gel 
containing the largest probe band excised using a scalpel. The gel was re-exposed to 
ensure that the correct region of the gel had been isolated. The gel slice was incubated 
in 0.5m1 of probe elution buffer (0.5M ammonium acetate; 1mM EDTA; 0.2% SDS) at 
37°C for 2 hours in a screw cap tube with vigorous shaking to elute the probe. The gel 
was pelleted by centrifugation at 13,000 x g for 5 minutes and the supernatant 
containing the probe removed. To measure the incorporation of each probe, 21.11  of 
riboprobe was added to imi of scintillation fluid (Ultima Gold). 
Hybridisation 
10ig target RNA, 3.5 x 105cpm of eluted riboprobe and 5 x 104cpm of 
GAPdH loading control riboprobe in a total volume 100111 was precipitated with 0.3M 
sodium acetate, 20mg glycogen (optional) and 2 volumes of 100% ethanol at -80°C for 
30 minutes. The RNA was pelleted by centrifugation at 13,000 x g for 10 minutes and 
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then washed with 70% ethanol and air dried. The RNA pellet was resuspended in 30tI 
of hybridisation mix (6jil 5x hybridisation buffer (2M NaCl; 200mM PIPES pH6.4; 
10mM EDTA); 24g1 deionised formamide). Hybridisation reactions were then 
denatured at 85°C for 15 minutes and hybridised overnight at 55°C. 
(d) RNase Digestion 
Digestion buffer was made up with 60p1 lMTris.HC1 pH7.5; 60.tl 0.5M EDTA; 360il 
5M NaCl; 5.25m1 sterile water; 9.6i.il (25mg/mi) RNaseA; 2. 1 g (2000 units) RNase 
Ti (GibcoBRL). 350iJ of digestion buffer was added to the hybridisation reaction and 
incubated at 370C  for 30 minutes to remove unhybridised RNA. The samples were 
then incubated for a further 10 minutes with lOj.il of 20%SDS and 5pJ of 10J.ig/ml 
proteinase K to stop the digestion. The reactions were then extracted with 
phenol/chloroform and precipitated with imI 100% ethanol (5mg tRNA as a carrier-
optional) at -80°C for 30 minutes. RNA was pelleted by centrifugation at 13,000 x g 
for 10 minutes, air dried and resuspended in 4.tl of loading dye. Samples were then 
denatured briefly at 95°C and separated on a 6% polyacrylamide gel at 60W for 2-3 
hours depending on the predicted size of the digestion products. The gel was dried 
before exposing to autoradiographic film at -800C. 
2.1.10. eDNA Library Screening 
The protocol for screening ?ZAP®II (Stratagene) libraries is essentially as 
manufacturers instructions. The XZAPII vector contains the pBluescript SK(-) 
phagemid into which the cDNAs are subcloned. Screening of the library to single 
colonies is performed in XZAPII. Using the in vivo excision protocol, pBluescript SK 
(-) can then be isolated as a plasmid. 
(a) Maintenance of Bacterial Strains 
XL1 Blue MRF' is used to propagate XZAPII and is maintained as a glycerol 
stock and bacterial streak using LB + tetracycline (12.5jig/ml). For incubating XZAPII, 
XL1 Blue MRF is plated on LB agar + 0.2% maltose + 10mM MgSO4. 
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SOLRTM strain is used in the in vivo excision protocol to recover excised 
phagemids and is maintained as a glycerol stock and bacterial streak using LB + 
kanamycin (50j.ig/ml). For incubating the excised phagemid, SOLRTM  is plated on LB 
agar with no supplements. 
Plating cultures were inoculated from a fresh LB plate (with appropriate 
antibiotic) of cells using a single colony. Cultures were either grown overnight at 300C 
in 50 ml LB (+1- supplements) or grown overnight at 37oC in lOmis LB (+ 
supplements) and added to fresh 50mls LB (+1- supplements) and grown for 2-3 hours. 
The cultures were spun at 2000 x g for 10 minutes in a Beckman-GPR benchtop 
centrifuge and gently resuspended in 10 mM MgSO4 to the appropriate 0D600 (0.5 for 
XL1-Blue and 1.0 for SOLR) 
Titering Procedure 
Titers of phage libraries and selected phage clones were determined by making 
several serial dilutions of the phage in SM buffer (100mM NaCl; 10mM MgSO4; 
50mM Tris.HCI pH7.5; 0.01% gelatin). Up to lOOj.tl of the diluted phage was added 
to 2001.11 0D600= 0.5 XL1-Blue in a Falcon 2059 tube and the phage were allowed to 
adsorb for 15 minutes at 370C. 3.5mls of molten (450C) top agarose (0.7% agarose in 
10mM MgSO4) was added and immediately poured onto pre-warmed (370C) 9cm LB 
plates. The top agarose was allowed to set and the plates incubated inverted at 370C 
overnight. Counting the number of plaques determined the plaque forming units (pfu) 
per ml concentration of the original phage stock. 
Library Plating and Plaque Lifts 
Phage stocks were mixed with plating culture 0D600= 0.5 XL 1-Blue, incubated 
at 370C for 15 minutes and then moulten top agarose(450C) added. The following 
proportions were used depending on the size of bacterial plate: 
plate size 	 maximum no. phage(pfulml) 	volume top agarose 
9cm 	 —5,000 	 3.5m1 
15cm 	 20-30,000 	 7m1 
20 x 20cm 	 150-200,000 	 20-25m1 
The top agarose was allowed to set and the plates incubated at 370C overnight. 
Plates were left at 40C for 1-2 hours to allow agarose to harden before performing 
plaque lifts. Hybond N+ nylon membrane (Amersham) was placed on to the agarose 
(avoiding bubbles) for 1 minute and asymmetric orientation marks made on the filter 
with a needle. A duplicate lift was taken by placing a fresh piece of membrane on the 
agarose for 2 minutes (using the same orientation marks). Membranes were placed face 
up on Whatman 3MM paper soaked in: denaturing solution (1.5M NaCl; 0.5M NaOH) 
for 2 minutes; neutralising solution (0.5M Tris.HC1 pH8.0; 1.5M NaCl) for 3 minutes; 
neutralising solution for 3 minutes and then rinsed in 2xSSC. The membranes were 
then air dried briefly and baked at 1200C for 30 minutes. 
(d) Library Screening 
In the primary screening a total of lxi 06  pfu were screened from a random-
primed D3 ES cell cDNA library cloned into AZAP H (gift from Hitoshi Niwa). Phage 
were plated onto 20cm x 20cm LB plates at the above proportions. 
Filters were individually soaked in prehybridisation buffer (5xDenhardt's; 
6xSSC; 0.5% Sarkosyl; 100mg/mi denatured herring sperm) and then incubated at 
650C for 2-3 hours in a sealed tupperware box on a shaking platform. The 
prehybridisation buffer was replaced with an equal volume of hybridisation buffer 
(5xDenhardt's; 6xSSC; 0.5% Sarkosyl; 100mg/mi denatured herring sperm; 100mg/mi 
dextran sulphate). 32P-labelled probe was added to the hybridisation buffer at 
106cpm/ml and incubated at 650C overnight. After hybridisation, filters were washed 
in 2xSSC; 0. 1%SDS four times for 30 minutes at 650C and subsequently exposed to 
autoradiographic film at -800C for 1-5 days depending on the signal intensity. From 
the primary screen, plaques with a duplicate positive signal were cored with the wide 
end of a sterile blue Gilson tip, placed in 500p1 of SM buffer and the phage eluted by 
shaking or overnight incubation. Secondary screening was performed by plating serial 
dilutions of each primary plaque onto 9cm agar plates and the same protocol followed 
as for the primary screen. Hybridisation from the secondary screen onwards was 
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performed in Church and Gilbert solution (Section 2.1.6). This procedure was 
repeated until a single, well isolated positive plaque could be purified. 
(e) In vivo Excision 
The pBluescript SK(-) plasmid carrying the cDNA insert was excised from 
7ZAPII using the Ex Assist helper phage (Stratagene). In ?ZAPII, pBluescript is 
flanked by the replication initiator (I) and terminator (T) signals of bacteriophage f 1. 
Co-infection of XZAPII and fl into E. coli results in the replication of pBluescript and 
any potential cDNA insert as a single stranded molecule by the co-infected f  phage 
proteins. The newly synthesised pBluescript DNA is circularised and packaged as a f  
phage. Subsequently, the pBluescript can be recovered by infecting an F strain 
(SOLR) and growing in the presence of Ampicillin. The helper phage carries an amber 
mutation that prevents its replication in a non suppressing E.coli strain such as SOLR. 
This allows only the excised plasmid to replicate in the host. 
In a 50 ml conical tube was added 200tl of 0D600= 1.0 XL1-Blue MRF cells; 
100tl of 2ZAPII phage stock (>1x105 pfu) from a positive plaque; 1il of ExAssist 
helper phage (>1x106 pfu/ml). The tube was incubated at 370C for 15 minutes and 
then 3 mis of LB broth added and incubated at 370C for 2-2.5 hours with shaking. The 
cultures were incubated at 700C for 15 minutes to kill the bacterial and the dead cells 
pelletted by centrifugation at 4000 x g for 15 minutes. The supematent contains 
pBluescript packaged as f  phage (may be stored at 40C for up to 2 months). To 
recover the excised phagemids, 200j.tl of a plating culture of SOLR cells (0D600= 1.0) 
was mixed with 1, 10 and 100tl of the supematent and incubated at 370C for 15 
minutes. lOOpl from each tube was plated on LB/Amp plates which were incubated at 
370C overnight. Approximately 5 colonies were selected per individual cDNA clone 
for plasmid preparation to confirm the presence of a cDNA insert. 
2.2. Protein Analysis 
The followiing procedure is adapted from Ausubel et al. (1998) using the 
Laemmli system (Laemmli, 1970). SDS-PAGE and immunoblotting was carried out 
using the Mini-PROTEAN II apparatus (Biorad). 
2.2.1. Protein Preparation 
Crude protein lysates were prepared by homogenising between 100-500mg of 
tissue in a ground glass homogeniser in 2mls of lysis buffer (2% SDS/ 50mM Tris 
pH7.4). The sample was then centrifuged for 5 minutes at 13,000 x g and the 
supernatent removed. The protein concentration of each sample was determined using 
the Biorad protein assay kit according to the manufacturers instructions. The OD595 of 
each sample was compared to a protein concentration curve using BSA standards. 
2.2.2. SDS-Polyacryamide Gel Electrophoresis (SDS-PAGE) 
The separating gel mix was prepared by adding 7.Oml dH20; 4.Oml 30% 
acrylamide mix (29.2% acylaniide; 0.8% Ni, NI-methylene-bis acrylamide); 3.8m1 
1.5M Tris (pH8.8); 150j.tl 10% SDS; 9tl ThMED (Sigma); 150j.tl 10% ammonium 
persuiphate (freshly made). Gel plates were cleaned, assembled and the separating gel 
poured. The gel was overlayed with Butan-2-ol -dH20 saturated (top phase) and 
allowed to set for 30 minutes. The set gel was then rinsed thoroughly with sterile water 
to remove any trace of Butan-2-ol 
The stacking gel mix was prepared by adding 3.4m1 dH20; 830pJ 30% 
acrylamide mix; 630j.il 1M Tris (pH6.8); 50pJ 10% SDS; 5tl TEMED; 50pJ 10% 
APS. The stacking gel was poured on top of the separating gel, the combs were 
inserted and the gel allowed to set for 10 minutes. 5x Laemmli Sample buffer dye 
(62.5mM Tris (pH6.8); 12.5% glycerol; 2% SDS; 20mM DTT; 0.0025% bromophenol 
Blue) was heated to 1000C and an added to 10-20mg protein samples. The protein 
samples and an aliquot (10p1) prestained SDS-PAGE broad-range molecular weight 
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markers (Biorad Cat No. 72807A) were denatured for 5 minutes at 1000C. Samples 
were loaded on the gel and ran at 90mA for 50minutes using Biorad's Mini-Protean II 
electrophoresis tank in lx Laemrnli running buffer (25mM Tris; 192mM glycine; 1% 
SDS). 
2.2.3. Coomassie Staining 
The electrophoresis equipment was disassembled, the gel plates separated, the 
stacking gel removed and an orientation mark put on the gel The gel was fixed for 15-
30 minutes in fix solution (20% methanol; 10% acetic acid) and then Coomassie stain 
(0.25% w/v Coomassie blue R; 50% methanol; 10% acetic acid) was added for 20 
minutes. The gel was destained overnight at room temperature in water. 
2.2.4. Immunoblotting 
Sponge pads (Biorad), Hybond ECL membrane (Amersham) and the separating 
gel were equilibrated in protein transfer buffer (25m1v1 Tris; 192mM glycine; 20% 
methanol) for 10-15 minutes at 40C (membrane was pre-soaked in dH20). Blotting 
apparatus (Mini-PROTEAN II) was assembled in protein transfer buffer according to 
manufacturers instructions. The ice block was added to the protein transfer buffer 
(40C) and then the gel cassette was added. Blotting was carried out at lOOmA for 30 
minutes and then 300mA for 30 minutes with stirring. The apparatus was 
disassembled, the filter removed and rinsed briefly in PBS. 
2.2.5. Immunodetection 
The membrane was blocked in lOmis 5% milk (Marvel) in TBS-T for lhr at 
room temperature (or 4oC 0/N). The filter was probed with a polyclonal rabbit anti-
mouse -foetoprotein 10  antibody (ICN Biomedicals Cat. No: 64-561) at 1:1000 
dilution in TBST with 0.3% milk, 0.02% sodium azide for a minimum of 1 hour at 
room temperature. The filter was washed 5 times for 5 minutes each in TBST at room 
temperature. The filter was then probed with Anti-rabbit Ig- horseradish peroxidase 
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linked whole antibody (Amersham NA934) at 1:5000 (2tl in 10 mIs) for ihour at room 
temperature. The filter was washed 5 times for 5 minutes each in TBST at room 
temperature. Equal volumes (4mls each) of ECL reagents (Amersham) were added to 
the filter and left for 1 minute. The membrane was quickly exposed to film for 5, 10, 
30 and 60 seconds. The ECL system is a luminol based chemiluminescent reaction for 
the detection of horseradish peroxidase labelled antibodies. 
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2.3. ES Cell Culture 
General methods for the manipulation of ES cells are based on Hogan et al., 
1994. All ES cell manipulations were performed in laminar flow sterile hoods using a 
strict sterile technique which included wiping the hood down and spraying all items 
entering the hood with 70% industrial methylated spirits (IMS). ES cells were 
incubated at 7.5%CO2 at 370C in a humidified incubator (Heraeus). All solutions were 
filtered and subsequently tested for sterility and were also prewarmed to 370C prior to 
use. ES cells were examined using an inverted microscope (Olympus CK2). 
2.3.1. Reagents 
The parental R 1 ES cell line and the 1114 gene trap cell line were maintaied in lx 
G-MEM ES cells culture medium containing 15% FCS (lx Glasgow MEM 
(GibcoBRL); 0.25% sodium bicarbonate (GibcoBRL); 0.1% MEM non-essential amino 
acids (GibcoBRL); 4mM glutamine (GibcoBRL); 2mM sodium pyruvate (GibcoBRL); 
0.1mM 2-mercaptoethanol (Sigma); 15% foetal calf serum (FCS) (Globepharm, 
Surrey). All flasks were gelatinised (5 minutes with 0.1% gelatin in PBS) prior to 
addition of ES cells. ES cells were maintained in an undifferentiated state by 
Differentiation Inhibiting Activity/Leukemia Inhibitory Factor (DIA/LIF). Murine or 
human DIA/LIF expression plasmids were used to transiently express DIA/LIF in COS-
7 cells using the previously described method (Smith, 1991). Serial dilutions of the 
supernatant were tested on ES cells for their ability to maintain pluripotency. 
Routinely, lOOx the mininum concentration required to keep ES cells undifferentiated 
was used as the working concentration. All the stock solutions were prepared by 
Douglas Colby and Derek Rout at the CGR. 
2.3.2. Thawing ES Cells 
Frozen ES cell vials were taken directly from the liquid nitrogen storage and 
quickly thawed in a 370C water bath. The cell suspension was transferred to a 
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centrifuge tube containing lOmi of prewarmed ES cell medium and immediately 
centrifuged at 1,200 x g for 3 minutes (Denley BS400 Benctop). The media was 
aspirated and the pelleted cells were resuspended in imi of ES cell medium. The cell 
suspension was then used to seed a 25cm2 flask containing 9mls of ES cell medium 
(+DIAILIF) and the medium changed after 8 hours of culture to remove remove any 
dead cells. 
2.3.3. Passsage and Expansion of ES Cells 
Cultures were monitored every day to assure that ES cells had not grown past 
confluency. Cells were normally passaged every two days. Culture medium was 
aspirated off the ES cell culture and the cells rinsed twice with 5mls PBS for a 25cm2 
flask. irni of trypsin solution (0.025% trypsin (Gibco); 0.1% chicken serum (Flow 
Labs); 1.3mM EDTA (Sigma) in PBS) was added to the cells and incubated at 370C for 
1-2 minutes until a single cell suspension was achieved. 9mls of ES cell medium was 
added to neutralise the trypsin and the cell suspension was centrifuged for 5 minutes at 
1,200 x g, excess media was removed and the pellet resuspended in 5mls of fresh 
culture media. The cell were counted in a haemocytometer and 1x106 cells in 10 mIs of 
ES cell medium supplemented with DIA/LIF (100units/ml) were seeded to a 25cm2 
gelatinised flask. 
2.3.4. Freezing ES Cells 
ES cells were frozen at 1 vial per 25cm2. Cells were trypsinised into a single 
cell suspension as above. The cell suspension was centrifuged for 5 minutes at 1,200 x 
g and the pellet resuspended in 0.5ml of freezing mix (10% dimethyl sulphoxide in ES 
cell medium) and rapidly aliquotted into Nunc ciyotubes on ice. Vials were put 
immediately at -800C overnight before being transferred to a liquid nitrogen cell bank 
for long term storage. Exposure of ES cells to DMSO is kept to a minimum as it is 
toxic to cells and is an ES cell differentiation agent. 
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2.3.5. Selection of Retinoic Acid-Responsive Gene Trap Cell Lines 
After electroporation of the gene trap vector PT 1 -ATG (Hill and Wurst, 1993), 
the RI ES cells were maintained in G418 for 8 days. G418 resistant colonies were 
selected, replica plated onto filters (Hill and Wurst, 1993) and the filters treated with 
either ES cell medium or RA-induction medium (ES cell medium (without LIP) 
containing 5%FCS and 10-6M all-trans-RA - Sigma). After 42 hours, fresh medium 
was added to the filters and the filters left for an additional 6 hours before assaying the 
for 	- gal activity (Forrester et al., 1996). 
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2.4. Histology 
2.4.1. Maintenance of Animals 
All mice were housed and bred within the Centre for Genome Research, 
Edinburgh, according to the provisions of the animals (Scientific Procedures) Act (UK) 
1986. Mice were housed in a stabilised enviroment with a 14 hours light! 10 hours 
dark cycle (midpoint 12 O'Clock, midnight). They were provided with a constant 
supply of water and chow food. As standard practice, litters from natural matings were 
left with the parents until 3 weeks of age when they were weaned by separating the 
offspring from their parents. At weaning animals are sexed and tail tips taken for 
genotyping. At 6 weeks of age the mice can be used for mating. 
2.4.2. Preparation of Specimens for Histology 
All animals were culled by the schedule 1 method of cervical dislocation. 
For the collection of embryos at specific stages of gestation, matings were set up 
overnight and the females examined for the presence of a vaginal plug the next 
morning. If a vaginal plug was found, the stage of gestation was marked as 0.5 days 
post coitus. Pregnant females at the correct stage in gestation were sacrificed and the 
uterus dissected out in to cold PBS. Subsequently, the embryos were dissected from 
the uterus and all the extraembryonic tissues (decidua, placenta, Reichert's membrane) 
removed with the exception of the yolk sac. The age of the embryos up to 
approximately 10.5d.p.c. was determined from somite number. Foetuses 1 ld.p.c. and 
older were decapitated immediately. Adult tissues were dissected free of connective 
tissues and fat and placed in to ice cold PBS for cryosectioning. 
2.4.3. Cryostat Sectioning 
Freshly dissected tissues or embryos were embedded in OCT compound 
(Tissue Tek, Miles Inc, Diagnostic Division, Elichort, IN, USA), snap frozen in liquid 
nitrogen and stored at -800C. Prior to sectioning, OCT mounted tissues were placed in 
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the cryostat (Cryotomb 650- Anglia Scientific) and allowed to equlibrate to the cutting 
temperature (-15 to -200C) for 1 hour. Sections were typically cut at 1 0im and lifted 
directly onto room temperature TESPA coated slides (see below). The sections were 
dried onto the slides at room temperature and either stored at 200C  or stained for f3-gal 
activity. 
TESPA Coating Slides 
Glass microscope slides (Chance Popper) were treated with 10% HCl in 70% 
ethanol for 10 seconds, rinsed in dH20 for 10 seconds, dehydrated in 95% ethanol for 
10 seconds and baked dry at 1500C for 5 minutes. Once cooled to room temperature 
the slides were dipped in 2% TESPA (3-aminopropyl-tritheoxysilane; Sigma, A3648) 
in acetone for lOs, rinsed twice in 100% acetone for 10 seconds each, rinsed in dH20 
for 10 seconds and baked dry overnight at 420C. TESPA coated slides were stored 
dessicated at 40C with silica gel. 
2.4.4. Staining Embryos and Cryostat Sections for 3-gal Activity 
Cells and embryos were washed in PBS and treated with fix solution (0.2% 
glluteraldehyde; 5mM EGTA (pH7.3); 2mM MgCl2  in 0. 1M sodium phosphate) for 5 
minutes (cryostat sections and cells), 15 minutes (8.5d.p.c. embryos) and 30 minutes 
(9.5-10.5d.p.c. embryos) at room temperature. The samples were then treated with 
wash buffer (20mM MgC12; 0.01% deoxycholate; 0.02% nonidet in 0. 1M sodium 
phosphate pH7.3) 3 times for 5 minutes (cryostat sections and cells) or 20 minutes 
(embryos) at room temperature. Samples were then stained overnight at 370C using X-
gal stain (1mg/mi X-gal; 250mM potassium ferrocyanide; 250mM potassium 
ferricyanide in wash buffer). The stain was replaced with wash buffer and the samples 
stored at 40C. 
2.4.5. Haematoxylin and Eosin Counterstaining 
Cryostat sections were counterstained after X-gal staining for 2-3 minutes with 
haematoxylin (stock solution- Sigma, diluted 1/12 in water). The sections were rinsed 
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clear in water and then treated for 1 minute 0.1% eosin (BDH) in 70% ethanol, and 
dehydrated by washing 2 times for 5 minutes in 95% alcohol and 2 times 5 minutes in 
100% ethanol. The sections were treated for 5 minutes in histoclear, coverslipped and 
mounted using DPX mountant (BDH) and allowed to dry overnight. 
2.4.6. Microscopy and Photography of Specimens 
Whole embryos were examined using Olympus SZ40 and Olympus SZH1O dissection 
microscopes and photographed using an Olympus C-35AD-4 camera. 
Sections were examined using an Olympus Vanox AHBT3 microscope and 




Characterisation of 1114 Reporter Expression Profile and Phenotype 
3.1. Introduction 
The integration of a gene trap vector into a transcription unit is predicted to 
produce a fusion transcript consisting of endogenous message upstream of the lacZ 
reporter gene (Figure 1.213). The consequences of this are threefold: (i) translation of 
this transcript will produce —galactosidase (P—gal) activity that correlates with the 
temporal and spatial expression of the endogenous gene; (ii) the endogenous message 
will be disrupted downstream of the lacZ polyA signal and (iii) the endogenous gene 
can be identified using 5'RACE-PCR (Skarnes et al., 1992). In this chapter, the —gal 
activity profile and, by inference, the expression profile of the endogenous gene trapped 
in the 1114 gene trap integration is described. To identify potential recessive 
phenotypes associated with gene trap vector insertion, the germline transmission and 
breeding to homozygosity of the 1114 integration is also reported. 
3.2. 1114 Gene Trap Cell Line 
The 1114 gene trap cell line was derived from electroporation of the gene trap 
vector PT1-ATG into the R  ES cell line (Forrester et al., 1996). Using an in vitro pre-
screening strategy designed to enrich for genes with developmentally restricted 
expression patterns, the 1114 ES cell line was selected after showing a 2.6 fold 
induction in 3-galactosidase reporter activity after RA treatment for 48 hours. Whole 
mount in situ X-gal staining of tetraploid aggregation chimaeras derived from the 1114 
ES cells line revealed developmentally restricted reporter activity in the foetal liver 
between 9.5-10.5 d.p.c. Southern blot analysis of 1114 ES cell DNA digested with 
EcoRI and hybridised to a lacZ probe detects four distinct sized restriction fragments 
suggesting that four copies of PT 1 -ATG have inserted into the 1114 cell line (Forrester 
et al., 1996). 
C5711316 blastocysts were injected with the 1114 ES cell line and transferred to 
the uteri of pseudopregnant mothers by Jan Ure (CGR). Using coat colour to assess 
ES cell contribution to offspring, four chimaeric males (48, 49, 50 and 51) were 
identified which were subsequently testcrossed onto MF1 females. All four chimaeras 
transmitted the gene trap integration through the germline as judged by coat colour and 
tail DNA genotyping of testcross offspring. Animals heterozygous for the 1114 
integration were used for subsequent backcross matings and for the generation of 
heterozygous and homozygous animals for detailed reporter gene expression. 
3.3. 1114 Expression Analysis 
3.3.1. Embryonic Expression 
Embryos heterozygous for the 1114 gene trap intergration displayed f3—gal 
activity in the developing liver between 9.5-10.5 d.p.c., agreeing with the original data 
from aggregation chimaeras (Forrester et al., 1996). To examine in more detail the 
extent of 3—gal activity throughout embryogenesis, X-gal staining of whole mount and 
cryostat sectioned embryos from 8.0 d.p.c. through to 17.5 d.p.c. was performed. 
The data shown is generated from embryos heterozygous for the 1114 gene trap 
integration after five generations of backcrossing to the C57BL/6 background unless 
otherwise stated. The reported f3-gal activity profile is also observed in 1114 
homozygous embryos from (129xMF1)F1 intercrosses at all stages and 1114 
heterozygous embryos from (129x129)F3 intercrosses between 9.5 and 12.5 d.p.c. 
(data not shown). Wild type siblings from intercross and backcross litters were used to 
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control for background 13—gal activity. No background activity was observed in control 
embryos. 
The earliest detectable 3—gal activity was observed in the 9 somite stage embryo 
(8.0-8.5 d.p.c.) in the region destined to form the liver diverticulum immediately 
posterior to the heart (Figure 3.1A). The ventral view of the same embryo resolves the 
13—gal activity as two distinct lateral strips in the ventral endoderm of the foregut pocket 
prior to the fusion of this ventral region to form the foregut tube (Figure 3. 1B). At the 
12 sornite stage (8.5 d.p.c), as closure of the ventral surfaces of the foregut proceeds 
caudally, the lateral strips of 13—gal activity merge at the anterior end (corresponding to 
the posterior most extent of foregut closure), resulting in a 'horseshoe' of 13—gal activity 
(Figure 3.1Q. Following closure of this region of the foregut, 13—gal activity is 
maintained in the liver diverticulum and is seen at high levels at 10 d.p.c. (27-29 
somites) in the foetal liver (Figure 3.1D). From 10 d.p.c., 13—gal activity in the 
developing liver is maintained throughout gestation and in neonates (data not shown). 
Cryostat sections of 11.5 d.p.c. foetal livers show reporter activity restricted to 
hepatic parenchyme and not in the haematopoetic cells which have colonised the foetal 
liver by this stage (Figure 3.2A). The haematopoetic cells can be identified both 
morphologically and by their location in the liver sinusoids (Figure 3.2A). This data in 
conjunction with the fact that 1114 reporter activity is observed in the foetal liver prior to 
its colonisation by haematopoetic cells suggests that 1114 reporter activity is restricted to 
the hepatic lineage. 
As gestation proceeds the first additional site of 13—gal activity outwith the liver 
is observed in the region of the follicles of vibrissae primordia in the upper lip at 15.5 
d.p.c. (Figure 3.2B). The follicles of vibrissae will give rise to the hair follicles of the 
whiskers. By 17.5 d.p.c., activity is still observed in this region (data not shown) with 
additional activity identified in the dorsal root ganglia of the peripheral nervous system 
(Figure 3.2C). The dorsal root ganglia represent discrete aggregations of primary 
sensory neurone cell bodies. 
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Figure 3.1: 1114 reporter activity during early liver development 
Whole mount X-gal staining of 1114 heterozygous mouse embryos 
Lateral view of 9 somite stage embryo (8.0-8.5d.p.c.); the arrow highlights the 3-gal 
activity in the region immediately posterior to the developing heart. Scale bar 300pm. 
Ventral view of 9 somite stage embryo (same embryo as A.); f3-gal activity resolves as 
two lateral strips in the foregut pocket (arrowed). Scale bar 3001.tm. 
Ventral view of 12 somite stage embryo (8.5dpc); as foregut closure proceeds caudally 
(black arrow) f3-gal activity fuses at the posterior most extent of foregut closure (white 
arrow). Scale Bar 300j.tm. 
Lateral view of lOd.p.c. embryo (28 somites); f3-gal activity restricted to the foetal 
liver (arrowed). Scale bar 650 gm 
h, developing heart; ys, yolk sac. 
Figure 3.1 
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Figure 3.2: 1114 reporter activity from mid-late gestation 
X-gal staining of croystat sections from 1114 heterozygous mouse embryos: 
Transverse section of 11.5 d.p.c. liver showing reporter activity restricted to the 
parenchymal cells (arrowed) and not the haematopoeitic cells. Scale Bar 30.im. 
hc, haematopoeitic cells. 
Sagittal section of 15.5 d.p.c. head. Reporter activity can be seen in the upper lip in 
the region of the follicles of vibrissae (arrowed). Scale Bar 500tm. 
u, upper lip; t, tongue; I, lower lip. 
Sagittal sections of 17.5 d.p.c. embryo. Reporter activity is localised to the dorsal root 
ganglia (arrowed). Scale Bar 500tM. Higher magnification of boxed area shows in more 
detail 3-gal activity in the dorsal root ganglia. Scale Bar 100jtm. 
1, lung; s, spinal cord. 
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3.3.2. Adult Expression 
To examine the extent of 3-gal activity in adults, X-gal staining was performed 
on cryostat sections from a range of tissues from 3-5 month old 1114 homozygous 
animals on the outbred MF1 background. The same tissues from age matched wild 
type animals were processed in parallel to control for background 13-gal activity. No 
background 13-gal activity was observed in any of the tissues examined. 
Sectioning of the adult liver revealed reporter activity in isolated single cells. 
The exact identity of these cells is difficult to ascertain from the poor cellular 
morphology presented after cryostat sectioning (Figure 3.3A). The ovaries showed 
reporter activity which is restricted to the oocytes of the developing follicles (Figure 
3.313). Although Figure 3.313 shows reporter activity only in the oocyte of a secondary 
follicle, activity has been observed in the oocyte throughout follicle maturation (data not 
shown). Transverse sections of the testes shows low level, punctate staining of 3-gal 
activity in the germinal epithelium of the seminiferous tubules (Figure 3.3C). In the 
seminiferous tubules of the testes, spermatogenesis occurs radially from the basal 
membrane towards the lumen where mature sperm is released. Sertoli cells support this 
process and can be found throughout the germinal epithelium, although the nucleii are 
localised to the basal membrane. 1114 reporter activity is seen throughout the radius of 
the germinal epithelium but it is difficult to assign to a specific cell type. Double 
staining with X-gal and markers for the cell types of the seminiferous tubules and 
stages of spermatogenesis would help to resolve this question. Examination of neonate 
ovaries and testes failed to detect any reporter activity. Longitudinal sections of the 
kidney displays a significant level of reporter activity restricted to the pelvic region as it 
enters the ureter (Figure 3.313). Little is known of any distinct function of this tissue 
other than to collect urine. Sectioning and staining of the heart, gut, lung, spleen and 
skeletal muscle failed to detect reporter activity in these tissues (data not shown). 
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Figure 3.3: 1114 adult reporter activty 
X-gal staining of cryostat sections of adult 1114 homozygous tissues. 
Sectioning of the liver reveals reporter activity restricted to single, isolated cells of 
hepatic parenchyme (arrowed). Scale Bars 5001.Im and 5Opm. 
Sectioning of the ovary with reporter activity in secondary follicle. Scale Bar 200 gm. 
Higher magnification of boxed area shows reporter activity in the oocyte of the secondary 
follicle. Scale Bar 50jim. 
c, cortex; m, medulla; g, Graafian follicle; p, primordial follicle; f, follicular antrum; z, 
zona granulosa. 
Longitudinal section of testes with low level staining (arrowed) throughout the 
seminiferous tubules. Scale Bar 100im. 
i, interstitial cells; 1, lumen; b, basal membrane. 
Longitudinal section of the kidney with staining in the collecting ducts of the pelvic 







3.4. Comparison of 1114 Reporter Activity With AFP Expression 
3.4.1. Embryonic Expression 
1114 embryos display 3—gal activity in the ventral endoderm of the foregut 
pocket prior to any morphological signs of liver development. To correlate this specific 
activity to a well characterised marker of early hepatic differentiation, 1114 3—gal 
activity was compared to expression of AFP (Shiojiri, 1981; Gualdi etal., 1996). 
Animals carrying a targeted allele of AFP were generated by homologous 
recombination in ES cells. A 3-geo cassette was inserted between exon 1 and 3, 
disrupting AFP function and placing 3-geo under the control of the AFP promoter 
(Philippe Gabant, manuscript in preparation). 3—gal activity in heterozygous animals 
(AFP(-geot+)) will mimic the expression of AFP, thus providing a simple, comparable 
assay of AFP expression relative to 1114 ç3—gal activity. All comparisons of 1114 
heterozyogus and 	p(l-geo/+)  were carried out with wild type embryos from both 
litters used as controls. 
Whole mount in situ X-gal staining of 6 somite stage embryos shows no 11 14 
activity. At this stage, AFP expression is observed as patchy expression in the visceral 
endoderm (Figure 3.4A). At the 9 somite stage (8.0-8.5 d.p.c.), when 1114 (+1-) 3— 
gal activity is first detected in the foregut pocket of the embryo, 	p(J3-geoI+) reporter 
activity is still limited to extra-embryonic tissue (Figure 3.413). AFP reporter activity is 
first observed in embryonic tissue at 8.5 d.p.c. (15 somites) in the liver diverticulum 
and is also maintained in the yolk sac (Figure 3.4C). By 11.5 d.p.c., pp([3-geo/+) 
embryos show high levels of reporter activity in the liver and yolk sac (Figure 3.41)). 
No other embryonic stages were examined for reporter activity. 
In all embryonic stages examined, 	p(!3-geo/+)  embryos show patchy reporter 
activity in the yolk sac. However, whole mount in situ hybridisation of wild type 
embryos with an antisense AFP riboprobe shows ubiquitous expression throughout the 
yolk sac (Philippe Gabant, manuscript in preparation). The discrepancy between 
Figure 3.4: Comparison of 1114 and AFP reporter activity during embryogenesis. 
X-gal staining of whole mount 1114 heterozygous and AFP (3-geo/+)  embryos. 
Posterior view of 6 somite embryos (8.0 d.p.c.). No staining is observed in the 1114 
heterozygotes. AFP (3-geo/+)  embryos show staining in the yolk sac (arrowed). Scale Bar 
330m. 
ps, primitive streak. 
Lateral view of 9 somite embryos (8-8.5 d.p.c.). As reported previously, f3-gal 
activity is seen in the presumptive hepatic endoderm in 1114 heterozygotes. Same stage 
p.jp (3-geo/+) embryos have activity solely in the yolk sac. Scale Bar 500pm. 
h, heart; ys, yolk sac. 
Lateral view of 15 somite AFP (f3-geol+)  embryo showing reporter activity in the liver 
diverticulum and yolk sac (arrowed). Scale Bar 660pm. 
Lateral view of 11.5 d.p.c. AFP (-geo/+)  embryo with reporter activity in the foetal 






p(-geo/+) activity and wild type AFP expression is possibilty a result of the 
disruption of a yolk sac specific promoter in the first intron of the AFP gene by the 
targeting vector (Philippe Gabant, manuscript in preparation). A good correlation is 
seen between 	p(-geo/+) reporter activity and wild type APP expression in the foetal 
liver (Philippe Gabant, manuscript in preparation). 
In conclusion, comparing 1114 and 	p(-geo/+)  reporter activity has shown that 
1114 reporter activity is detected earlier in the foetal liver than AFP and that this 
expression is specific to embryonic tissue with no significant 1114 n—gal activity 
detected in the yolk sac. 
3.4.2. Adult Expression 
A comparison of 1114 heterozygous and 	p(1-geo/+) reporter activity was 
carried out on age matched tissues from 3 month old mice to identify common regions 
of expression in the adult. Wild type littermates of both 1114 (+1-) and 	p(I3-ge0I+) 
animals were used to control for background 3-gal activity. The reporter activity of 
1114 heterozygous animals matched that of the 1114 homozygous animals as described 
previously (data not shown). In common with 1114 heterozygotes, 	p(i3ge0i'+) 
reporter activity is observed in the adult liver in isolated regions of the hepatic 
parenchyme. However, activity is more widespread than the single cells observed for 
1114 heterozygotes (Figure 3.5A compared to Figure 3.3A). The only other common 
site of expression in the adult was in the testes. Longitudinal sections of 	p(-geo/+) 
testes reveals punctate reporter activity in the seminiferous tubules which, in 
comparison to 1114 heterozygotes (Figure 3.3C), appears more widespread and at a 
higher level (Figure 3.5C). Expression was also seen, restricted to single cells, of the 
crypts of Lieberkuhn in the small intestine (Figure 3.5B). No reporter activity is 
observed in the small intestine of 1114 heterozygotes (data not shown). Background I- 
gal activity was observed in 	p(3-geoI+) 1114 heterozygous and wild type animals in 
the cortex and medulla of the ovary and the cortex and medulla of the kidney (data not 
Figure 3.5: AFP (-geo/+)  adult reporter activity 
X-gal staining of cryostat sections from AFP (3-geo/+)  adult tissues. 
Reporter activity is observed in the hepatic parenchyme of p.pp (geo/+) livers. Scale 
Bar 1OOpm. 
Longitudinal section of p.jp (-geo/+) small intestine reveals reporter activity in a single 
cell of the crypts of Lieberkuhn. Scale Bar 100pm. 
v, villi; m, muscularis mucosae; c, crypts of Lieberkuhn. 
Longitudinal section of AFP (-geo/+)  testes with reporter activity in the seminiferous 
tubules. Scale Bar 100.tm. 





Table 3.1: Comparison of 11 14(+/-) and 	p(geOf+) -gal activity 
Embryonic Adult 
n-gal activity -ga1 activity 
Stage! tissue 11 14(+/-) 	FPge0) Tissue 11 14(+/-) 	
p(f3ge0/+) 
6.0 d.p.c. gut - 	 + 
v.endoderm - 	 + heart - - 
8.5 d.p.c. kidney 
+ 	 - * 
v.endoderm - 	 + liver + + 
def. endoderm + - lung - 	 - 
9.5-11.5 d.p.c. ovary 
+ -* 
v.endoderm - 	 + sk' muscle - 	 - 
liver + + spleen - - 
testes + 	 + 
v.endoderm, visceral endoderm; def. endoderm, definitive endoderm; sk' muscle, skeletal muscle. 
* high  level of background activity in these tissues. 
shown). However, no overlap was seen between the 1114 specific activity in the 
oocytes and the pelvic region of the kidney and this background activity. The presence 
of background f'-gal activity in 1114 heterozygous, 	p(f3-ge0/+) and wild type ovaries 
and kidneys is at odds with the results from the sectioning of 1114 homozygous and 
wild type tissues which showed no such background activity (Section 3.3.2.). This 
probably reflects unmonitored variations in the pH of the different solutions used for 
the X-gal staining protocols in Section 3.3.2 and Section 3.4.2. If the solutions used in 
Section 3.4.2. had a lower pH, this would increase the likelihood of background 
mammalian n-gal activity which has a more acidic pH optimum compared to the higher 
optimal pH for bacterial 3-gal activity (Alam and Cook, 1990). 
Sectioning and staining of spleen, heart, skeletal muscle and lung failed to detect 
reporter activity. A summary of the comparison between the reporter activity of 1114 
heterozygotes and 	p(O-geo/+)  animals is given in Table 3.1 
3.5. 1114 Reporter Activity During Tumourigenesis 
A limited study was undertaken to assess if, like other markers expressed in the 
foetal liver, (e.g. AFP; Abelev et al., 1971; Chen et al., 1997), 1114 reporter activity is 
upregulated during liver tumourigenesis. 
Diethylnitrosamine (DEN) is a carcinogen of the liver predominantly inducing 
hepatic adenomas and hepatocellular carcinomas (Moore et al., 1981; Drinkwater and 
Ginsler 1986). DEN was injected by Chris Kemp (Beatson Institute, Glasgow) 
interperitoneally into 12 1114 homozygous animals at 3 weeks of age. Total livers were 
dissected from each animal and tumours identified as abnormal foci of cells on the 
surface of the liver (Drinkwater and Ginsler, 1981). Livers were subsequently frozen 
for cryostat sectioning and X-gal staining. Ten months after DEN injection, 3 out of 
the 5 animals sacrificed showed gross signs of tumourigenesis in the liver. On 
sectioning the 3 tumour-bearing livers, 2 displayed an modest increase (Figure 3.6A) 
and the third a massive increase in f3-gal activity (Figure 3.613) within undefined 
Figure 3.6: 1114 reporter activity during tumourigenesis 
X-gal staining of cryostat sections from two individual 1114 homozygous animals (10 
months after DEN injection) 
A.+B. Sectioning of liver from two separate animals shows a modest increase in reporter 
activity (arrowed) in comparison to normal liver (Figure 3.3A). Scale Bar A=200jim, 
B=1O0im. 
C. Sectioning of liver shows a massive increase in reporter activity over normal liver 





regions of the hepatic parenchyme when compared to an untreated adult (Figure 3.3A). 
This apparent induction in 3-gal activity could be an artefact of the mutagenesis. 
However, DEN induces DNA point mutations (Drinkwater and Ginsler, 1986) so it 
would perhaps be unlikely that the induction in n-gal activity is due to the clonal 
expansion of a mutagenic event which, for example, causes the ubiquitous expression 
of the reporter gene. 
Obviously, little can be concluded from such a limited study. To confirm that 
the induction in 3-gal activity marks hepatic tumours, the study would need to be 
repeated on a larger scale with suitable controls. Wild type animals injected with DEN 
and untreated 1114 and wild type animals would be processed in parallel. A 
comparison of the 1114 f3-gal activity with the expression of the endogenous trapped 
gene (see Chapter 6) and hepatic tumour markers would also help to define nature of the 
13-gal activity. 
3.6. 1114 Breeding Analysis 
Four chimaeric male offspring derived from the injection of 1114 ES cells into 
blastocyst stage embryos transmitted the gene trap integration into the germline. 
Chimaeras were subsequently backcrossed onto different genetic backgrounds to 
examine the viability of animals homozygous for the 1114 integration. Chimaeras 48 
and 51 were backcrossed onto the MEl outbred genetic background and chimaera 49 
was backcrossed onto the inbred 129/CGR and C5713L/6 backgrounds. The majority 
of the genotyping work was carried out by Tony Coyle and Dianne Peddie. 
On the MF1 outbred background, (129xMF1)N1 generation heterozygote 
offspring were intercrossed. Genotyping of intercross litters was performed by 
Southern blotting of tail genomic DNA restriction digested with BglII followed by 
hybridisation to the 500bp en-2 fragment of the gene trap vector. This resolves a 
fragment of approximately 3kb corresponding to the endogenous genomic copy of en-2 
and 4 distinct fragments greater than 10kb corresponding to the integrated copies of the 
M. 
gene trap vector (Figure 3.7). The endogenous en-2 fragment provides a loading 
control to aid the genotyping of 1114 heterozygous and homozygous animals based on 
the signal intensity of the en-2 hybridising vector fragments (Figure 3.7). Animals not 
readily genotyped by this method were testcrossed onto wild type animals to distinguish 
between heterozygotes and homozygotes. Table 3.2 shows that animals homozygous 
for the 1114 gene trap integration are produced at the expected Mendelian ratio of 1:2:1 
(wild type: heterozygous: homozygous) at weaning stage. Moreover, intercrossing of 
1114 homozygous animals has produced a homozygous line. 
Intercrosses were set up after 5 generations of backcrossing the gene trap 
integration onto the C57BL/6 inbred genetic background. Reliable genotyping of these 
intercrosses was carried out using the dot blot technique which was developed in the 
laboratory by Dianne Peddle. (Section 2.1.4.4.). As with intercrosses for the other 
backgrounds, animals homozygous for the gene trap integration showed no overt 
phenotype being produced at the expected frequency (Table 3.2). 	A viable 
homozygous line has been set up on the C57BL6 background by intercrossing IFS 
generation 1114 homozygotes. To date 11 litters have been born with an average of 4.5 
pups per litter, which is within the expected litter size for the inbred genetic 
backgrounds. 
Intercrosses on the 129/CGR background were set up after backcrossing to the 
N3 and N4 generations. To quickly assess the genotype ratio of the 129/CGR 
intercross offspring, the numbers of 1114 heterozygous and homozygous offspring 
were pooled and compared to the numbers of wild type offspring. At weaning, 52 1114 
heterozygous and homozygous versus 19 wild type offspring were genotyped which is 
in keeping with the expected Mendelian ratio of 3:1, wt: heterozygote and homozygote. 
Therefore, the integration of the gene trap vector in the 1114 cell line has no 
overt effect on viability or fertility when bred to homozygosity on the outbred MIF1 and 
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Figure 3.7: Southern blot analysis of 1114 genomic DNA. 
Genomic DNA from 1114 heterozygous intercross litters digested with BglII 
and hybridised to en-2 exon probe. The four positively hybridising bands greater than 
10kb in lanes 2-5 correspond to gene trap vector copies. The band at 3kb corresponds 
to endogenous en-2 and serves as a DNA loading control. For example, comparison 
of lanes 3 and 4 shows equal DNA loading. Lane 4 has a greater signal intensity 
of the vector copies indicative of an 1114 homozygous animal. 
Table 3.2: Genotype of 1114 heterozygous intercross litters at weaning 
Genetic Background 	 wild type 	1114 	 1114 
heterozygotes 	homozygotes 
(129xMF1)FlI-X 	 33 	 79 	 32 
(C57B116 x C57B16) F5 I-X 	10 	 22 	 12 
3.7. Discussion 
Does 1114 Define Hepatic Specification? 
The 1114 13—gal activity observed in the ventral foregut endoderm corresponds 
to the location of the presumptive hepatic endoderm identified in previous studies 
(Houssaint, 1980; Gualdi et al., 1996). In the explant studies of Houssaint (1980), 
only this presumptive hepatic endoderm isolated from the 9 somite mouse embryo 
onwards was capable of differentiation into morphologically distinct hepatocytes on 
culturing with chick hepatic mesenchyme. Accordingly, this study suggests that the 
hepatic lineage has been specified, at earliest, by the 9 somite stage. In another study 
by Gualdi et al. (1996), hepatic specification was defined by expression of serum 
albumin using an RT-PCR assay and was determined to have occurred by the 7-8 
somite stage. This slightly earlier timing of hepatic specification compared to Houssaint 
(1980) may reflect the different assays used to define specification in this study. 
The earliest 13—gal activity observed in 1114 embryos, at the 9 somite stage, 
corresponds well to the perceived threshold of hepatic specification observed in the 
study by Houssaint (1980). Moreover, it is likely that 1114 reporter gene transcription 
is activated earlier than at the 9 somite stage when protein activity is detected. 
Consequently, this would correlate well to the specification of the presumptive hepatic 
endoderm as determined by the transcriptional activation of liver specific genes as seen 
in the study of Gualdi et al. (1996). 
The reporter activity associated with the 1114 integration is observed prior to the 
thickening of the foregut endoderm to form the liver diverticulum, the first 
morphological signs of liver differentiation. Moreover, it suggests that hepatic 
specification occurs before the ventral closure of the foregut endoderm in two 
apparently distinct cell populations. 	This has not previously been reported. 
Specification of the hepatic lineage from gut endoderm is dependent on inductive 
signals from the adjacent cardiac mesoderm from the 4 somite stage (Le Douarmn, 1975; 
M. 
Gualdi et al., 1996). At this stage, and up to the 9 somite stage, the foregut endoderm 
has yet to fuse ventrally with two populations of cells existing adjacent to inductive 
cardiac mesoderm. 1114 reporter activity nicely illustrates that hepatic specification of 
the gut endoderm occurs at such an early developmental stage due to its position relative 
to cardiac mesoderm, rather than from a intrinsic property of an endodermal cell 
population. 
The comparison of the earliest detectable 1114 and pp(1-geo/+)  reporter 
activities suggests that the 1114 gene trap integration provides the earliest, most specific 
marker of hepatic specification and development identified to date. Subsequently, it is 
appealing to propose that the trapped gene associated with this activity is one of the first 
genes to be activated as a result of hepatic specification, which to some degree defines 
the hepatic phenotype. Consequently, the 1114 gene trap cell line would provide a 
simple and cheap assay of hepatic specification which could be used in tissue explant 
culture studies or in the phenotype analysis of future gene knock-outs affecting hepatic 
specification. 
Previous studies have highlighted that, as with 1114 reporter activity, 
expression of both APP and alb in the definitive endoderm occurs prior to 
morphological signs of liver development (Gualdi et al., 1996; Shiojiri, 1981; Cascio 
and Zaret, 1991). However, unlike both AFP and alb, which are expressed in the 
visceral and definitive endoderm during liver development (Meehan et al., 1994; 
Dziadek and Adamson, 1978), 1114 reporter activity is restricted to the definitive 
endoderm. Given that visceral endoderm is continuous with the emerging definitive 
endoderm during hepatic specification, markers such as AFP and a/bcannot distinguish 
between the two lineages at this stage. 1114 3-gal activity, being exclusive to the 
definitive endoderm, affords excellent definition of the morphology of liver 
specification and development from the definitive endoderm at this early stage. 
In the study of reporter activity in 	p(I-ge0/+) embryos, activity is restricted to 
the liver diverticulum from the 15 somite stage onwards. In the study of Gualdi et al. 
(1996), AFP expression is detected by RT-PCR throughout the anterior and posterior 
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definitive endoderm from the 4 somite stage which was subsequently upregulated in the 
liver diverticulum and down regulated in the rest of the gut endoderm. The difference 
observed in AFP expression between these two studies may reflect the higher 
sensitivity of the RT-PCR assay compared to X-gal staining for 3-gal activity. 
However, there are two other possibilities that could explain the discrepancy between 
the two studies. Firstly, in the study by Gualdi et al. (1996), the AFP expression 
observed in the isolated definitive endoderm could be due to the co-isolation of AFP 
expressing visceral endoderm, which is continuous with definitive endoderm at this 
stage. Secondly, the disruption of the AFP allele with the 3-geo targeting cassette 
affects the expression pattern of AFP in the yolk sac by removing a promoter element in 
the first intron. It is conceivable that this or another promoter element disrupted by the 
targeting construct is necessary for AFP expression throughout the gut endoderm at this 
earlier stage. 
What Cell Type is Marked by 1114 Activity in the Adult? 
In the adult, 1114 reporter activity is observed in single, isolated cells of the 
liver. Such a striking pattern of n-gal activity may be a faithful report of endogenous 
gene expression marking a sub-population of hepatic cells or it may be a consequence 
of variegated reporter gene expression. In the mouse, pericentromeric and high copy 
number transgene insertions can contribute to transgene silencing resulting in a mosaic 
pattern of reporter gene expression in tissues where more widespread expression of the 
reporter is predicted (Dobie et al., 1997). Although this phenomenon has only been 
reported in transgenic mice generated by pro-nuclear injection of DNA, it could be 
causing the highly restricted reporter activity observed in 1114 adult livers. 
Another alternative is that 1114 reporter activity could mark a specific hepatic 
cell type expressing the endogenous trapped gene. From the profile of 1114 reporter 
activity in the foetal and adult liver, it is intriguing to speculate that the marked cells are 
the potential stem cells of the adult liver. In normal adult livers the stem cells are 
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postulated to exist as very small sub-population of phenotypically indistinct cells located 
in the interlobular bile ducts and canals of Hering. As with other stem cells systems, 
the actual liver stem cells are defined more by their progeny, the oval cells, than by their 
own phenotype. Oval cells can be studied during liver regeneration in response to liver 
damage. Experimentally, a two-thirds partial hepatectomy (2/3 PH) or administration of 
hepatotoxins such as carbon tetrachloride (Cd4) induces the proliferation of mature 
hepatocytes which have a replicative potential approaching that of haematopoietic stem 
cells (Gerlach et al., 1997; Overturf et al., 1997). However, when this hepatocyte 
mediated regenerative process is blocked, for example, by administration of 2-
acetylaminofluorene (AAF), a proliferation of phenotypic biliary cells known as oval 
cells is observed around the hepatic portal area. Certain aspects of the oval cell 
phenotype are similar to foetal liver cells. The proliferating oval cells invade the 
surrounding hepatic parenchyme where they differentiate into mature hepatocytes. 
Moreover, oval cell proliferation is associated with an increase in the expression of 
foetally expressed genes such as AFP and alb (Golding et al., 1995). The function of 
growth factors intrinsic in foetal liver development, for example SF/HGF, are also 
implicated in the proliferation of oval cells (Alison, 1998). 
From this overview, there are several similarities between 1114 reporter activity 
and the characteristics of liver stem cells. Firstly, the highly restricted, infrequent 
reporter activity observed in 1114 adult livers may correlate with the small population of 
stem cells present in the normal adult liver. Unfortunately, the poor cellular 
morphology of the cryostat sections makes it difficult to assign 1114 reporter activity to 
individual hepatic cell types or structures. Secondly, there is a foetal phenotype 
associated with oval cells, the immediate progeny of stem cells. This allows one to 
postulate that 1114 reporter activity, being a foetal marker, may also mark the liver stem 
cells. By inference, the same would be true of p.J?p(-geo/+)  reporter activity which is 
also highly restricted in the adult liver although not to the same degree as 1114 activity. 
Our preliminary experiment suggesting the induction in 1114 reporter activity is 
associated with hepatocarcinogenesis may also support this idea. Evidence exists for 
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both hepatocytes and oval cells as the cellular origins of hepatic tumours (Alison, 
1998). In different animal models, an increased proliferation of oval cells, as well as 
the inability of proliferating oval cells to differentiate into hepatocytes (and therefore 
continue proliferating), is associated with an increased incidence of hepatocellular 
carcinomas (Isfort et at., 1997; Betto et at., 1996). However, DEN is believed to 
induce hepatic tumours without oval cell proliferation (Bralet et al., 1996). It is 
therefore unclear if the induction of 1114 reporter activity during tumourigenesis (if 
indeed there is an induction) is concomitant with an increase in oval cell or hepatocyte 
proliferation. 
Although the above is highly speculative, it would be of considerable interest to 
identify the nature of the cells with 1114 reporter activity. The different morphology 
and antigenic profile of hepatocytes, bile duct cells and oval cells would allow the 
specification of 1114 reporter activity to a hepatic cell type. For example, using double 
staining protocols, one could investigate if 1114 reporter activity co-localised with the 
oval cell specific markers SCF, c-kit and 0V6 antibody (Fujio et at., 1996; Hixson et 
at., 1997) in liver sections during oval cell proliferation. 
Functional Analysis of the Endogenous 1114 Gene 
Intercrossing of the 1114 gene trap integration to homozygosity has no overt 
effect on the viability or fertility of these animals. Chapters 4 and 6 will show that this 
lack of phenotype is due to the failure of the 1114 gene trap integration to disrupt the 
function of the endogenous trapped gene. A number of gene trap lines published to 
date also report the incomplete knock-out of the endogenous gene by the gene trap 
vector (McClive et al., 1998; Voss et al., 1998; Sam et at., 1998; Faisst and Gruss, 
1998). Integrations into TFEB, MAP-4, aquarius and bodenin have little or no effect 
on the wild type expression levels of these genes when the integration is bred to 
homozygosity. Consequently, these gene trap lines show no phenotype (McClive et 
at., 1998; Voss et at., 1998b; Sam et at., 1998; Faisst and Gruss, 1998). Expression 
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of the wild type transcript is predicted to result from the splicing around of the gene trap 
vector by the endogenous gene, producing sequences 3 of the vector insertion (Voss et 
al., 1998b; Gasca et al., 1995). 
Despite the failure of the 1114 gene trap integration to disrupt the endogenous 
gene, the 1114 cell line presents a excellent opportunity to identify and characterise a 
gene intrinsically involved in liver specification and development. Moreover, 1114 
reporter activity is an excellent marker of liver ontogeny which could be widely used in 




Molecular Characterisation of the 1114 Gene Trap Integration 
4.1. Introduction 
Gene trapping introduces a molecular tag into a locus, facilitating the 
identification of the endogenous gene it has disrupted (Skarnes et al., 1992). Splicing 
of the gene trap vector to an endogenous splice donor produces a fusion transcript 
which allows for the amplification of endogenous gene sequences by 5' RACE-PCR 
using primers complementary to vector sequences (Frohman et al., 1988; Section 
2.1.8.1.). The molecular characterisation of the 1114 gene trap integration has proven 
to be more complex than conventional gene trap integrations. This chapter describes the 
identification of multiple different fusion transcripts from the 1114 line and compares 
the expression pattern of these fusion transcripts with reporter activity in the 1114 
embryo. 
4.2. 1114 Molecular Analysis 
Northern blot analysis of 1114 ES cell RNA hybridised to a 2.2kb lacZ probe 
(Section 2.1.5.3.) resolves a single fusion transcript of approximately 4kb (Figure 
4.1). Furthermore, in agreement with reporter activity, the expression of this fusion 
transcript is induced in 1114 ES cells differentiated in the presence of RA (data not 
shown, Forrester et al., 1996). The 4kb fusion transcript will comprise 3.4kb of the 
en2-lacZ reporter and the remaining 600bp is likely to be derived from the endogenous 
trapped gene. This suggests that the vector has inserted towards the 5' end of the 
endogenous gene as observed for the majority of cell lines isolated in this screen 
93 
	










Figure 4.1: Analysis of the 1114 fusion transcript by Northern Blot 
Detection of fusion transcipts by Northern Blot analysis of total RNA from R121, 1114 and 
R68 gene trap cell lines hybridised to 32P labelled lacZ probe. 
Cell line R121 (lane 1) expresses the minimum lacZ transcript of 3.3kb (asterisk) providing a 
size standard for comparison to the fusion transcripts of the 1114 and R68 cell lines. R68 was 
included as a known lacZ-fusion expressing cell line. 
R121, 1114 and R68 were all isolated in the RA responsive pre-screen (Forrester et al., 1996). 
Markers (GibcoBRL. Cat No. 15620-016). 
(Forrester et al., 1995). Hybridisation of 1114 ES cell RNA to the en2 intron probe 
derived from the gene trap vector (Appendix IV; Section 2.1.5.3.) failed to detect a 
transcript (data not shown) indicating that the en-2 splice acceptor is operating 
efficiently in the 1114 gene trap cell line (Townley et al., 1997). 
4.2.1. Identification of 1114 Fusion Transcripts Using 5'RACE-PCR 
ES Cells 
5'RACE-PCR (Protocol 2) was performed on RNA isolated from 1114 ES cells 
treated with RA for 48hours to maximise the level of the fusion transcript in the initial 
RNA sample. Plasmid DNA was isolated from recombinant RACE clones that 
hybridised to the gene trap vector en2 probe. Positive clones were rescreened by 
restriction digest with KpnI and Spel, and clones containing an insert of greater than 
120bp were sequenced. Manual sequencing identified 9 RACE clones containing 
endogenous sequences correctly spliced to the en2 splice acceptor site. They were 
divided into 4 groups (Table 4.1). Six of these clones (ES-c3, (X23, 1311, 1313, 1315 
and nl:3; Group I) contained between 50 and 70 nucleotides of identical sequence 
(Figure 4.2) with the remaining three clones (ES-nl:7, nl:2 and 0; Groups II, III, and 
IV respectively) showing no sequence homology to the Group I clones or each other 
(Figure 4.2). A further three clones, (ES-1339, 1347 and nl:8; Group V) contained en-2 
intronic vector sequence upstream of the splice acceptor, indicative of unspliced 
transcripts (Table 4.1). 
Foetal Liver 
Given the presence of multiple, correctly spliced transcripts in 1114 ES cell 
RNA, 5'RACE-PCR was carried out on two different foetal liver RNA samples to 
analyse the presence and relative abundance of the different fusion transcripts in vivo. 
TABLE 4.1: Number and size of the different RACE clones isolated from the 1114 gene trap line 
GROUP RACE 1 (ES cells) 
No. Clones 	Size(bp) 
RACE 2 (liver) 
No.Clones 	Size(bp) 
RACE 3 (liver) 
No.Clones 	Size(bp) 
TOTAL 
I (L-A8) 6 	25-76 2 	64+79 13 	NA 21(58%) 
II (L-35) 1 	54 0 	- 3 	46-58 4(11%) 
III (ES-nl:2) 1 	141 0 	- 0 	- 1(3%) 
IV (ES-0) 1 	95 0 	- 0 	- 1(3%) 
V (intron)* 3 	>100 2 	>100 4 	NA 9 (25%) 
NA, not applicable, Group I & V clones were identified by hybridisation in this screen and were not sequenced. 
* In the RACE 1 and 2 screens, the exact size of the intron containing clones was not determined. 
Figure 4.2: 1114 fusion transcript sequences 
Longest sequence of the fusion transcript Groups I-IV isolated from the RACE-PCR of 
RNA from 1114 ES cells and 11 14(-/-) 10.5d.p.c. and 13d.p.c. liver RNA. The translation 
of endogenous fusion transcript sequence is given in all three frames. Translation in-frame 
with en-2/lacZ is highlighted in red. Lower case sequence at the 3' end of each fusion 
transcript corresponds to the en-2 exon sequence from the PT1-ATG gene trap vector. 
(I) corresponds to the splice junction. 
Underlined sequence in L-A8 is complementary to oligonucleotide UBT- 1. 
G (blue); artificial poly G tail added during RACE-PCR (protocol 2). 
T (blue); artificial poly T tail added during RACE-PCR (protocol 1). 
Figure 4.2: 
Group I: L-A8 (79bp) 
5' 
GGGGAGGAGGAGGCGGCGGCACCAGCAGCAACAACAGCGAGGAAGAGGA 
frame 	 L( t. 	 () ( j 	 P 
2 G G G G G T S S N SEE E E 
3 	E E A A A P A A T TAR KR 
GGACGACGACGACGAGGAAGAGGAGGTTTCTGAG Igtcccaggtcc3  
G 
	
	R R F A F 	F . 	 > n2 
D D D D E E E E VS E 
R T T T T R K RR FL 
Group II: L-69 (58bp) 
51  
TTTTGGCGAGCTTGGTAGTTTTCTGTCAGTGGAAGGTGGCCGGGAGCAGTT 
frame  C F: L C S F L S V F G C F S L A 
2 AS L 	V F C Q W K V AG S S 
3 RAW. FFVSGRWPGAV 
GTGGAGGGGCG /gtcccaggtcc 
W F C 	G P > en-2 
C G GA 
V E G 
Group III: ES-nl:2 (141bp) 
GGGGCC TGAACCCTTGCTGACACAGAGGAGTGGTTCCTGCTGGCAATGATCTA 
frame 1 	A A A D T .5 5 F F A A A MI 
2 PEP L L T Q R S G SC W Q .S 
3 L N PC. HR G V V PA G N DL 
ATCATAGTGCAGTAAGAAAGATGGCAGTTTGATAAAACATGGTGGAGACAGCG 
S 	C S K K D C S A I K H C G D S 
N H S A V R K MA V. . N MV ETA 
II V Q . ER W Q F D K T W W R Q R 
GCTGAAATGGAAGCATATGTGCTAGAAGACATTCTTGAG / gtccc aggtcc 3
,  
C 	N C S I C A R F H S . 	G P>en-2 
A EM E A Y V LED IL E 
L K W K H MC. K T FL 
Group IV: EScL7 (95bp) 
GGGSTGATACCAAGCCTGGCGGCCC TGGGGATC TTCGATGATGGCCCGCGTGGTT 
frame 	D T K P G G P G D A F 	F P A F F 
2 Y Q A W R P W G S S MAR V V 
3 	I PS LA AL G IF D D G PR G 
3,  
CGCCTCACAGCTTTCCTAGGCTTAAGGAAATCCCTTTCCTGACT /gtcccaggtcc 
I S Q A. S . A 	AN? F P P C P>en-2 
R L TA FL G L R K S L S. 
S PH SF PR L K El P FL T 
In the first study, 5'RACE-PCR (Protocol 2) using 10.5d.p.c. 1114 homozygous liver 
RNA isolated only 4 en-2 positive clones. Clones L-A8 and L-139 contained sequence 
identical to Group I clones. Clone L-A8 contained 79bp of novel sequence spliced to 
the en-2 exon making it the largest Group I clone isolated to date (Figure 4.1). The two 
remaining RACE clones, L-A20 and L-A46, contained en-2 intronic sequence (Group 
V, Table 4.1). 
To isolate a larger sample of RACE clones from the foetal liver, 5'RACE-PCR 
(Protocol 1) was repeated on liver RNA from 13d.p.c. 1114 homozygotes. The 2nd 
round of PCR was carried out using Pfu polymerase (Stratagene) to produce blunt 
ended PCR products for cloning into the pCR-BluntTM vector using the for ZeroBluntTM 
PCR Cloning Kit (Invitrogen). A total of 50 en-2 positive clones were identified by 
colony PCR. 	The clones were characterised either by hybridisation to an 
oligonucleotide probe (UBT- 1; Section 2.1.5.3.) complementary to L-A8, the most 
abundant sequence (Group I; Figure 4.2), or by sequencing. Of the clones large 
enough to contain an endogenous sequence upstream of the splice acceptor, 13 clones 
hybridised to the UBT- 1 probe (Group I), 4 clones corresponded to unspliced vector 
sequence (Group V) and 3 clones, L-30, L-35, L-69, identified sequence comparable to 
clone ES-n 1:7 (Group II; Figure 4.2; Table 4.1). The largest of these 3 clones, L-69, 
contained 58bp of endogenous sequence (Figure 4.2). 
(c) Direct Sequencing 
Direct sequencing was developed to eliminate the time consuming step of 
cloning 5'RACE-PCR products prior to sequencing. Consequently, it allows for the 
rapid analysis of fusion transcript sequences from a large number of gene trap cell lines 
(Townley et al., 1997). Moreover, in gene trap cell lines containing more than a single 
fusion transcript, direct sequencing produces multiple sequences superimposed on one 
another corresponding to the population of fusion transcripts present (Townley et 
al., 1997). The products of 5'RACE-PCR (Protocol 1) from 11.5 d.p.c. 1114 
95 
homozygous liver RNA were analysed using the direct sequencing protocol. Figure 
4.3 shows the autoradiograph of the direct sequencing products. The en-2 exon 
sequence up to the splice acceptor site is easy to read as it represents a single sequence. 
Upstream of the splice acceptor site the sequence becomes more difficult to read 
because there is more than one endogenous sequence correctly spliced to en-2. 
However, a dominant sequence is identifiable and corresponds to the most abundant 
fusion transcript (Group I) identified from the cloning of RACE products. This pattern 
is characteristic of gene trap cell lines producing multiple fusion transcripts (Townley et 
al., 1997) and substantiates what we had observed from the cloning of 5RACE-PCR 
products from the 11 14 cell line. 
The isolation of multiple fusion transcripts by RACE-PCR is inconsistent with 
the identification of only a single fusion transcript by Northern analysis. This 
presumably reflects the sensitivity of RACE-PCR at identifying transcripts expressed at 
levels undetectable by Northern analysis. If the proportion of the different fusion 
transcripts identifed after PCR amplification reflects their relative abundance in 1114 
tissues, then the Northern analysis is likely to be detecting expression of the abundant 
Group I fusion transcript. 
4.2.2. Analysis of RACE Clone Sequence 
The gene trap vector pTl-ATG allows for vector insertion events into the 
untranslated regions (UTRs) of transcripts to be recovered (Hill and Wurst, 1993). The 
presence of the lacZ start codon allows for protein translation and production of 3-gal 
activity from UTRs. Translation of the four fusion transcript sequences in frame with 
the lacZ open reading frame (ORF) is shown in Figure 4.2. The Group I, III and N 
fusion transcripts contain stop codons in frame with the ORF of the lacZ gene. 
Theoretically, if functional LacZ protein is produced from any of these fusion 
sequences, this would indicate that the vector is splicing to the 5'UTR of the 





Figure 4.3: Direct Sequence of 1114 fusion transcripts 
Autoradiograph of direct sequencing products from 1114 (-I-) 11 .5dpc liver RNA separated 
on polyacrylamide gel. The en-2 exon sequence of PT1-ATG produces a clear, single 
sequence ladder. After the splice junction, the sequence is more ambiguous reflecting the 
multiple endogenous fusion sequences splice correctly to en-2 exon splice acceptor. 
The red dots highlight the strongest sequence which corresponds to the abundant Group I 
fusion transcript from RACE cloning. 
Group II fusion transcript has no stop codons in-frame with the ORF of lacZ. 
Assuming the presence of a upstream start codon, translation of this sequence would 
produce active LacZ protein. 
Endogenous sequence derived from the RACE clones of Groups 1-4 was 
compared to a non-redundant GenBank database using the BLASTN algorithm 
(Altschul et al., 1990; National Center for Biotechnology Information (USA) website 
http://www.ncbi.nlm.nih.gov/index.html). The Group I sequence showed the highest 
level of homology with 86% identity over 46 nucleotides to the chick winged helix 
protein CWH-1 (accession number U37272; Freyaldenhoven et al., 1997) with a 
probability of 1 .4x 1 0 of this match occuring by chance. Moreover, the same region 
of the Group I sequence showed comparable levels of homology to a number of genes 
from a range of species (data not shown). In all the genes showing homology to the 
Group I sequence, the region of homology translates to a negatively charged protein 
domain consisting of aspartate and glutamate residues (the exact order of the D and E 
residues is not maintained between genes). Translation of the Group I sequence in 
frame 2 produces a comparable stretch of aspartate and glutamate residues although, as 
with the other genes, the absolute order of these residues is not homologous between 
genes (Figure 4.2). The possible function of this negatively charged domain is 
discussed in Chapter 6. None of the other fusion sequences generated a significant 
level of homology to database sequences. 
4.3. Expression Analysis of Group I and II Fusion Transcripts 
From the RACE-PCR analysis, Group I and II fusion transcripts represent the 
only endogenous sequences isolated from both 1114 ES cells and foetal liver. Groups 
ifi and IV were only isolated once each from ES cells and are therefore considered less 
significant. As the PCR technique is particularly sensitive to contamination and 
amplification artefacts (Kwok et al., 1989; Porter-Jordan and Garret, 1990), RNase 
protection assays (RPA) were performed using Groups I and II sequences to confirm 
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the presence of the fusion transcripts and to assess their expression profile in 1114 
embryonic tissues. 
(a) RNase Protection Assay with Group I Sequence 
A 32P-labelled riboprobe template was generated from clone L-A8 (Group I) in 
the antisense orientation to the fusion transcript. The L-A8 riboprobe was subsequently 
hybridised to RNA from the parental R  ES cell line, 1114 ES cells and liver, head and 
rest of body (R.O.B.) from wild type, 1114 heterozygous and 1114 homozygous 
13d.p.c. embryos. GAPdH expression was used to control for RNA loading in each 
sample. Polyacrylamide gel electrophoresis of RNase digestion products resolves the 
fusion transcript as a 199bp protected fragment in all 1114 tissues but not in wild type 
tissues (Figure 4.4, lanes 2 to 8). This ubiquitous expression pattern contradicts the 
1114 foetal liver specific embryonic f3-gal activity. The protected fragment at 120bp 
corresponds to en-2 transcript. In wild type tissues, en-2 expression from the 
endogenous locus is observed solely in the embryonic head (Figure 4.4, lane 10) in 
agreement with the published expression pattern of en-2 (Joyner and Martin, 1987). 
Expression of en-2 is also observed in the parental Ri ES cell line (lane 1). The same 
120bp fragment is protected in all 1114 tissues and corresponds to both endogenous en-
2 expression (in ES cells and head only) and expression of the en-2 exon from the gene 
trap vector independent of this particular fusion transcript (Figure 4.4, lanes 2-8). The 
protected transcript of 79bp, observed at comparable levels in all tissues, corresponds 
to expression of the endogenous sequence independent of the fusion transcript (Figure 
4.4). As with the full fusion transcript, its expression does not match 1114 3-gal 
activity. 
The expression of the Group I fusion transcript and endogenous sequence in all 
1114 embryonic tissues examined, namely the liver, head and rest of body, does not 
correspond to the liver specific expression of the reporter activity. There are two 
posssible explanations for this result. Firstly, the LacZ protein produced from the 
Figure 4.4: Expression analysis of Group I fusion transcript LA-8 by RNase protection 
A 32P-labelled riboprobe was produced antisense to the LA-8 fusion transcript and 
hybridised to RNA from R  and 1114 ES cells, wild type, 1114 homozygous and 
heterozygous liver, head and rest of body (R.O.B.) from 13d.p.c. embryos. After 
hybridisation, products were digested and run on a polyacrylamide gel. 
The fusion transcript can be seen as a protected fragment of 199bp in all 1114 tissues (lanes 
2-8). En-2 and endogenous transcripts, produced independently of the fusion transcript are 
protected as 120bp and 79bp fragments respectively. The GAPdH riboprobe is protected 
as 65 and 67bp fragments and controls for the amount of total RNA in the hybridisation 
reaction. 
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ubiquitously expressed Group I fusion transcript is specifically translated and/or active 
in the embryonic liver. Alternatively, the Group I fusion transcript is not producing 
functional 3-gal and an alternative fusion transcript, expressed exclusively in the foetal 
liver, is responsible for 3-gal activity. This latter suggestion is supported by the 
isolation of three other fusion transcripts from the 5'RACE-PCR of 1114 ES cell RNA. 
Moreover, the RPA shows expression of en-2 independently of the fusion transcript in 
all 1114 tissues (taking into account the low level endogenous expression in the head). 
This is indicative of the presence of other fusion transcripts containing the gene trap 
vector derived en-2 exon. 
The RPA using the Group I probe also shows that in 1114 homozygous tissues, 
endogenous gene sequence is being produced independently of the Group I fusion 
transcript at levels approaching those seen in wild type tissues. This indicates that the 
endogenous gene may be splicing around the gene trap vector which could result in the 
production of wild type endogenous message, as has been observed for other gene trap 
lines (Table 1.1). 
(b) RNase Protection Assay with Group II Sequence 
An RPA was performed using an antisense riboprobe complementary to the L-
69 (Group II) fusion transcript. This riboprobe was hybridised to RNA from 1114 ES 
cells, 1114 homozygous and wild type 13d.p.c. liver, head and R.O.B., digested and 
the products resolved on a polyacrylamide gel. The L-69 fusion transcript is protected 
as a 188bp transcript in 1114 ES cells and 13d.p.c. 1114 homozygous liver only and not 
in the head and R.O.B. (Figure 4.5). This expression pattern is comparable to the 13-
gal activity in the 1114 line. As with the RPA shown in Figure 4.4, the en-2 protected 
transcript (130bp) is present in all tissues derived from 1114 embryos. This 
corresponds to en-2 exon expression from the gene trap vector independent of this 
specific fusion transcript and will presumably include expression of the abundant 
Figure 4.5: Expression analysis of Group II fusion transcript L-69 by RNase protection 
A 32P-labelled riboprobe antisense to L-69 was hybridised to RNA from 1114 ES cells 
(lane 1) and liver, head and R.O.B. from 1114 homozygous (lane 2, 3 and 4) and wild type 
13d.p.c. embryos (lanes 5, 6 and 7). Products were digested, and resolved on a 
polyacrylaniide gel. The fusion transcript is protected as a fragment of 188bp in 1114 ES 
cells (lane 1) and 1114 homozygous 13d.p.c. livers (lane 2). Expression of en-2 
independent of the fusion transcript is seen as a 1 3Obp protected fragment in all 1114 
tissues (lanes 1 to 4) and in wild type head (lane 6). Expression of the endogenous 
sequence independent of the gene trap vector protects a fragment of 58bp in all samples 
except 1114 homozygous 13d.p.c. head (lane 3). 
GAPdH is protected as a 65bp and 67bp fragment and controls for the amount of total 












(Groupl) fusion transcript. In wild type tissues, en-2 expression is seen exclusively in 
the foetal head as predicted from the expression of endogenous en-2. 
Expression of the endogenous L-69 sequence independent of the fusion transcript is 
protected as a 58bp fragment (Figure 4.5). Expression can be seen in 1114 ES cells, 
1114 homozygous foetal liver and R.O.B.and all tissues of wild type embryos (lane 1, 
2 and 4-7, Figure 4.5). This result is difficult to interpret. Expression of Group II 
endogenous sequence has since been shown to be liver specific in tissues from wild 
type embryos (Chapter 6). Although there is a protected fragment at the expected size 
for the endogenous sequence, the resolution around this region is poor with several 
bands present. These bands may represent digestion artefacts from the larger protected 
fragments, for example GAPdH, and not specifically expressed products. 
(c) RT-PCR Analysis of Group II Sequence 
To confirm the results of the Group II RPA in embryonic tissues and to extend 
the expression analysis to adult 1114 tissues, RT-PCR was performed using primers 
complementary to the L-69 (Group II) fusion transcript. Primer LST- 1, derived from 
clone L-69 endogenous sequence and primer 78, complementary to the 5' end of the 
lacZ gene were designed and used in the PCR reaction (Figure 4.6A+B). This is 
predicted to amplify a PCR product of 377bp in tissues expressing this transcript. 
HPRT primers were used to control for the amount of total RNA in each reaction 
(Johansson and Wiles, 1995). The PCR products were separated on an agarose gel, 
Southern blotted and probed with the en-2 exon probe (Figure 4.613). The L-69 fusion 
transcript is amplified from 1114 ES cell (lane 1) and 13d.p.c. 1114 homozyous liver 
RNA (lane 2) with no significant amplification product observed from 1114 
homozygous head (lane 3). A faint band is observed in the R.O.B. RNA sample (lane 
4) which is likely to be a result of contamination from the incomplete removal of liver 
tissue from the rest of body prior to RNA preparation. From the adult RNA samples, 
expression of the L-69 fusion transcript is seen at highest levels in the ovaries (lane 6) 
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Figure 4.6: Expression Analysis of Group II Fusion Transcript L-69 by RT-PCR 
Sequence of L-69 fusion transcript showing the primer LST- 1 used in the RT-PCR 
experiment. Lower case letters show en-2 exon sequence. 
T(blue); poly T tail added artificially during RACE-PCR (protocol 2). 
Predicted fusion transcript showing primers and probe used in RT-PCR assay. 
Results of RT-PCR using the LST- 1 primer from L-69 and primer 78 from lacZ. 
RT-PCR amplification products using primers LST-1 and 78 were separated on an agarose 
gel, Southern blotted and probed with 32P-radiolabelled en-2 exon. The expected 377bp 
product is observed at its highest level in 1114 ES cells, 11 14(-/-) 13d.p.c. liver and 1114 
(-I-) adult ovaries and kidney (lanes 1, 2, 6, and 11 respectively). Lower levels are seen in 
11 14(-/-) 13d.p.c. R.O.B. and 11 14(-/-) adult lung, liver and heart (lanes 4, 8, 9 and 10 
respectively). Lane 13 shows 11 14(-/-) liver RNA subjected to the RT-PCR protocol in the 
absence of reverse transcriptase. Amplification of HPRT is used to control for the amount 
of total RNA used in the RT reaction. The presence (+) or absence (-) of 3-gal enzymatic 
activity is indicated for comparison. 
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and kidney (lane 11), with low levels seen in the lung (lane 8), liver (lane9) and heart 
(lane 10). No product was amplified from wild type 13d.p.c. foetal liver (lane 5) 
eliminating the possibility that the product amplified from 1114 homozygous foetal liver 
is specific to foetal liver RNA rather than the 1114 line. As the genomic structure of the 
vector integration is unknown it is important to control for potential genomic DNA 
contamination of the 1114 homozygous foetal liver RNA sample. When reverse 
transcriptase was omitted from the RT-PCR reaction, no product was amplified (lane 
13) indicating no genomic DNA contamination. 
In summary, the expression of L-69 fusion transcript (Group II) in 1 3d.p.c. 
1114 homozygous embryos correlates with the embryonic profile of 1114 3-gal activity. 
In the adult, the highest level expression of the L-69 transcript is seen in the kidney and 
ovary correlating with 3-gal activity in these tissues (Figure 3.3). Lower level 
expression is seen in the liver, lung and heart. Although reporter activity is seen in the 
adult liver, none has been identified in the lung or heart. This may reflect L-69 
expression in the lung and heart being sensitive to detection by RT-PCR but not of a 
sufficient level to confer detectable 3-gal activity. The L-69 fusion transcript was not 
detected in the adult testes where reporter expression is observed. The RT-PCR 
protocol was repeated using different RNA preparations of 1114 homozygous testes and 
kidney. Using the kidney sample as a positive control, a low level of L-69 transcript 
was amplified in the testes (data not shown). 
Both the RT-PCR and RPA studies of embryonic tissues show that expression 
of the L-69 fusion transcript is highly restricted to the liver at mid gestation, correlating 
well with 1114 reporter activity. In addition, RT-PCR analysis of L-69 expression in 
adult tissues correlates well with adult 1114 reporter activity. This data suggests that the 
L-69 fusion transcript is directly responsible for the 3—gal activity observed in 1114 
embryos and adult. 
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4.4. LacZ Protein Expression Analysis 
It is important to determine whether expression of the p3-gal protein is restricted 
to the foetal liver or whether its enzymatic activity is restricted to the liver of 1114 
embryos with the 1114 gene trap integration expressing a predominant fusion transcript 
in all embryonic tissues. Crude protein lysates (2Otg) from 13.5d.p.c. wild type and 
1114 homozygous liver, head and R.O.B. were separated by SDS-polyacrylamide gel 
electrophoresis (PAGE), Western blotted and probed with a primary polyclonal (rabbit) 
anti-n-gal rabbit antibody. The primary antibody was probed with Horseradish 
peroxidase-labelled anti-rabbit 1g. antibody conjugate followed by chemiluminescent 
detection. The same amount of protein used in the Western blot was separated by SDS-
PAGE and stained with Coomassie Blue to control for protein loading. Despite the 
uneven loading of the protein samples, it is apparent that only the 1114 homozygous 
liver (lane 1) expresses the 11 5k 3-gal protein (Figure 4.4). The wild type samples 
serve as controls for the possibility of non-specific antibody binding. This result 
shows that the restricted 3-gal activity in the foetal liver is a result of restricted protein 
expression excluding the possibility that f3-gal protein is expressed throughout the 
embryo but only enzymatically active in the foetal liver. Therefore, the 1114 liver 
specific n-gal activity is a result of either liver specific translation or transcription. 
Within the sensitivity and resolution afforded by the Western blot analysis, the size of 
the n-gal protein in the 1114 foetal liver suggests that it does not exist as a large fusion 
protein. This is expected from the size of the 1114 fusion transcript identified by 
Northern analysis in Figure 4.1. 
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Figure 4.7: f3-galactosidase protein expression in 1114 embryos 
Western blotting and Coomassie staining of protein samples from 1114 homozygous and 
wild type 13d.p.c. liver, head and R.O.B after separation by SDS-PAGE. 
The upper panel shows a Western blotted gel which has been probed with mouse 
polyclonal anti-f3-gal antibody. Anti-rabbit Ig antibody conjugated to horseradish 
peroxidase was then used to probe for primary antibody which was in turn visualised by 
chemiluminescence. 
Only the 11 14(-/-) 13d.p.c. liver contains the 3-gal protein at the expected size of 1 l5kD 
(lane 1-asterisk). 
M; Molecular Weight Standards (Biorad, Cat No. 161 0318). ll5kD standard 
corresponds to 3-galactosidase. The positive size marker at 79.5 kD suggests that bovine 
serum albumin is cross reacting with either the primary anti-f3-gal antibody or the 
secondary anti-rabbit antibody. 
The lower panel shows a second gel, with the same amount of protein as the Western 
blotted gel, after Coomassie Blue staining which serves as a protein loading control. 
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4.5. Discussion 
The molecular characterisation of the 1114 gene trap integration has identified a 
complex integration event with multiple fusion transcripts isolated from both ES cells 
and foetal liver. The most abundant Group I fusion transcript is expressed throughout 
the embryo while expression of the rarer Group II fusion transcript correlates well with 
the highly restricted 3-gal activity in the embryo and adult. 
The production of multiple fusion transcripts in individual gene trap cell lines 
has been reported previously. From the RACE-PCR cloning of 55 gene trap cell lines, 
3 lines produced multiple fusion transcripts (Chowdhury et al., 1997). The direct 
sequencing of 153 secretory trap cell lines identified 14 lines (9%) with multiple 
sequences correctly spliced to the gene trap vector (Townley et al., 1997). In both the 
studies, these integrations were not characterised further. Certain gene trap vector 
integration events can be predicted to result in the production of multiple fusion 
transcripts. These include the integration of multiple vectors into several sites in the 
genome, trans-splicing and alternative splicing from a single vector integration site to 
more than one exon (Figure 4.8). 
The 1114 gene trap integration contains a minimum of four gene trap vector 
copies. It is therefore possible that individual vectors have inserted into transcription 
units at separate chromosomal sites where splicing to different upstream exons occurs 
(Figure 4.8A). Five generations of backcrossing the 1114 gene trap integration onto the 
C5713L/6 genetic background has failed to segregate any of the vector copies, indicating 
some degree of linkage between the vector copies. Interestingly, in the cell lines 123 
and 1163, identified in the same RA pre-screen as 1114 and also containing multiple 
vector copies, a single vector copy was segregated after only two generations of 
backcrossing (Forrester et al., 1996). Chapter 5 describes experiments which define 
more accurately the linkage between the vector copies in the 1114 gene trap integration. 
The study of two separate gene trap integrations into RNA polymerase I 
transcribed rRNA genes identified that such insertions induced the trans-splicing of the 
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Figure 4.8: Mechanisms of multiple fusion transcript production 
Vector insertion into separate chromosomal sites. 
Insertion of the gene trap vector into different transcription units which could be located 
relatively closely to one another or on different chromosomes. 
Trans-splicing after insertion into RNA polymerase I and III transcription units. 
Insertion of a gene trap vector into the extra transcribed spacer (ETS-yellow boxes) of the 
rRNA gene will produce a pre-rRNA with the gene trap vector downstream of the ETS. 
This results in the splicing of the vector splice acceptor to in cis to two cryptic splice sites 
within the vector intron or in trans to endogenous splice donor (SD) sequences. This will 
produce fusion transcripts containing endogenous sequence and rRNA/en-2 intron 
sequence. As the rRNA transcripts are uncapped, they will not be substrates for 
translation. 
Alternate splicing of gene trap vector after insertion into a single chromosomal site. 
Tandem insertion of the gene trap vectors in a head-to-tail orientation. Vector splicing 
to alternate upstream endogenous exons would produce multiple fusion trascripts. 
Tandem insertion of the gene trap vector in a tail-to-tail orientation. Vector splicing to 
alternate exons from two different converging transcripts 
SA, vector splice acceptor; SD, endogenous splice donors; SD*,  cryptic splice donors in 
the en-2 intron sequence at positions -32 and -435; arrows=direction of transcription. 
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gene trap vector to several different endogenous gene sequences (J. E. Sleeman & W. 
C. Skarnes, unpublished results). The exact mechanism of trans-splicing is unclear. 
One hypothesis is that the low efficiency of cis-splicing by RNA polymerase I 
transcripts allows the interaction of splicing machinery associated with the vector splice 
acceptor to interact with other splice donors in trans (W. C. Skarnes, personal 
communication; Figure 4.8B). In both these trans-spliced lines, fusion transcripts 
containing en-2 intron sequence were also isolated. However, these transcripts did not 
represent unspliced en-2 intron sequence. Rather, the production of the entire en-2 
intron-exon sequence as a part of the RNA polymerase I transcript was predicted to 
have induced the splicing of the en-2 splice acceptor to two upstream cryptic splice 
donor sequences in the en-2 intron sequence (Figure 4.813). Although the en-2 intron 
sequences isolated from the 1114 gene trap cell line represent unspliced intron, trans-
splicing could still be a feature of the 1114 gene trap integration. 
Another possibility is that the 1114 gene trap vectors have integrated into a 
single chromosomal site where they interact with multiple splice donor sites (Figure 
4.8C). Integration of the vectors, such that the two external vector copies are in a head-
to-tail tandem array within a single transcription unit, could result in vector splicing to 
alternative upstream exons (Figure 4.8C(i)). Vector insertion downstream of exons, 
whose splicing is normally regulated in a tissue specific manner (for examples see 
Adams et al., 1996), could produce alternate splicing. Alternatively, the presence of the 
splice acceptor of the gene trap vector could disrupt the normal splicing pattern of the 
endogenous gene and induce alternate splicing. Another possibilty is that the 
integration of the external vector copies in a tail-to-tail orientation between two adjacent 
genes transcribed in opposite directions could present two separate vector splice 
acceptor sequences to different upstream exons (Figure 4.8C(ii)). A similar situation 
could potentially arise from the insertion of a head-to-head vector array in the same site. 
As well as identifying different fusion transcripts, en-2 intronic sequence has 
repeatedly been isolated by RACE-PCR from different 1114 tissues. Moreover, en-2 
intron has also been isolated from the screening of an 1114 homozygous 13d.p.c. liver 
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cDNA library (constructed by Pierre Drèze, Brussels) with an en-2 exon probe (data not 
shown). It is perhaps more likely that the isolation of this sequence reflects inefficient 
vector splicing rather than an artefact arising from genomic DNA contamination of the 
RNA samples. In the study of Townley et al., (1997), 21(14%) of the 153 directly 
sequenced cell lines produced en-2 intronic sequence with endogenous fusion 
sequence. Moreover, all these lines were subsequently shown to express en-2 intron 
sequence by Northern blot analysis. The failure to detect en-2 expression by Northern 
blot in 1114 ES cells probably reflects the low level of en-2 intron expression these 
cells. 
Inefficient vector splicing has been hypothesised to be a feature of several 
different gene trap vector integration events. The insertion of a gene trap vector into the 
exon of an endogenous gene is predicted to result in en-2 intron expression. Such an 
event would result in competition between the vector splice acceptor and the 
endogenous splice acceptor of the exon into which insertion has occurred (which will 
be immediately upstream). If splicing to the endogenous splice acceptor occurred, a 
transcript containing the vector intronic sequence as part of the endogenous exon would 
be produced. From several cell lines characterised in our own and Bill Skames 
laboratory, it appears that insertion into an endogenous exon induces splicing between 
the en-2 splice acceptor and cryptic splice donor sequences within the en-2 intron as 
seen for trans-spliced lines (McClive et al., 1998; W. C. Skarnes, unpublished results). 
Moreover, this cryptic splicing was relatively efficient as no unspliced vector sequences 
were isolated from the RACE cloning of two of these lines (McClive et al., 1997). 
Another possible cause of inefficient splicing is that it is a intrinsic property of 
the site into which the vector has integrated. For example, if vector insertion has 
occurred into a large intron, the distance between the vector and endogenous exon may 
affect splicing efficiency. 
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How do Multiple Fusion Transcripts Produce Specific Reporter Activity? 
The presence of the lacZ start codon in pTl-ATG means that all of the fusion 
transcripts isolated so far could potentially produce active 3-gal. How does the 1114 
gene trap cell line display such a localised reporter expression pattern in the embryo 
when multiple fusion transcripts are produced, the most abundant of which is 
ubiquitously expressed? The Western blot analysis shows that the n-gal protein 
expression is restricted to the foetal liver. It is therefore likely that only the liver 
specific fusion transcript is translated and produces 3-gal activity. From the translation 
of the different fusion transcripts, only the liver specific fusion transcript (Group II, 
Figure 4.2) has no stop codons in-frame with the lacZ ORF. Moreover, the prevalent 
fusion transcript (Group I) and the Group IV fusion transcript contain at least one frame 
with no stop codons when translated in all three frames. Translation in this frame may 
correspond to the open reading frame of the endogenous sequence, which, in the 
context of splicing to the gene trap vector, would place lacZ out of frame. The Group 
III fusion transcript contains stop codons in all reading frames and should therefore 
translate lacZ from its own start codon. However, both Group III and Group IV 
transcripts have never been isolated from foetal liver RNA and only a single clone of 
each was isolated from ES cells making it unlikely that they are expressed at sufficiently 
high levels to produce detectable f3-gal activity. One way of resolving this question 
would be to isolate the corresponding endogenous gene sequence of each fusion 
transcript, conceptually translate these sequences and analyse if the fusion transcripts 
are within the hypothesised ORF. 
An interesting aspect of this situation is that, although potentially not 
responsible for the 3-gal activity, the wild type message of the Group I fusion transcript 
should be disrupted by the gene trap vector. Consequently, any phenotype(s) arising 
from the 1114 gene trap integration could be attributed to the disruption of the prevalent 
fusion transcript and/or the disruption of the other fusion transcripts. However, from 
the RNase protection assay using the Group I fusion transcript L-A8 as a probe, it is 
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apparent that animals homozygous for the 1114 gene trap integration produce significant 
levels of endogenous message. This suggests that the endogenous gene is splicing 
around the gene trap vector and therefore is not a null allele. The same situation may 
also be occuring with the Group II liver specific fusion sequence although expression 
of the endogenous transcript in homozygous tissue is unclear from the L-69 RPA data. 
In the 1114 gene trap cell line, the Group II fusion transcript is likely to be 
responsible for the 3-gal activity observed in the embryo and adult. The repeated 
screening of a 12-13d.p.c. wild type foetal liver cDNA library (constructed by Pierre 
Drèze, Brussels) with the fusion transcript L-69 (Group II) has failed to isolate the 
endogenous cDNA corresponding to this sequence. This prevents the analysis of this 
sequence independent of the gene trap vector to confirm the liver specific expression 
pattern. Even with such striking reporter activity, the possibility remains that this 
activity may be an artefact of the gene trap vector integration and not represent an 
endogenous transcript expressed exclusively in the foetal liver. The failure to isolate 
Group II sequence from this foetal liver library may reflect the low level of expression 
at this stage in gestation. The screening of genomic DNA for Group II sequence would 
provide a means of isolating this sequence independently of its expression state. 
In Chapter 5, the liver specific fusion sequence is isolated from genomic DNA 
independently of the gene trap vector. The relationship between this liver specific 
fusion sequence (Group II) and the Group I transcript is subsequently determined at the 
genomic level helping to define an alternative splicing event resulting in the production 




Genomic Characterisation of the 1114 Gene Trap Integration 
5.1 Introduction 
As stated in the previous chapter, the 1114 gene trap integration produces 
multiple fusion transcripts which we predicted to be a consequence of either individual 
vector insertion at separate chromosomal sites, trans-splicing or alternate splicing from 
the vectors integrated at a single chromosomal site (Figure 4.8). The work described in 
this chapter sets out to define the relationship between the two major fusion transcripts, 
the ubiquitous Group I and the liver specific Group II. 
5.2. Chromosomal Location of the 1114 Gene Trap Integration 
To examine if the gene trap vectors have integrated into more than one 
chromosomal site and to identify the chromosomal location of the vector copies, pTl-
ATG was used as a probe for fluorescent in situ hybridisation (FISH) analysis of 
chromosomal spreads from 1114 ES cells (Muriel Lee, MRC HGU). Within the 
resolution afforded by FISH analysis, the vector copies resolved to a single 
chromosomal site which the G-banding pattern of the chromosome suggested was 
chromosome 5, band El (data not shown). The chromosomal location was confirmed 
from the hybridisation of texas red labelled pTl-ATG in parallel with a chromosome 5 
specific fluorescein isothiocyanate (F1TC) paint (Figure 5. 1A; Rabbits et al., 1995). 
A total of 8 cDNAs were isolated using the Group I fusion transcript L-A8 (see 
Chapter 6, Appendix III). We used the largest of these clones GC7 (5.1Kb) for the 
Figure 5.1: Chromosomal mapping of the 1114 gene trap integration 
PT1-ATG 
FISH analysis of 1114 ES cell metaphase chromosomes with flourescently labelled pTl-
ATG. Green flourescence identifies chromosome 5 (FITC Ch5 specific paint). pTl-ATG 
(texas red labelled) hybridises to a single chromosomal site on chromosome 5 (arrowed). 
PT1-ATG and GC7 
FISH analysis of 1114 ES cell metaphase chromosomes with FITC (green) labelled PT1-
ATG and texas red labelled GC7. Co-localisation of hybridisation of PT1-ATG and GC7 
resolves as yellow flourescence (arrowed). 

FISH analysis of wild type cells and showed that it mapped to the same chromosomal 
location as the gene trap vector (data not shown) 
Two colour FISH analysis was performed on 1114 ES cell chromosome spreads 
using FITC labelled PT1-ATG and texas red labelled GC7 as probes. Figure 5.113 
shows the colocalisation of PT1-ATG (green) and GC7 (red) on 1114 ES cell 
metaphase choromosome spreads. This data shows that the endogenous gene 
associated with the Group I fusion transcript and the gene trap vector map to the same 
chromosomal site. The Group II fusion transcript has not been mapped by FISH due to 
the failure to isolate an associated cDNA clone. 
5.3. Genomic Structure Analysis of the 1114 Vector Copies 
To define more accurately the proximity of the gene trap vector copies to each 
other, 1114 ES cell genomic DNA was digested with rare cutting restriction enzymes in 
an attempt to resolve the multiple copies of the gene trap vectors to a single genomic 
DNA fragment. Digestion products were separated by pulse field gel electrophoresis 
(PFGE), Southern blotted and hybridised to a 32P-radiolabelled lacZ probe. Digestion 
by both Sail and XhoI, which do not cut within pTl-ATG, resolves all the gene trap 
vector copies to a single genomic restriction fragment of approximately 145kb (Figure 
5.2). This data strongly suggests that the gene trap vector copies have integrated into a 
single genomic site as a concatemeric array. 
HindIII digestion of 1114 genomic DNA resolves two positively hybridising 
fragments at approximately 33Kb and 10Kb (Figure 5.2). The fragment intensities 
suggest that the 33Kb fragment represents 3 copies of the gene trap vector and the 
10Kb fragment a single vector copy. The production of the 1114 gene trap cell line 
involved linearisation of the pT 1 -ATG vector prior to electroporation with Hindifi. The 
separation of gene trap vector copies by a Hindll probably reflects the production of a 
HindHI site after extrachromosomal ligation of the gene trap vectors and their 
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Figure 5.2: PFGE analysis of 1114 genomic DNA 
- The positively hybridising fragments at 200kb represent undigested genomic DNA (A). 
The uncut sample shows very little non-specific degradation with most of the lacZ positive 
genomic DNA greater than 200Kb in size. A large proportion of the lacZ positive genomic 
DNA in the Sail digest (lanes 5 & 6) remains undigested (>200Kb) suggesting that this has 
been an inefficient reaction. 
- Sail and XhoI digested 1114 genomic DNA (lanes 5-8) resolves all vector copies to a 
fragment of approximately 140kb (B). 
- Hindlil digested 1114 genomic DNA (lanes 2 &3) identifies two positively hybridising 
fragments of approximately 33kb and 10kb (C+D). 
- pTl-ATG: Basic restriction map of the gene trap vector showing the rare cutting 
restriction enzyme sites used in the study. The black bar indicates the lacZ fragment used 
to probe the Southern blot. 
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pTl-ATG: 
subsequent genomic integration rather than the separation of vector copies by genomic 
DNA. 
5.4. Cloning and Analysis of Group I and II Genomic DNA 
The mouse genomic P1 derived artificial chromosome (PAC) library RPC121 
was constructed from female (129/SvEvTACfBr) spleen genomic DNA (K. Osoegawa 
& P. de Jongs, unpublished results; http://bacpac.med.buffalo.edu). This library is 
available from the UK HGMP Resource Centre on 7 on gridded filters (http://www. 
hgmp.mrc.ac.uk/Biology/descriptions/mouse—pac.html). The library contains 128,889 
recombinant clones with an average insert size of 147Kbp which represents 6.3 times 
genomic coverage. Each clone has been spotted in duplicate onto the membranes, 
providing each with a unique co-ordinate which can subsequently be used to order these 
clones from the UK HGMP Resource Centre. 
The Mouse PAC1-7 filters were initially probed with en-2 exon sequence to 
exclude these clones from future screenings with en-2 containing fusion transcript 
sequences. Six positively hybridising clones were identified, correlating well with the 
predicted 6.3 times genomic coverage of this library. The filters were stripped, probed 
with the Group II fusion transcript (L-69) and 3 positive clones were isolated (352-j9; 
390-ml; 439-a23). 
An oligonuleotide (UBT-1) complementary to the Group I fusion transcript 
(Figure 4.2) was used to probe Southern blotted DNA from the three Group II positive 
PAC clones. All three clones hybridised to UBT- 1 (data not shown) indicating that the 
Group I and Group II sequences were directly linked at the genomic level. 
Restriction digests of 439-a23 were carried out with individual or combinations 
of the rare cutting restriction enzymes Clal, Nod, Sail, SfiI, XhoI. Digestion products 
were initially resolved by PFGE and subsequently by normal gel electrophoresis when 
restriction fragments were less than 15kb in size. The gels were Southern blotted and 
hybridised to a number of different probes. The L-69 fusion transcript and the UBT-i 
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oligonucleotide were used as Group I and II fusion sequence probes respectively. End 
labelled SP6 and T7 primers defined restriction fragments containing vector sequence 
and served to orientate the genomic DNA insert (Figure 5.3A). Both the liver specific 
Group II fusion sequence (L-69) and the Group I fusion sequence (UBT-l) mapped at 
the NotI/SfiJJXhoI sites (Figure 5.3A). A 1.5Kb PstI restriction fragment that 
hybridised to both Group I and Group II probes (Figure 5.313) was subcloned into 
pZEROTM2 (Invitrogen) and sequenced (Appendix I). 
Analysis of the sequence reveals that within this genomic DNA fragment both 
the Group I and Group II endogenous fusion sequences are in the same orientation 
relative to the splice donor sites used by the gene trap vector (Figure 5.3C; Appendix I). 
Consequently, a single gene trap vector would be capable of alternate splicing to the 
Group I and II fusion transcripts from a single chromosomal integration site. 
The genomic sequence was entered into the NIX suite of DNA analysis 
programs available at the UK HGMP Resource Centre (http://www.hgmp.mrc.ac.uk). 
NIX provides a single interface with which to run multiple DNA analysis programs 
against a specified DNA sequence (Appendix II). 
(a) CpG island 
CpG islands have a high overall guanine and cytosine nucleotide content as well 
as a high frequency of CpG dinucleotides relative to bulk genomic DNA. CpG islands 
are associated with the 5' ends of housekeeping genes as well as the 5' and 3' of many 
tissue specific genes (Gardiner-Garden and Frommer, 1987). The GRAIL CpG island 
algorithm (using the definition of a CpG island as reported by Gardiner-Garden and 
Frommer, 1987) defines an excellent CpG island between nucleotide positions 51 and 
1197 of p439-a23.fP (Figure 5.3C; Appendix II). This is in agreement with the 
relatively high number of rare cutting restriction enzyme sites found within and flanking 
this region in the the PAC clone (Figure 5.3B&C). The size of the fusion transcript 
identified by Northern blot (Figure 4.1) predicted that the gene trap vector had 
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Figure 5.3: Characterisation of genomic DNA containing Group I and Group II 
sequences. 
Restriction map of PAC clone 439-a23. 
The genomic insert is approximately 190Kb. Additional XhoI sites crudely mapped 
between the T7 end and the NotJISfiIIXhoI sites. The Group I (L-69) and Group II (UBT-
1) fusion sequences map to the region of the NotJJSfiIIXhoI sites at the centre of the 
genomic insert (highlighted in red). Hatched areas correspond to the pPAC4 vector 
sequences. 
Scale: 1cm to 10Kb. 
A 1.5Kb PstI genomic fragment contains the Group I and Group II sequences. 
Higher resolution restriction map of the genomic region surrounding the NotIISfihIXhoI 
sites. The Group I sequence maps to the 1Kb PstJIXhoI fragment and the Group II 
sequence to the 200bp SfiJfPstI fragment. 
Scale: 2cm to 1Kb. 
Subclone p439-a23.fP 
Sequencing of the 1.5Kb PstI fragment enabled the precise mapping of the Group I and 
Group H fusion sequences. Both splice donors (SD) used by the gene trap vector are in the 
same orientation within this sequence. The GRAIL CpG island algorithm identified the 
sequence between nucleotides 51 and 1197 as being an excellent CpG island (blue bar). 
Scale: 1cm to lOObp. 
C, Clal; Sa, Sall; Sf, SfiI; N, NotI; X, XhoI. 
Figure 5.3: 
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integrated into the 5' end of the endogenous transcript. The identification of a CpG 
island in this region supports this prediction. 
(b) Group I and Group II fusion sequences 
The sequence analysis of the ubiquitously expressed Group I fusion transcript 
predicted that translation of lacZ would be out-of-frame and no 3-gal acitvity would be 
produced from this transcript. The Group II fusion transcript expression correlated 
with 1114 reporter activity and was subsequently predicted to produce reporter activity. 
Analysis of the nucleotide sequence of the splice donor site used by the gene 
trap vector in splicing to the ubiquitous Group I fusion sequence reveals a good overall 
match to the splice donor consensus (Alberts et al., 1994; Figure 5.4A). However, a 
cytosine residue replaces the almost invariant thymine at position 905 in the intronic 
sequence (Figure 5.4A). This may explain why none of the exon prediction algorithms 
available on the NIX program identified the splice donor site used by the gene trap 
vector at position 903 (Appendix II). Although the different exon prediction algorithms 
identified several different splice donor sequences, the majority of these programs 
identified the same open reading frame from a translational start codon at position 523 
(Appendix I). This ORF corresponds to translation of the Group I fusion sequence in 
frame 2 in the context of the gene trap integration (Figure 5.4A; Figure 4.2). The 
isolation and conceptual translation of the corresponding cDNA sequence of this 
genomic region confirms position 903 as the endogenous splice donor and frame 2 of 
the Group I sequence as the ORF of the endogenous gene (see Chapter 6). Therefore, 
as predicted in Chapter 4, lacZ will not be translated from the Group I fusion transcript 
and no 3-gal activity will be produced (Figure 5.5A). 
An excellent correlation is observed betweeen the splice donor sequence used by 
the gene trap vector in splicing to the Group H liver specific fusion sequence and the 
consensus splice donor sequence (Figure 5.4B). Using NIX analysis, two exon 
prediction programs (Fex and FGene) identified the same splice donor site at position 
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Figure 5.4: Analysis of 439-a23.fP genomic sequence 
Genomic sequence of the Group I splice donor site. 
The Group I fusion sequence (highlighted in green) from p439-a23.fP is compared to the 
splice donor consensus sequence. Position 903 corresponds to the splice donor site used 
by the gene trap vector. The nearly invariant G and T residues within the splice donor 
consensus are highlighted in blue. The Group I fusion sequence has been translated in-
frame with lacZ (frame 2 - Figure 4.2). 
Group II genomic sequence in context of NIX predicted exon 
The Group II fusion sequence is highlighted in red. Comparison of the splice donor site 
used by the gene trap vector (position 1379) and the NIX identified splice acceptor 
sequence at position 1301 is compared to the consensus splice donor and acceptor 
sequences respectively. Nearly invariant residues within these consensus are highligted in 
blue. Translation of this predicted exon identifies an ORF corresponding to frame 1 in the 
context of the Group II fusion transcript (Figure 4.2). 
(i) Splicing of the exon containing the Group II sequence (via SA at 1301) to the upstream 
Group I sequence (via SD at 903) maintains the predicted ORF. 
Group H genomic sequence in context of NIX predicted promoter 
Predicted promoter sequence immedately upstream of the Group II fusion sequence. 
Transcriptonal start site is at position 1320 with the TATA box identified at 1292 (promoter 
position -28). 
Figure 5.4: 
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1379 (Appendix II). However, the NIX analysis of the sequence immediately upstream 
of the Group II fusion transcript identifies this sequence as either an internal exon or the 
first exon downstream of a RNA polymerase II promoter. 
The two exon prediction programs which identified the Group II splice donor 
sequence at position 1379 also predicted an upstream splice acceptor site to be at 
position 1301 (Figure 5.413). It is of interest to note, however, that this putative splice 
acceptor does not have a consensus polypyrimidine stretch upstream (Figure 5.413). 
Conceptual translation of this predicted exon produces 26 amino acid residues with no 
stop codons, corresponding to frame 1 of the Group II fusion transcript. In the context 
of gene trap vector splicing, this would result in the in-frame translation of the lacZ 
gene generating 3-gal activity from this transcript. Splicing of this exon to the Group I 
splice donor site used by the gene trap vector at position 903 (Figure 5.413(i)) maintains 
the ORF corresponding to frame 2 for the Group I sequence (endogenous cDNA ORF) 
and frame 1 for the Group II sequence (Figure 4.2 & 5.413). 
The transcriptional start site Wingender (TSSW) algorithm predicts human RNA 
polymerase II promoter regions and transcriptional start sites. The predictions are 
based on the presence of transcription factor binding sites coupled with the 
oligonucleotide composition of predicted transcriptional start sites. The TSSW 
algorithm predicted an excellent promoter with a TATA box 28 nucleotides upstream of 
the predicted transcriptional start site at position 1320 (Figure 5.4C). However, 
although this region is AT rich, it does not fit the TATA box consensus of TATAa/tAa/t 
(Breathnach and Chambon, 1981). Additional general transcription factor binding sites 
were identified upstream including a GC box which is bound by Spi (Appendix I). 
The transcriptional start site is immediately upstream of the Group II liver specific 
fusion transcript sequence (Figure 5.4C). No start codon is present within this 
potentially transcribed sequence from position 1320. Therefore, the production of 1-
gal activity from this sequence, when spliced to the gene trap vector, would require the 
translation of lacZ from its own start codon. 
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5.5. Summary 
Although there are inherent inaccuracies in predicting sequence function from 
computer algorithms, the results of the NIX analysis identifies two potential 
mechanisms which could be responsible for the liver specific expression of the Group 
II fusion transcript. The Group II fusion sequence may represent an internal exon of 
the endogenous trapped gene. The expression of the Group I fusion transcript suggests 
that the endogenous gene is ubiquitously expressed. Therefore, expression of the 
Group II exon in the endogenous gene may be under the control of a liver specific 
splicing mechanism. If the Group II sequence represents an internal exon, splicing of 
the gene trap vector results in the ORF of the endogenous gene being in-frame with lacZ 
which will result in the production of reporter activity (Figure 5.5Bi). 
The other possibility is that the Group II fusion sequence represents an 
alternative first exon of the endogenous gene which is expressed from a liver specific 
promoter independently of the promoter driving expression of the ubiquitous Group I 
fusion sequence (Figure 5.513ii). If the Group II sequence represents the first exon of 
the gene, then the lack of a methionine start codon identifies this sequence as being 
untranslated. Therefore, lacZ will be translated from its own translational start codon 
producing active -gal (Figure 5.513ii). 
The evidence for and against these two possibilities and their consequences in 
the context of the full length cDNA are discussed at the end of Chapter 6. 
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Figure 5.5: Summary of the 1114 gene trap integration event 
Splicing of the gene trap vector to the Group I fusion sequence 
The Group I sequence is ubiquitously expressed from the endogenous promoter. The 
Group I fusion transcript is translated from the endogenous upstream start codon which 
places lacZ translation out-of-frame. No -gal activity is produced from this fusion 
transcript. 
Gene trap vector splicing to the Group II fusion sequence 
Group II sequence as an internal exon 
The Group I containing exon is ubiquitously expressed from the endogenous promoter. In 
the foetal liver, the Group II fusion sequence is alternatively spliced to the gene trap vector 
and the upstream Group I fusion sequence. The fusion transcript is translated from the 
endogenous upstream start codon which will place translation of lacZ in-frame. f3-gal 
activity will be produced from this transcript. 
Group II sequence expressed from an alternative promoter 
In the foetal liver, an alternative promoter drives expression of the Group II fusion 
sequence. Splicing to the gene trap vector produces the Group II fusion transcript which 
will be translated from the lacZ start codon because the Group H sequence is untranslated. 
3-gal activity will be produced from this transcript. 
Figure 5.5: 
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Isolation and Characterisation of Gene Trap Ankyrin Repeat (gtar) 
6.1. cDNA Library Screening Using the Group I Sequence 
The Group I and Group II fusion sequences show a close association at the 
genomic level. In order to isolate the gene associated with this genomic region, cDNA 
library screening was carried out with the Group I fusion sequence. The fusion 
transcript L-A8 (Figure 4.2) was used to probe a random primed RI ES cell cDNA 
library cloned into the 2ZAPII vector (gift from Dr Hitoshi Niwa). Fifty positive 
plaques were identified from the primary screening of lx 10-6  clones of which 4 clones 
(plBa-2, p3Aa-2, p4Aa-1 and p5A(x-1) were characterised and showed overlapping 
restriction digest patterns (Appendix III). The largest clone (plB(X-2) is 4kb in size and 
spans the sequence contained in clones p3Aa-2, p4Aot-1 and p5Acx-1 (Appendix III). 
To isolate cDNA sequence downstream of these clones, a probe derived from the most 
3' sequence of clone plBa-2 (Appendix III) was used to screen the same Ri ES cell 
cDNA library. A further 3 clones were isolated (pGC3, pGC7 and pGC1O) which 
overlapped with the 3' end of clone plBa-2 (Appendix III). 
The sequencing strategy outlined in Appendix III produced a contiguous 
sequence of 6139 nucleotides. Conceptual translation of this sequence identifies an 
open reading frame encoding a protein of 1637 amino acids with a predicted molecular 
weight of 174 KD. The translational stop codon at nucleotide position 28 identifies the 
first in-frame methionine translational start codon as being at position 523 (Figure 6.1). 
Moreover, this putative start codon is in the context of a strong Kozak consensus 
sequence for translational initiation (Kozak, 1996, Figure 6.1). We have named this 
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Figure 6.1: Nucleotide and protein sequence of gtar 
- The PstI site identifies the same S limit of sequence derived from cDNA and PAC fragment 
- Start codon: .: at position 523 with bold underlined nucleotides at 520(-3) and 526(+4) in 
agreement with the Kozak consensus (RNNatgG, where R=purine). TAG at position 28, in-
frame stop. 
- Novel tandem repeat sequence flanked by Q and G residues boxed in blue. 
- Group I fusion sequence is highlighted in green with potential gene trap vector integration 
site marked by arrow. 
- Hyperacidic cluster underlined. 
- Ankyrin repeats underlined and numbered (R1-R25) with highly conserved residues in red. 
- Splice sites defining the different splice variants are arrowed at positions 2957, 3707, 3836 
and 5058. 








CCCACCCCCTCrICCCGCGGG GAGAAGGCGACGGTTCCGGCGGCGGCTGAGGGAGAAGGGAGCCCCCCGGCGGCGGCGGCAGTGGCGGCCCCCCCC 600 
NE K A TV FAA AK GE G 5 PP A A A A VA A P P 26 
GCGGCGGCGGCGGCGGAGGTCGGCGGCGGGCTCGCCCGGCCTC'1PCTCCTCGTGGGAGGTGCGAGTCTGCGACCTGCTCCTGAAGAAGAAGCCACCGC 700 
A A A A A E V G G G A R P A S S P R G N V R V C D L L L K K K P P 	59 
AGAACAGCAGCAGCAGCAGCCGCCGCACCACAAGGCCAAGCGGAACCGGACI'IGCCGACCCCCGAGCAGCAGCGmGCAGCAGCGACAGCGACAACAG 800 
[9_QQQQQQPPHHKAKRNRTCRPPSSS S S S S D S D N S 93 
900 
G G G G_GjIQ Q 99 H PP N N K A K RN R 	C 	PP 55 SEES S 12 
1000 
SD N S G G G G G G G 9 G G G G 
	
T S S N N S E EE E D D D D 5 	159 
Ft rCi GIGGTGGAGTCTITCAT"ITPGGACCAGGATGATITGGAGAATCCAATGCTGGWCAGCrI1CCAAGTTGCTI2CTATCAGGCACTGC 1100 
E E K V S E V K S F I L D Q D D L S N P N L E T A S K L L L S G T A 193 
TGACGGTGCTGACCTCAGGACAGTAGATCCAGAGACGCAGGCTCGACTGGAAGCTTTACTAGAAGCTGCAGGAATAGGCAAGTTATCGACGGCGGATGGT 1200 
D GAD L R TV D PET 9 AR LEA L LEA A GIG K LET A ID G 226 
AAAGCCTTTGCAGACCCTGAAGTGCTCCGCAGGTTAACATCGTCTGTCAGTTGTGCGTTGGATGAAGCTGCTGCTGCACTTACCCGGATGAGAGCTGAGA 1300 
K A FAD PS V L S R L T SE V SCALDS A A A ALT R 	RAE 	259 
GCACAGCAAATGCAGGGCAGTCGGACAACCGCAGTCTGGCAGAAGCGTGCAGAAGGAGATGTTGCTGTGCGGCTACTCATTAGGTCGGAG 1400 
S T A N A G Q $ D N R S L A S A 	S E G D V N A V R K L L 	S CR5 293 
RI> 
TGTGAATGAGCACACCGAGGAAGGGGAGAGCCTCC1FGTCTCGCTGTTCTGCTGGGTACTATGAGCTTGCACAGGTT1ATTGGCAATGCACGCWT 1500 
V NE H T ES GE S L L CL A C SAG Y Y EL Ag V L LAM H A N 326 
52> 
GTGGAAGACAGGGGAATCAAAGGTGACATCACACCTITAATGGCTGCTGCTAATGGAGGACATGTcATCGTGAAGTFGCTGCTAGCTCATAAAGCTG 1600 
V S D R G I K G D I T P L H A A A N G C S V K I V K L L L A H K A 	359 
R3> 
ATGTCAATGCACAGTCTTCAACAGGCAACACAGCTCTCACCTATGCTTGTGCTGGAGGCTACGTAGATGTTGTAGAGGTGCTCTTGGAATCCGGTGCTAG 1700 
ID V N A O__$ 
	
	T C N 1' A L I Y A C A G C Y V 9_T_. V S V L LE S GAS 393 
54> 
TAT GGGGACCATAATGAGAATGGTCACACACCTCI IATGGAAGCTGGAAGTGCTGGGCATGTGGAAGTAGCCAGATTGCTGCTAGAAAATGGAGCTGGC 1800 
TGDHNE L_cL_H T P L H SAGS A C H V E i1 A R L L_L S N P AG 426 
55> 
ATCAATACGCATTCCAATGAATTTAAAGAGAGTGCCCTTACATTAGCTTGTrATAAAGGACATCTAGAGATGGTGCGATTTCTTTTGGAAGCAGGCGCTG 1900 
I N T H S N E r K E S A L T L ACY 	C II L X M V R F 1. L K A_J1 	4.2 
56> 
ATCAAGAACATAAGACAGATGAAATGCACACTGCTCTAATGGAGGCTTGCATGGATGGCCATGTqIGAAGTAGCTAGGTTGCTTCTGGACAGTGGTGCTCA 2000 
D 0 E HK__P H M HJL_I A H S A C H _V A S L L L D S G A__Q 493  
R7> 
AGTGACATGCCAGCTGATTCATITGAGTCACCATTGACTTTGGCTGCATGTGGAGGACATGTGGAACTTGCAGCCTTACATTGAAAGAGGAGCTAGC 2100 
Y_PP $__ 	 LiLc P C IL V S 	 LLIERGASA S 526 
CTGGAAGAGGTCAATGATGAAGGTTATACTCCTTTGATGGAGGCAGCTCGTGAAGGACATGAAGAAATGGTGGCGTTACTTCTTGGCCAAGGAGCAAATA 2200 
_ S E V N D $_9 Y I P L H E A A R E C JE __EHjtAL_J_L G p p A 	559 
R9> 
TCAATGCACAGACAGAAGAACTCAAGAAACTGCCTGACCCTGPCT2GCTGTGGAGGCTTTCTGGAAGTAGCAGACTTCTGATTAAGGCTGGGGCTGA 2300 
91_ 	 I ALT L AC C G C FL E V A D FL IE 	GAP 593 
RIO> 
2400 
IEJ H S A A 0 E G H L E L V K YLL A A G A NVH.A 626 
RH> 
2500 
T TAT G PT ALT Y AC EN P H TD VA DV L L GA c -AD L E II 	659 
R12> 
AGTCAGAAGGTGGAAGAACTCCTrTAATGAAAGCTGCAAGAGCGGGTCATGTTTGCACAGTCCAGTTCTTAATTAGCAAAGGAGCAAATGTGAATCGAAC 2600 
G G R 3 P L 	 H V C T V 0 FLI S K H A N V N F T 693 
R13> 
CACAGCTAATAATGATCATACTGTACTGTCCCTGGCTTGTGCAGGAGGTCAT3GGCAGTGGTAGAACTACTTTTGGCTCATGGAGcAGACCCTAC'pAc 2700 
TA N N_D H TV L S LA C AG G H LA V.-V- EL L L A H G AD PT H 226 
R14> 
cGrAAAGATGGcTcAAccATGTrGATAGAAGcAGcAAAGGGTGGccATAcGAGpGrTGrrTGcTATcTTAGAcTATcccAATAjTcTAcTrGcAG 2800 
R L K PGS T FLI E A AK Q G H T S V VILLDY P N N L .J..A 	759  
RI> 
2900 
A P P P D V T Q L T P P S H D L N R A P R V P V Q A L P M V V P P Q 793 
y2957 
GGAGCCTGACAAACCACCTGCCAACCTTGCTGCTACTCTTCCCGTTAGGAGTAAAGCTGCTTCTAAACAAAAGTCCAACAGCCATTTGCCAGCAAACAGC 3000 
E P D K P P A N L A A T L P V R S K A A S K Q K S N S H L P A N S 826 
CAGGATGTACAGGGTTACATCACCAATCAGTCTCCAGAGAGCATTGTAGAAGAGGCTCAGGGAAAGTTAACAGAACTGGAACAGAGGATAAAAGAAGCCA 3100 
Q DV Q G Y IT N Q S P ES IV SEA Q GEL TEL E 	RI K E A 	859 
TAGAAAAAAATGCACAGCTGCAGTCCTTGGAGCTGGCTCATGCTGACCAACTCACCAAGGAGAAGATCGAGGAGCTGAACAAAACGAGGGAGGAACmT 3200 
I S K N A Q L Q S L S L A H A D Q L T K S K I S S L N K T R S S Q I 893 
TCAGAAGAAGCAAAAGATrCTGGAGGAGCTGCAGAAAGTAGAGCGAGAGCTACAACTGAAAACTCAGCAGCAGCTTAWJACAGTATCTAGAAGTrAAA 3300 
Q K K Q K I L E E L Q K V E R S L Q L K T a a 0 L K K Q Y L E V K 926 
3400 
A Q RI Q L Q 00 Q Q Q SC Q H L G L L T S V G V GE Q L SE G 	959 
ATGCACGGTTACAGCAAGTGGATCCTG3rGCTTAAAGATGAACCCCAGCAGACTGCTGCTCAGATGGGlTTrGcACcAATccAGCCTcTGGCGATGCC 3500 
Y A R L Q Q V D P V L L K P E P Q Q P A A Q N G F A P I Q P L A M P 993 
3600 
0 ALP LA T G P L pp G S I A N L TEL Q P VI V G Q P V L G Q 1026  
GCACAGTTGGCAGGGCTGGGGCAAGGAATTCTCACTGAAACACAACAAGGGTTAATGGTAGCCAGCCCTGCTCAGACCCTCAATGACACGCTGGATGACA 3700 
A Q LAG L G Q GILT E T Q Q G L MV A SPA Q T L ND T L D D 	1059 
3707 
TCATGGCAGTCAGTGGAAGAGCATCTGCAATGTCAAACACTCCTACCCACAGTATCGCTGCTTCTGTTTCCCAACCTCAGACTCCAACTCCAAGTCCCAT 3800 
3M A VS GRAS AM S 	T PT H S 	A AS VS Q P Q T PT PS P1 1093 
3836 
CATCTCTCCTTCAGCCATGCTACCTATCTACCCTGC kPTGATATPHATGCACAGACTGAGAGTAATCATGATACTGCACTAACACTTGCCTGTGCTGGT 3900 
I S P S A ML PlY PAID I D A Q T ES N_JD TA L T L A CA G 1126 
R16> 
4000 
G H E E L V p T L L E R H A S I E H ft D K KG F P P L I L A A P A 	1159 
RI?> 
GTCATGPrGTGTFGTAGAGATATTGCTGGACAATGGTGCAGACATTGAAGCCCAGTCAGAAGAACCAAGGACACACCACTGTCCTrGGCTrGTCTGG 4100 
P H V H V VEIL L D 	H 3 DIE A Q SERFK Dr p L S LACE G 113 
RI8 
GGGCAGGCAGGAGGTGGTGGAGTrGITGTTAGCTCGCGGTGCAEATAAAGAACACAGGAATGrrPCTGATIATACACCTCTAAGCCTGGCTGCTTCTGGT 4200 
GRQ E V V ELL L A R L_ R N V S D Y P P 
R19> 
GGCTATG3ACATCATCAATACTGCTAAATGCAGGAGCTGAGATCAATTCAAGAACTGGCAGCAAA1rGGGCATTPCTCCACTGATGTTGGCAGCTA 4300 
H Y V N I I K I LIN_G A S I N S R T H S K L 	I S P L H L A A 	1259 
R20> 
TGAATGGGCATACAGCTGCAGTTAAGCTCCTTTTAGACATGGGCTCTGACATAAATGCTCAGATAGAAACCAATCGGAACACTGCCCTTACATTAGCCTG 4400 
MN H H P A A V K L I L P M H S D I N A 0 I S T N R N 'P A L 'P L A C 1293 
R21> 
4500 
F p s R T S V V S L L L D K K A N V E HRAK T G L P P L 11 5 A A1326 
R22> 
TCTGGTGGTTATGCAGAGGTGGGCCGAGTTCTTTTGGATAAAGGTGCTGATGTGAATGCCCCTCCAGTGCCCTCCTCCAGAGACACAGCTTTAACCATAG 4600 
SGGY A H V H R V L L D K H 3 0 V N A P P V P S S R P 1 A L I 	1359 
R23> 
CCGCAGATAAGGGCATrATAAAITGTGAACTTCT1'ATTGGCAAGGGAGCTCATATTGATGTGCGAAACAAGAAGGGGAACACTCCGT"l'ATGGCTAGC 4700 
A A D K G H Y K PC ELLIGKHAHID V RN KEG N p p L WA 132 
R24> 
AGCATGGTGGACACCTAGATGTGGTTCAGCTACPHHTGcAAGCAACTGCAGATHTAHATGCAGCAGATAACCGCAAGATAACTCCGCTCATGGCTGCA 4800 
A N H H H L D V V 0 L L V p A T A D V P A A P N R 	I r P L H A A 1426 
R25> 
TAGAAAGGGTCATGTGAAGGTGGTGCGCTAC'P'TAGTCAAAGAGGTCAATCAG'ITrCCATCAGAFICGGAATGCATGAGGTATATAGCAACCAPCACTG 4900 
P5KG 9 VK V V F Y L 	K E V N OF PS DSS CM R Y IA TI T 	1459 
ATAAGGAGATGCTGAAGAAGTGTCATCTTTGTATGGAGTCAATAGTACAAGCCAAAGACAGGCAGGCTGCTGAAGCAAATAAGAATGCCAGCATACTACT 5000 
D K E M L K K C H L CM E S I V OAK D R 	A A SANK N A SILL 14 
5100 
y5058  
E S L D L S K L R S E S 	 12 
GAACAAAGAAGGAAATTAGAGGAAATGAAGCCATAAGGAGAACTPGAACTTCAAGCTGCTCAAGAA8AGAGAAACTTAAAGTTGAAGAAGAAC 5200 
El E A K N KEEP EL Q A A p EKE K 	K V SEE 	1559 
CTGAAGTCPrGACAHAGCCTCCAAGTGCCACTACCACCACTACCATAGGAATATCTGCTACATGpACTACTTTGGCAGGTI'CCCATGGTAAAAGwTAA 5300 
PS V L PEP P SAT P PT TIP I S A T W T P LAGS HG 	 1593 
5400 
N KIT PHNV QIT PD PP L PIE Y 1626 
AGTCAGCCAHAGAAGGTGAATGTC'ITrl'CTATAAPCCTGAGACTGCTGTTCATCAACCCCCCGGCGTCTGCACCACAATGTCCCAHTGAGTAGTTCCG 5500 








gene gtar (gene trap ankyrin repeat). The presence of translational stop codons in all 
three reading frames at the 5' and 3' ends of the contiguous sequence identifies the 5' 
and 3' UTRs, which suggests that the 6139bp contiguous sequence contains the 
complete coding sequence of gtar. However, no poly A addition signal (AATAAA) has 
been identified in the 3' UTR, suggesting sequence is missing from the 3' end of this 
cDNA sequence. None of the cDNAs isolated contained Group II fusion sequences as 
determined by the Southern blotting of the seven cDNA clones with the L-69 RACE 
clone. 
6.2. Analysis of the Group I Sequence 
The Group I fusion sequence is within the coding region of the cDNA, between 
position 938 and 1017 (Figure 6.1), suggesting insertion of the gene trap vector has 
occurred into an intron between the splice donor site at position 1017 and the putative 
downstream endogenous splice acceptor site at position 1018. Furthermore, it indicates 
that the same splice acceptor site used by the gene trap vector is used in the context of 
gtar splicing. The cDNA sequence from position 1 to position 1017 matches exactly the 
sequence from position 1 to 1017 of the genomic sequence derived from the 439-a23 
PAC clone (p439-a23.fP). This identifies nucleotides 1 t 1017 of gtar as a single exon 
at the genomic level. The ORF identified from gtar corresponds to translation of the 
Group I fusion transcript in frame 2 (Figure 4.2) confirming that the Group I fusion 
transcript is translated from the endogenous upstream start codon resulting in the out-
of-frame translation of the lacZ gene. n-gal activity is not therefore generated from this 
gene trap splicing event. 
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6.3. Protein Sequence Analysis of gtar 
Ankyrin Repeats 
The BLASTP algorithm was used to compare gtar protein sequence against a 
non-redundant GenBank protein database. BLASTP identified significant homology 
between the protein sequence and a number of ankyrin-like (ANK) repeat containing 
genes (data not shown). This homology lead to the identification of a total of 25 ANK 
repeats ranging from 30-35 amino acids in length (Figure 6.2). The consensus from 
these repeats matches well with the human erythrocyte ankyrin repeat consensus (Lux et 
al., 1990; Figure 6.2). The ANK repeats are organised into two separate domains of 
15 and 10 repeats (Figures 6.1 & 6.2). The terminal ANK repeats of these domains are 
more divergent from the ANK consensus sequence than the centrally located repeats, a 
common feature of ANK repeat domains (Bork, 1993). 
Hyperacidic Cluster 
Such strong homology to ANK repeat containing genes may obscure protein 
homologies outwith the ANK repeat domains. Therefore, the N-terminal amino acid 
residues 1 to 266, residues 769 to 1114 between the ANK repeat domains 1 and 2 and 
and the C-terminal residues 1450 to 1637 were compared to the GenBank protein 
database using BLASTP. 
The 13 consecutive aspartate and glutamate residues between amino acid 
position 151 and 162 (within the Group I fusion sequence, Figure 6.1) represent a 
region with a strong local negative charge. Such hyperacidic clusters were identified in 
a number of different transcription factors including the winged helix transcription 
factors human FREAC-4 (accession nos. U59832), CWH-1 (chick, U37272) and 
MBF-2 (mouse, L38607), the zinc finger transcription factor ö/UCRBP (mouse, 
M74590) and the nucleolar transcription factor UBF-1 (mouse, P25976). Studies on 
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Figure 6.2: Optimal alignment of the gtar ANK repeats 
The alignment of the amino acid sequence of the 1114 endogenous gene from residues 237-
792 and 1087-1476 identifies a total of 25 tandem ANK repeats arranged into two domains 
of 15 repeats (Domain 1) and 10 repeats (Domain 2). 
Amino acids conserved in at least two thirds of the repeats are are highlighted in red and 
summarised in the consensus below. A good corrrelation is seen between the 1114 
endogenous gene ANK consensus and the human erythrocyte ANK consensus (Lux et al., 
1990). ANK repeat residues are numbered 1-33. 
1114 ENDOGENOUS GENE 
ANKYRIN CONSENSUS 
---237R L T S S VS CAL D E A A A ALT R MR A E S TAN AG Q 
S D N R S L A E A C S E G D V N A V R K L L I E G R S V N E H T E 
EGESLLCLACSAGYYELAQVLLAMHANVEDRGIK 
G  I T P L M A A A N G G H V K I V K L L L A H K A D V N A Q S S 
T G N T A L T Y A C A G G Y V D V V E V L L E S G A S I G D H N E 
NGHTPLMEAGSAGHVEVARLLLENGRGINTHSNE 
F K E S A L T L A C Y K G H L E M V R F L L E A G A D Q E H K T D 
EMHTALMEACMDGHVEVARLLLDSGAQvNMpAD 
SFESPLTLAACGGHVELAALLIERGA S L E E V N D 
EGYTPLMEAAREGHEEMVALLLGQGANINAQTEE 
T Q E T A L T L A C C G G F L E V A D F L I K A G A D I E L 
GCSTPLMEAAQEGHLELVKyLLAAGANvHATTA 
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S D Y T P L S L A A S G G Y V N I I K I L L N A G A E I N S R T G S K 
L G I S P L M L A A M N G H T A A V K L L L D M G S D I N A Q I E T 
N R N T A L T L A C F Q G R T E V V S L L L D R K A N V E H R A K 
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UBF- 1 have identified the hyperacidic cluster as being essential for transcriptional 
activation (Voit et al., 1992). As well as transcription factors, hyperacidic clusters are 
present in functionally diverse proteins for example -tubulin (rice, X79367) and the 
neuronal anion exchanger AE3 (mouse, M28383). None of the other protein regions 
entered using BLASTP showed a significant level of homology to database sequences. 
(c) Bipartite Nuclear Localisation Signals 
Computer-based motif searching was performed on the full protein sequence 
using the suite of protein analysis programs available at the HGMP Resource Centre 
(http://www.hgmp.mrc.ac.uk). The PSort program searches for motifs involved in 
determining the sub-cellular localisation of the protein. The amino acid sequences from 
residues 1506 to 1522, 1516 to 1533 and 1590 to 1607 correspond to the consensus 
sequence for the bipartite nuclear localisation signal (NLS) initially identified from the 
nucleoplasrnin protein of Xenopus laevis (Figure 6.1). The bipartite NLS consists of 
two clusters of basic amino acids separated by a 10 amino acid spacer and has been 
found in more than 50% of nuclear proteins, but only 4% of the non-nuclear proteins 
analysed from a sequence database (Dingwall and Laskey, 1998; Hicks and Raikel, 
1995). The same three putative bipartite NLS were also identified using the ProfileScan 
program which searches protein profile databases for protein motifs (http://expasy. 
hcuge.chl). Moreover, within the region containing the bipartite NLS, a simpler NLS 
consensus identified from the SV40 large T antigen protein consisting of four 
consecutive basic residues is also present (Hicks and Raikhel, 1995). The whole 
region containing the three putative NLS (1506-1607) is rich in basic amino acid 
residues (Figure 6.1). 
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(d) Identification of a Novel Tandem Repeat 
Another intriguing feature of the protein sequence is the presence of two highly 
conserved tandem repeat sequences at the N-terminus. Comparison of the nucleotide 
sequence between nucleotide position 700 to 819 and position 820 and 954 identifies 
92% homology between these sequences. This homology is preserved at the amino 
acid level with residues 62-99 aligning against residues 100-137 (Figure 6.3A). A 
single repeat unit consists of flanking homopolymeric runs of glutamine residues at the 
N-terminal end and glycine residues at the C-terminal end (Figure 6.3A). Within the 
flanking homopolymeric residues, a 28 amino acid motif is present with 25 out of 28 
(89%) of the residues identical between the two repeats (Figure 6.3A). This core amino 
acid sequence is rich in proline, serine, glutamic acid, threonine and aspartic acid 
residues 16/28 (57%, Figure 6.3A). Regions high in these residues flanked by basic 
residues are a feature of PEST sequences characteristic of proteins with a short half-life 
(Rogers et al., 1986). Although potential PEST sequences are not contained absolutely 
within each repeat, residues 79 to 104 and 117 to 186 are identified as PEST sequences 
(Figure 6.3B; Rogers et al., 1986). It is of interest to note that the second putative 
PEST sequence (117-186) also incorporates the hyperacidic cluster. No significant 
level of homology was observed between the nucleotide sequence of both repeats (700-
954) and sequences in both the the non-redundant GenBank database and the expressed 
sequence tag database dbEST using BLASTN. Similary, the protein sequence of both 
repeats between amino acid residues 60-144 showed no homology to protein sequence 
databases or dbEST translated in all six reading frames. 
6.4. Isolation of gtar Splice Variants 
The full gtar cDNA sequence presented above consists essentially of the 5' and 
3' ends of clones plBa-2 and pGC7 respectively to give the full coding region. 
However, sequences present in the full cDNA presented in Figure 6.1 are absent in 
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Figure 6.3: Identification of a novel tandem repeat sequence 
Optimal alignment of the amino acid residues 60 to 99 with 100 to 144 identifies a core 
repeat sequence showing 89% identity between the two repeats flanked by homopolymeric 
runs of glutamine residues at the N-terminal end and glycine residues at the C-terminal end 
(boxed in blue). The residues highlighted in red correspond to amino acid residues 
associated with PEST sequences. 
Amino acid sequence of two potential PEST sequences. 
The PEST sequence consists of P, E, S, T, and to a lesser extent D residues (highlighted in 
red) flanked by a least a single positive amino acid residue (+). PEST sequence 1 is from 
residue 74- 104 and is contained absolutely within the two novel repeat sequences. PEST 
sequence 2 between residues 117 and 186 spans the second novel repeat sequence and 
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clones plBcz-2, pGC3 and pGC1O suggesting that these clones represent gtar splice 
variants (Figure 6.4). The nucleotide sequence between position 2957 and 3707 is 
absent in clones plBcx-2, pGC3 and pGC1O (Figure 6.4). The ORF of the full length 
cDNA is maintained but amino acid residues between position 812 to 1063 are 
eliminated. The putative protein sequence of this eliminated sequence showed no 
homology to existing protein sequences or motifs in the database. 
The sequence of clones plBcx-2 and GC3 continues into the ANK repeat 
domain 2 and the sequence of these clones terminates at position 3904 and 4680 
respectively. This sequence correponds to splice variant 1 (SV-1; Figure 6.4). 
Assuming that the 5' and 3' ends of SV-1 correspond to the same sequence as the full 
length cDNA (Figure 6.4), then SV-1 would represent a 5389bp transcript producing a 
protein of 1387 amino acids (146kD). 
Clone pGC1O sequence represents a different splice isoform (SV-2). Splicing 
between nucleotide position 3836 and 5058 maintains the ORF of the full length cDNA 
eliminating amino acid residues 1106 to 1513 from the protein sequence. This results 
in the deletion of ANK repeat domain 2 but maintains the putative NLS at position 1516 
which (Figure 6.4) potentially represents a transcript of 41 68bp producing a protein of 
980 amino acids (103kD). 
6.5. Genomic structure of gtar 
In order to define the genomic structure of PAC clone 439-a23 relative to gtar, 
various regions of the cDNA were used to probe 439-a23 digested with rare cutting 
restriction enzymes. As previously identified, the oligonucleotide UBT- 1 derived from 
the Group I fusion sequence (corresponding to nucleotide residues 966-1007 from the 
cDNA) is located towards the centre of the genomic insert around the NotIJSfiIIXhoI 
restriction sites (Figures 6.5). 
The probe GC1O.fXb is derived from clone pGC10 and corresponds to 
nucleotides 1528-1870 (Appendix III). This cDNA fragment hybridises to the 80kb 
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Figure 6.4: Splice variants of gtar 
The total cDNA sequence is represented at the top of the diagram. The open boxed region 
corresponds to translated sequence with the solid black lines representing untranslated 
regions. The nucleotide position of each clone relative to the full length cDNA is given 
above and the corresponding amino acid residue below each clone. 
ANK repeats are indicated by the numbered blue boxes. 
Yellow boxes denote the novel tandem repeat. 
The green box shows the hyperacidic cluster. 
Orange boxes denote the bipartite NLS. 
Scale 1.5cm to 500bp 
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Figure 6.5: Genomic structure of gtar 
Diagram showing the where different probes derived from the full length endogenous 
cDNA mapped to the restriction map of the genomic DNA from PAC clone 439-a23. 
Restriction map of the full length cDNA clone shows the Group I sequence (green box) and 
the potential gene trap vector integration site (arrowed). The position and names of the 
cDNA fragments used to probe the PAC clone 439-a23 are represented as blue bars 
underneath the cDNA. The arrows indicate which cDNA probe mapped to which 
restriction fragment from the PAC clone genomic DNA. Fragment pGC7.fP failed to 
hybridise to 439-a23 (crossed). The predicted genomic gene trap vector insertion site is 
underline 
Scale 1.5cm to 500bp for cDNA, 1cm to 10kb for 439-a23. 
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genomic DNA fragment towards the SP6 end of the genomic insert which contains 
none of the rare cutting restriction enzyme used, making it impossible to define more 
accurately its position within the genomic insert (Figure 6.5). 	Probe GC7.fE, 
corresponding to nucleotides 3310-3360 of the full length cDNA (Appendix III), 
hybridised to the 10kb XhoI genomic fragment closest to the SP6 end of the genomic 
insert. This same XhoI genomic fragment also hybridised to probe 1Ba2.fXh 
(nucleotides 2860-2957/3707-3904) derived from the SV-1 clone plBa-2 (Figure 
6.5). Finally, probe pGC7.fP from the 3' end of the full length cDNA (nucleotides 
4750-6139) did not hybridise to PAC clone 439-a23 (Figure 6.5). 
The hybridisation pattern of probes UBT-1 and GC1O.fXb which flank the 
predicted gene trap vector insertion site in the cDNA, suggests that the genomic 
integration site of the gene trap vector resides within the 80kb XhoI genomic fragment 
of the PAC clone 439-a23 (Figure 6.5). Probes UBT-1 and 1Ba2.fXh, which 
represent sequences separated by only 1 800bp at the cDNA level, are approximately 
80kb apart at the genomic level. This indicates that the genomic structure of the 5' end 
of gtar into which the gene trap vector has integrated consists of a single or several large 
intronic regions. Integration of the gene trap vectors into an intron distant from the 
Group I and Group II sequences would explain the failure to detect an RFLP between 
wild type and 1114 genomic DNA (Appendix HI). 
6.6. Expression Analysis of gtar 
(a) RNase Protection Assay Analysis 
The results from the RPA performed in Chapter 4 using the Group I fusion 
transcript highlighted two important characteristics of the endogenous trapped gene in 
the context of the gene trap integration event. Firstly, the expression of the endogenous 
gene is more widespread than the liver specific reporter activity associated with the 1114 
gene trap integration. Secondly, the endogenous gene sequence was expressed 
121 
independently of the gene trap vector in 1114 homozygous tissues indicating that the 
endogenous gene is splicing around the gene trap vector integration and producing wild 
type transcript (Figure 4.4). 
An RPA assay was performed to investigate the expression pattern of gtar and 
also to assess the expression of the gtar sequences 3' of the putative gene trap 
integration site in 1114 homozygous tissues. A riboprobe antisense to the endogenous 
cDNA sequence was generated from plasmid p5Aa.fPE(150). This plasmid contains 
the 15 6b fragment from the 3' end of clone p5AcL-1 (Appendix Ill) which corresponds 
to nucleotides 2377 to 2533 of the full length cDNA clone (Figure 6.1). This riboprobe 
was hybridised to RNA isolated from R  and 1114 ES cells and liver, head and rest of 
body (R.O.B.) from wild type, 1114 heterozygous and homozygous tissues. The RNA 
was digested and the products resolved by polyaciylamide gel electrophoresis. GAPdH 
was used as a loading control in all samples. The riboprobe is predicted to be protected 
as a 156bp fragment in tissues expressing this region of the endogenous cDNA. Figure 
6.6 shows that the endogenous gene is expressed in all of the RNA samples analysed 
(lanes 1-11). The ubiquitous expression pattern of the 1114 endogenous gene at mid-
gestation is in agreement with the result of the RPA using the Group I fusion transcript. 
The expression of the endogenous gene sequence in 1114 homozygous tissues (lane 3-
5) confirms that the insertion of the gene trap vector has not generated a null allele. 
Wild type transcript is produced, presumably due to splicing around gene trap vector by 
gtar (Voss et al., 1998b). However, the uneven loading of the RNA samples makes it 
difficult to determine if there is a reduced level of endogenous gene expression as a 
result of gene trap vector insertion. There is a possibility that this riboprobe, which 
includes part of gtar ANK repeat 11, all of repeat 12 and part of repeat 13 (Figure 6.1) 
is hybridising to other ANK repeat containing genes, resulting in the ubiquitous 
expression pattern. Although this specific probe has never been hybridised to genomic 
DNA, all the probes used in the RFLP analysis (Appendix III) which span other ANK 
repeats identify single copy DNA. This suggests that the gtar ANK repeats do not 
cross-hybridise to other ANK repeat containing genes. 
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Figure 6.6: Expression analysis of gtar by RNase protection 
A riboprobe antisense to the cDNA sequence between positions 2377 and 2533 was 
hybridised to RNA from RI and 1114 ES cells, wild type, 1114 homozygous and 
heterozygous liver, head and rest of body (R.O.B.) from 13d.p.c. embryos. After 
hybridisation, products were digested and run on a polyacrylamide gel. 
Expression of the endogenous gene can be seen as a protected fragment of 1 56bp (A) in all 
the RNA samples (lanes 1-11). The GAPdH riboprobe is protected as 65 and 67bp 
fragments (B) and controls for the amount of total RNA in the hybridisation reaction. 
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(b) RT-PCR Analysis 
Repeated screening of cDNA libraries with both the Group I and Group II 
fusion sequences has failed to identify the cDNAs containing the Group II fusion 
sequence. However, transcripts containing the Group II fusion sequence can be 
predicted from the relative position of the Group I and Group II fusion sequences in the 
genome and gtar sequence (Figure 6.7A). To assess if this predicted transcript exists 
and to analyse its expression pattern in the embryo, RT-PCR was performed on 
embryonic RNA samples using primers complementary to the predicted transcript 
(Figure 6.7A). RT-PCR was carried out on RNA from Ri ES cells, and the liver, head 
and R.O.B. from wild type 10.5d.p.c. embryos using primer LST-1 (complementary to 
the Group II fusion sequence) in combination with two different primers RTANK-2 
and RTANK-3 (complementary to gtar; Figure 6.7A). 
Both primer pairs amplified the predicted size product. Expression of this 
transcript in wild type tissues is restricted to the liver of mid-gestation in a similar 
pattern to the expression of the reporter gene in 1114 embryos (Figure 6.713 lanes 1, 2, 
5, and 6). No product was amplified in the absence of reverse transcriptase confirming 
that the products observed were not due to genomic contamination (Figure 6.7B lanes 
10 and 12). 
HPRT was used to control for the even loading of RNA in the RT-PCR 
reactions (Johansson and Wiles, 1995). The RT-PCR reactions were stopped after 25 
and 30 PCR cycles to ensure that, in individual RNA samples, the RT-PCR 
amplification had not exhausted the reaction components. This is particularly important 
when using the HPRT primers. Individual samples, judged to be evenly loaded relative 
to other samples, could have reached an amplification plateau after fewer PCR cycles 
which would give the appearance of even RNA loading. The RT-PCR products were 
separated on an agarose gel and analysed by Southern blot hybridisation. End labelled 
primer LST-2 complementary to the Group II fusion sequence was used to probe for 
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Figure 6.7: Expression analysis of the endogenous Group II sequence using RT-PCR 
RT-PCR strategy 
The sequence of the PstI fragment from 439-a23 places the gtar cDNA sequence from 
position 1-10 17 which incudes the Group I sequence (green box) and the Group II fusion 
sequence (red box) within 200bp of each other. 
From the genomic structure, a cDNA molecule containing the Group H fusion sequence can 
be predicted with the Group II sequence inserted between nucleotides 1017 and 1018. 
Primers were designed complementary to this hypothetical molecule. LST-1 to the Group 
II sequence and RTANK-2 and RTANK-3 to the endogenous cDNA sequence. The 
predicted PCR products of 338bp and 651 bp are shown which could be probed with 
oligo' LST-2 complementary to the Group II sequence. 
Results of RT-PCR using LST-1 with either RTANK 2 & RTANK-3. 
The RT-PCR amplification products were separated on an agarose gel, Southern blotted 
and probed with end labelled LST-2 oligo'. The PCR products from each reaction were 
analysed after 25 PCR cycles (lanes 1-4) or 30 PCR cycles (lanes 5-8). The expected 
381bp amd 651bp PCR products from the LST-1/RTANK-2 and the LST-1IRTANK-3 
reactions respectively are only amplified a from R  ES cells and wild type 10.5d.p.c. foetal 
liver after 25 and 30 cycles (lanes 1, 2, 5 and 6). No product is amplified from wild type 
10.5d.p.c. head and R.O.B. (lanes 3, 4, 7 and 8). 
Amplification of HPRT is used to control for the amount of total RNA used in the RT 
reaction (lanes 1-8). 
To control for genomic DNA contamination, RT-PCR reactions were performed on RNA 
from RI ES cells and wild type 10.5d.p.c. foetal liver with (lanes 9 and 11) without (lanes 
10 and 12) reverse transcriptase. 
Lane 13 shows that both primer sets amplify product from Ii 14(-/-) 10.5d.p.c. RNA. 
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the predicted Group II containing transcript (Figure 6.713). Primer 22 was used to 
probe for the HPRT amplification products. 
The same three primer sets were used on RNA from 10.5d.p.c. 1114 
homozygous livers to assess if the integration of the gene trap vector had disrupted the 
production of the Group II containing transcript. Figure 6.713 (lane 13) shows that the 
Group II transcript is produced in 1114 homozygous livers. The failure of the gene trap 
vector to disrupt the production of the Group II containing transcript in 1114 
homozygous tissues is consistent with what is observed for the endogenous Group I 
fusion transcript sequence (Figure 4.4) and the endogenous gene sequence downstream 
of the putative gene trap vector insertion site (Figure 6.6) in 1114 homozygous tissues. 
6.7. Cloning and Sequencing of the Group II Containing Transcript 
The RT-PCR amplification products using the LST- 1IRTANK-2 and LST-
l/RTANK-3 primer sets were subcloned into pCRII-TOPO using the TOPO TA 
Cloning® kit (Invitrogen) and sequenced. The sequence of the RT-PCR products 
using primers LST-1 and RTANK-3 is shown in Figure 6.8. The splicing of the 
Group II sequence to the downstream gtar sequence is mediated by the same splice 
donor site used by the gene trap vector and predicted by the NIX database analysis of 
the Group II genomic sequence (position 49). Moreover, the splicing of the Group II 
sequence occurs via the same downstream endogenous splice acceptor used by the 
Group I sequence in gtar (position 50, Figure 6.8; position 1018, Figure 6.1). 
Conceptual translation of the Group II containing transcript identifies an ORF 
corresponding to the same reading frame predicted for the gtar. Translation of the 
endogenous Group II transcript in this frame corresponds to translation of the Group II 
fusion transcript in frame 2 (Figure 4.2). The sequence and conceptual translation of 
the endogenous Group II transcript will have predictable consequences on the protein 
produced from this transcript. The consequences will however be different depending 
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Figure 6.8: Sequence of the endogenous Group II transcript 
The RT-PCR products from the LST-1IRTANK-2 and LST-1/RTANK-3 primer sets were 
subcloned and sequenced isolating the endogenous Group II sequence independent of the 
gene trap vector. 
The primers used to amplify the 651 bp Group II transcript are overlined. 
The Group II sequence (highlighted in red) splices to the endogenous downstream 
sequence via the splice donor used by the gene trap vector (49) and the splice acceptor used 
by the Group I sequence in the endogenous gene (50). This would put the vector insertion 
site between nucleotide 49 and 50 (black arrow). 
Conceptual translation of the nucleotide sequence identifies an ORF which maintains the 
sequence of the endogenous cDNA and includes the first three ANK repeats (underlined 
and numbered). Frame 1 and 2 refers to the reading frame of the Group II sequence 
relative to the gene trap vector integration (Figure 4.2). 
Frame 1 would be the reading frame if this transcript (via the Group II sequence) splices to 
the upstream Group I sequence as predicted in Figure 5.6B(i). Translation in this reading 
frame would terminate at amino acid position 26. 
Frame 2 would potentially be the reading frame if this transcript is produced from a 
separate promoter immediately upstream of the Group II sequence. Consequently, the 
potential translational start codon is at amino acid residue 31 (highlighted in orange) which 
corresponds to amino acid residue 180 of the full length protein. 
Figure 6.8: 
vector 
LST-1 	 insertion 
V GGTAGTTTTCTGTCAGTGGAAGGTGGCCGGGAGCAGTTGTGGAGGGGCGGTGGAGTCTTTCATTTTAC 70 
(frame 2): V V r C 0 W K V A G S 	G 0 A V E S F I L D 23 
(frame l):G S F L S V E G G R E Q L W R G G G V F H F G 	23 
CAGGATGATTTGGAGAATCCA CTGGAAACAGCTTCCAAGTTGCTTCTATCAGGCACTGCTGACGGTG 140 
Q D DL EN P 	LET A S K L L L S G TAD G 	46 
P G .(26) 
CTGACCTCAGGACAGTAGATCCAGAGACGCAGGCTCGACTGGAAGCTTTACTAGAAGCTGCAGGTAGG 210 
A DL R TV D PET Q AR LEA L LEA A GIG 7 
CAGTTATCGACGGCGGATGGTAGCCTTTGCAGACCCTGGTGCTCCGCAGGTTCATCGTCTGTC 280 
K L ST AD G K A FAD P E V L R R L T S S V j 
- RTANK-2 
AGTTGTGCGTTGGATGAAGCTGCTGCTGCACTTACCCGGATGAGAGCTGAGAGCACAGCTGCAGGGC 350 
SCALD E A A A ALT R MR A ES TAN AG fl 
AGTCGGACAACCGCAGTCTGGCAGAAGCGTGTTCAGAAGGAGATGTAAATGCTGTGCGGCTACTcAT 420 
Q SD N R S LA E A C SE C DV N A V R K L L 1140 
Ri> 
TGAAGGTCGGAGTGTGAATGAGCACACCGAGGAAGGGGAGAGCCTCCTTTGTCTCGCTTGTTCTGCTGGG 490 
E C R S V N H H T H E G E S L Y, C L A C S A C 163 
R2> 
TACTATGAGCTCGCACAGGTTTTATTGGCAATGCACGCAATGTGGGACAGGGGTCGGTGA 560 
Y Y E L A 0 V L L A M LI 2 N V E D R G I K GD 186 
P.3> 
TCACACCCTTAATGGCTGCTGCTAATGGAGGACATGTCAAAATCGTGAAGTTGCTGCTAGCTCATAAAGC 630 
I T P L MA A A N G C P V K I V K L A LA H K \210 
--- RTAM<-3 
TGATGTCAATGCACAGTCTTC 651 
DV N A OSS 211 
on whether the endogenous Group II transcript is expressed as an internal exon or from 
a separate promoter. 
In Chapter 5, it was proposed that the Group II sequence could potentially 
splice to the upstream Group I fusion sequence via an upstream consensus splice 
acceptor sequence (Figure 5.413). It was predicted that this splicing event would 
maintain the open reading frame of the Group I sequence (and by inference the ORF of 
the endogenous gene) by translation of the Group II sequence in frame 1 which 
contained no stop codons (Figure 5.413i). Moreover, such a splicing event and the 
translation of the Group II sequence in frame 1 would, in the context of gene trap vector 
splicing, result in the in-frame translation of lacZ and subsequently 3-gal activity from 
this transcript. If the Group II transcript is translated in frame 1 as predicted, then 
splicing of this sequence to the downstream splice acceptor site results in the translation 
of the downstream endogenous gene sequence in a reading frame containing a stop 
codon 9 residues downstream of the translated Group II sequence (Figure 6.8). 
Consequently, if a protein is produced from this transcript, it will contain the first 65 
amino acids from the upstream endogenous sequence (including the Group I sequence), 
27 amino acids from the Group II sequence and a further 9 amino acids from the 
downstream endogenous sequence before termination. This would result in a 101 
amino acid protein containing the two novel tandem repeat sequences, the hyperacidic 
cluster but lacking the downstream ANK repeat sequences. The liver specific 
expression of the Group II sequence (via an alternate liver specific splicing mechanism) 
would consequently result in this truncated protein isoform being expressed exclusively 
in the liver. 
Another possible mechanism of the liver specific expression of the Group II 
sequence was via an alternative liver specific promoter. 	From the predicted 
transcriptional start site two nucleotides upstream of the Group II sequence, no 
translational start codons were found, suggesting that the Group II sequence would be 
untranslated in such a transcript. 	Consequently, translational initiation of the 
endogenous Group II transcript should occur downstream of the Group II sequence. 
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The first methionine codon in-frame with the same ORF of the full length cDNA is at 
position 92 (Figure 6.8). The use of this methionine codon for translational initiation 
would, relative to the full length protein sequence, produce a protein lacking the N-
terminal 179 amino acid residues which includes the two novel repeat regions and the 
hyperacidic cluster. However, it is unclear if this is a genuine start codon as it is not in 
the context of a strong Kozak sequence necessary for translational initiation (Figure 
6.8). In the context of splicing to the gene trap vector, the production of 3-gal activity 
from the Group II fusion transcript transcribed from the predicted promoter would 
require translation of lacZ from its own start codon. 
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6.8. Discussion 
Function of gtar 
Translation of the gtar mRNA has identified a number of different protein motifs 
which may help to elucidate the cellular function of this gene. The most obvious are the 
26 ANK repeat units which are present in two domains of 15 and 10 repeats. In 
addition, two potential PEST sequences and three potential bipartite NLS have also 
been identified. 
Function of ANK Repeats 
The ANK repeat was initially identified in the cell cycle regulatory proteins 
cdclO and SW16 from Scizosaccharomyces pombe and Saccharomyces cerevisiae 
respectively. Subsequently, the ANK repeat motif has been identified in many different 
species, from E.coli to humans, in functionally diverse proteins including transcription 
factors (e.g. NFK-B and GABPI3), cytoskeletal proteins (Ank 1, 2 and 3), and 
transmembrane proteins (e.g. Notch, lin-12) (Bork, 1993). The number of tandem 
ANK repeats varies between the different ANK repeat containing proteins. The 
majority of ANK repeat containing genes contain 3 to 8 ANK repeats. Outside of this 
group, inversin contains 16 ANK repeats, with the three mammalian ankyrins (Anki -3) 
and o-latrotoxin from black widow spider venom containing 22 - 24 repeats (Bork, 
1993; Morgan et al., 1998). These repeat numbers compare to the 25 repeats identified 
in gtar. Despite the varied number of ANK repeats and the different functions of the 
ANK repeat containing genes, the ANK repeat itself is predicted to have a common role 
involved in mediating protein-protein interactions (Michaely and Bennett, 1992; Bork, 
1993). 
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ANK Repeat Structure 
The crystal structure of a number of ANK repeat containing proteins including 
pl8IN (4C, 53BP2, and GABP13 has identified a common ANK repeat structure 
comprising essentially of a 13-strand helix-turn-helix extended 13-strand element 
(Wolberger, 1998; Figure 6.9D). The correlation between the ANK repeat residues and 
the different secondary structure elements is shown in Figure 6.9A. 
The arrangement of the secondary structure units of the ANK repeat identifies 
essentially an L-shaped structure with the pairs of cx-helices packing antiparallel to each 
other which, with adjacent ANK repeats, form cc-helical bundles (stem of the L, Figure 
6.9B). The first 13-sheet of the ANK repeat packs antiparallell with the last f3-sheet of 
the previous ANK repeat forming a 13-hairpin structure in a perpendicular plane to the 
a-helices (base of the L, Figure 6.9B, Wolberger, 1998; Gonna and Pavletich, 1996; 
Venkataramani et al., 1998). The highly conserved residues within the ANK repeat 
consensus play an important role in determining the folding of the secondary structure 
units. For example, the conserved glycine residues at position 2, 13, and 25 promote a 
sharp turn between the antiparallel 13-strands, the two a-helices and the second a-helix 
and the adjacent 13-strand respectively as well as terminating a-helices. 	Small 
hydrophobic residues are conserved at positions 5, 10, 18, 21 and 22 and promote 
intra- and inter-repeat packaging of the a-helices (Gonna and Pavletich, 1996; 
Venkataramani et at., 1998). As well as the primary sequence of the ANK repeat, the 
folding of the ANK repeat secondary structure elements is also dependent on the 
presence of other ANK repeats, as extensive interaction between adjacent secondary 
structure elements stabilise the ANK repeat structure (Wolberger, 1998; Gonna and 
Pavletich, 1996; Venkataramani et al., 1998). Consequently, the tertiary structure of 
ANK repeat regions is remarkably similar between different proteins (Figure 6.9D). 
An additional level of structural complexity has been postulated in proteins containing 
larger numbers of ANK repeats. Anki has been shown to comprise four independently 
folded ANK repeat subdomains comprising of 6 ANK repeats each (Michaely and 
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Figure 6.9: Protein structure of ankyrin repeats 
Diagram showing the relationship between the 33 amino acid residue ankyrin 
consensus and secondary structure elements. al and a2 are to two a-helices with 131 and 
02 referring to two 13-strands (adapted from Venkataramani et al., 1998). 
*: The ankyrin consensus is derived from 19 different ANK repeat containing proteins 
(Michaely and Bennett, 1992). 
Topology diagram of the secondary structure elements of the 5 ANK repeat units from 
the cell cycle protein p1 8INK4c• 
The a-helices are depicted as circles (helical axis is perpendicular to the page) and the 
strands as arrows. The numbers refer to the amino acid residues of p1 8I'4c  and are given 
at the beginning and end of each structural element. The third a-helix (0) in the second 
ANK repeat is uncharacteristically short with a long loop between a3 and a4 (from 
Venkataramani et al., 1998). 
Overall structure of p181<  with the a-helical axis roughly perpendicular to the page 
and the (3-strands parallel with the page (from Venkataramani et al., 1998). 
Comparison of the ANK repeat structure from p1 8'K4C  and p53BP2. 
ANK repeats 2-5 from p1 8I'4C  are superimposed onto the 4 ANK repeats from p53BP. 
A remarkable similarity in tertiary structure is seen betweeen the two proteins (from 
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Bennett, 1993). It is, however, unknown if the six repeat sub-domains tertiary 
structure is the same as the other ANK repeat domains. 
Although the highly conserved residues are important for ANK structure, they 
are not uniformly conserved in every ANK repeat only in selected ANK repeat units 
(Venkataramani et al., 1998). This agrees with what is observed for gtar ANK repeat 
consensus where, for example, the glycine residue at position 2 is conserved in only 11 
out of 26 repeats (Figure 6.2). 
The ANK repeat motif binds to a range of target proteins from which no 
obvious sequence consensus or structural motif has been identfied (Bennett, 1992). 
The nature of the specificity of binding between the different ANK repeat containing 
genes and their different target proteins is potentially a consequence of variation within 
the ANK repeat consensus. The 3-hairpin region, the solvent exposed a-helical 
regions and the large looped region connecting the second a-helix to the 13-strand, 
generally lack sequence homology between ANK repeats. From crystal structure 
studies of both GABPI3 and 53BP2, the 13-hairpin region has been shown to be 
involved in interaction with their respective target molecules GABPOt and p53 
(Wolberger, 1998; Gonna and Pavletich, 1996). 
The transcription factor GABP is a regulator of nuclear mitochondial genes 
functioning as a heterodimer consisting of the GABPa and GABPf3 subunits. The 
GABPa subunit contains the ETS helix-turn-helix DNA binding domain which can 
bind DNA as a monomer. The GABPI3 subunit contains 4 ANK repeats, functioning 
as the transactivation domain as well as increasing the affinity of GABPa DNA binding 
after dimerisation. All four ANK repeats within the GAPB13 subunit mediate 
dimerisation via the four 13-hairpin structures (Wolberger, 1998). 
Studies of other ANK repeat containing genes suggests that not every ANK 
repeat is equal in terms of their binding affinity to target molecules. The p513 binding 
protein 53BP2 contains 4 ANK repeats with 3 13-hairpin loops. Only the third 13-
hairpin structure is necessary for the interaction between 53BP2 and p513 (Gonna and 
Pavletich, 1996). Similarly, Ank-] (erythrocyte ankyrin) contains a 24 ANK repeat 
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domain which mediates high affinity binding to the membrane associated anion 
exchanger AE1. However, using defined regions of the ANK repeat domain, only 
repeats 21 and 22 were shown to be necessary for this high affinity binding. The ANK 
repeats not interacting with AE 1 have the ability to bind other proteins including tubulin 
(Davis et al., 1991). 
From these studies it is apparent that the conserved residues within the ANK 
repeat consensus and the tandem arrangement of these repeats provides a scaffold for 
the interaction of the more variable residues within the ANK consensus (for example, 
the 13-hairpin region) with the respective target proteins. 
Functional Comparison Between ankyrins and gtar 
The ANK repeat containing genes whose structure has been elucidated contain 
far fewer repeats than identified in gtar (26 ANK repeats). Ankyrins, which typically 
contain between 22-24 ANK repeats, have a more comparable repeat number. 
Moreover, the sequence of the ANK repeats from the endogenous trapped gene showed 
the highest homology to the ANK repeats found in ankyrin genes. 
In mammals, 3 different ankyrin genes have been identified to date (Ank], 
Ank2 and Ank3) whose general function is to bind integral membrane proteins to the 
spectrin cytoskeleton (Lux et al., 1990; Otto et al., 1991; Peters et al., 1995). Ankyrins 
are defined by a three domain structure comprising the N-terminal repeat domain, the 
spectrin binding domain and the C-terminal regulatory domain. The 89kD N-terminal 
domain contains 22-24 tandem ANK repeats and binds to a diverse array of membrane 
spanning molecules. The spectrin binding domain is approximately 62kD and is 
comprised of two sub-domains. The N-terminal sub-domain is highly acidic and is 
responsible for binding spectrin/fodrin. The C-terminal domain is overall basic in 
character with its sequence highly conserved between different ankyrins (Bennett, 
1992; Peters et al., 1995). The regulatory domain functions to modulate the binding 
affinity of the repeat domain and the spectrin binding domain. The sequence of the 
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regulatory domain is the least conserved region between the different ankyrins, a 
characteristic which is postulated to contribute to the different binding affinities of the 
ankyrin proteins (Bennett, 1992, Peters et al., 1995). The ANK repeat domain of the 
ankyrin proteins has been shown to interact with a range of integral membrane proteins 
including the voltage-dependent Na channel, the Na1iCa exchanger, CD44, 1P3 
receptor and N&iK+ATPase as well as the defining anion exchanger AEI (Peters et 
al., 1995). The role of ankyrin binding these ligands, with the exception of Anki 
binding AE1 and spectrin in erythrocytes, is postulated to be in establishing and/or 
maintaining the polarized distribution of the integral membrane proteins in the cell 
(Peters et al., 1995; Nelson and Veshnock, 1987; Hammerton et al., 1991). Although 
in vitro the different ankyrins are capable of binding many of the same membrane 
proteins, the tissue restricted expression of the different ankyrin forms will presumably 
prevent them from doing so in vivo (Peters et al., 1995). 
It is highly unlikely that gtar corresponds to a novel ankyrin gene as no spectrin 
binding domain, which is highly conserved between ankyrins, was identified in the 
endogenous protein by motif searching or by homology to other proteins. Moreover, in 
ankyrins, the 24 ANK repeats are arranged in tandem. From studies on Ank], these 
are folded into four separate subdomains of 6 ANK repeats. The full length gtar protein 
contains two separate ANK repeat domains of 15 and 10 repeats separated by 353 
amino acid residues containing no obvious motifs or homologies. The splice variant 
SV- 1, which has the majority of the sequence separating the ANK repeat domains 
deleted, still contains 59 amino acid residues between the separate ANK domains. The 
presence of either sequence separating the two ANK repeat domains is likely to 
preclude the formation of a similar sub-domain arrangement as observed for Anki. 
Interestingly, the arrangement of the ANK repeats into two separate domains as 
observed in the endogenous gene has not been previously reported. Consequently, it 
would be of significant interest to determine which proteins acted as ligands for the 
1114 endogenous ANK repeat domain. 
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Common to both gtar and ankyrin genes is the use of alternative splicing to 
generate diversity from a single gene. All three ankyrin genes characterised to date 
display alternative splicing producing multiple protein isoforms (Lux et al., 1990; Otto 
et al., 1991; Peters et al., 1995). For example, a minimum of seven different splice 
isoforms have been identified for the Ank3 gene (Peters et al., 1995; Dc Matteis and 
Morrow, 1998). Several studies have identified functional differences between splice 
isoforms and their respective major ankyrin isoforms. For example, a splice variant of 
Anki (2.2) lacks a 486 nucleotide sequence corresponding to a highly acidic amino acid 
sequence in the regulatory domain. The absence of this insert activates the ankyrin 
protein, enhancing both the binding of the ANK repeat domain to different membrane 
proteins and its spectrin binding affinity (Lux et al., 1990). Interestingly, an alternative 
splice isoform of Ank3 has been identified which, although the amino acid sequence 
differs from Ank 1, represents a deletion of a highly acidic region from the C-terminal 
regulatory domain. However, the functional significance of the Ank3 splice isoform is 
not known (Peters et al., 1995). 
The identification of three potential splice isoforms of gtar may reflect a similar 
mechanism as observed for ankyrins where the splice isoforms alter the specificity of 
the ANK repeat domain binding to potential target proteins. For example, the splice 
isoform SV-2 contains only 13 ANK repeats and would be predicted to have a different 
binding specificity to the splice isoforms containing 25 repeats. This may be a 
consequence of the lower ANK repeat number and also the presence of the highly basic 
region containing the potential NLS immediately downstream of the 13 ANK repeats. 
Interestingly, a splice isoform of Anki has been identified containing a variable region 
of highly basic residues within the regulatory domain (Lambert et al., 1990). 
However, it is unknown whether this alternative region has an effect on Anki binding 
specificity. 
The identification of a tissue specific isoform of the Anki gene expressed from 
a separate promoter, is similar to the potential use of an liver specific alternative 
promoter by gtar to express the Group II sequence. The main Anki protein isoform is 
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expressed as a 210kDa protein in erythrocytes and cerebellum (Bennett, 1992). A 
25kDa isoform of Anki, lacking the ANK repeats, has been identified which is 
expressed exclusively in skeletal muscle. Expression of this isoform is under the 
control of a muscle specific promoter located within intron 39 of the full length gene 
and expresses an alternative first exon which splices to three previously described Anki 
exons (Birkenmeier et at., 1998). 
Identification of a Liver Specific Promoter? 
Two potential mechanisms have been proposed as being responsible for the 
liver specific expression of the Group II sequence. Expression was either as a liver 
specific alternatively spliced internal exon or as the first exon of a transcript expressed 
from a liver specific promoter. Most of the evidence accumulated to date would suggest 
that the Group II sequence is expressed from a separate liver specific promoter. 
RACE-PCR cloning from Il 14 RNA failed to isolate a fusion transcript 
containing the predicted splicing event between the Group I and Group II sequences 
(Figure 5.4B(i) & 5.5B(i)). The largest Group II RACE clone isolated from Il 14 RNA 
contained 58bp of endogenous sequence. From the predicted splicing event, the Group 
II sequence would extend a further 22 bases upstream to the putative splice acceptor 
sequence (Figure 5.4B). This sequence has never been amplified. The Group I and 
Group II sequences have never been isolated as a single transcript. These data are 
supported by the screening of an 1114 12.5d.p.c. cDNA library with the en-2 exon 
probe. Of 13 Group I positive cDNA clones isolated, none contained Group II 
sequence (data not shown). The 58bp of Group II sequence isolated from RACE is 
only 3 bases short of the transcriptional start site predicted from the putative promoter 
sequence (Figure 5.4C). Repeated attempts to clone larger Group II fusion transcripts 
by RACE-PCR using size selection and the use of a nested primer complementary to the 
Group II sequence proved unsuccessful. The failure to isolate sequence upstream of 
the Group II transcript suggests that this sequence may represent the 5 end of the 
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transcript as predicted from the promoter. Alternatively, this result may reflect a 
technical limitation of the RACE cloning protocol. Secondary structure within the 
postulated Group I and II transcript could be preventing reverse transcriptase from 
transcribing this sequence. 
By examination of the sequence information, it is difficult to predict which 
model results in the expression of the Group II sequence. The predicted Group II 
splice acceptor sequence fits the consensus for a splice acceptor when the residues 
proximal to the splice site are examined and maintains the open reading frame initiated 
upstream. However, the Group II splice acceptor does not have a polypyrimidine 
stretch upstream of the proximal consensus sequence. Only 2 out of the 11 nucleotides 
immediately upstream of the proximal consensus are pyrimidines (Figure 5.4B), with 
only 7 pyrimidines present in the 40 nucleotides upstream (Appendix I). Whether this 
sequence functions as a splice acceptor is therefore unclear. Similarly, the promoter 
sequence identified by the TSSW algorithm does not contain an exact TATA box 
consensus sequence. Moreover, the three other promoter prediction algorithms in the 
NIX program failed to identify this sequence as being a promoter. 
Conceptual translation of the endogenous Group II transcript identifies the same 
ORF as the full length cDNA. However, translation in this reading frame is 
incompatible with the reading frame of the Group I sequence in the context of the 
Group II sequence being an internal exon. This is, however, no absolute reason to 
eliminate the possibility of the Group II sequence existing as an internal exon. The role 
of the Group II sequence as the predicted internal exon could be to truncate the 
endogenous protein, eliminating the function of the ANK repeats. 
The RT-PCR experiment described in Section 6.6 identified the endogenous 
Group II transcript using primers complementary to the Group II sequence and the 
downstream full length cDNA sequence. To assess if the Group II sequence is 
expressed as an internal exon, RT-PCR was performed using primers complementary 
to the Group II sequence and sequence potentially upstream in the endogenous full 
length cDNA. The predicted product would span the Group I sequence. In addition, 
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RT-PCR was performed to amplify the characterised endogenous cDNA using a primer 
upstream of the Group I sequence and the RTANK-2 primer complementary to the 
endogenous cDNA downstream of the Group I sequence. However, problems were 
encountered with both reactions in amplifying the expected product (data not shown). 
In the case of the Group II amplification reaction, this could be taken as an indication 
that the transcript containing the Group II sequence and the upstream sequences does 
not exist. However, the failure to amplify the expected product from the characterised 
endogenous cDNA suggests it is more likely to be a design limitation of the RT-PCR 
reaction. The results of the RACE cloning experiments suggests that amplification of 
the endogenous sequence upstream of the Group I sequence may be problematic with 
the largest Group I RACE clone isolated containing only 79bp of endogenous 
sequence. The failure to amplify upstream sequences may be a consequence of RNA 
secondary structure preventing the transcription of these sequences by reverse 
transcriptase. 
Specific experiments can be designed to answer definitively whether expression 
of the Group II sequence is via alternate splicing or a separate promoter. Si nuclease 
mapping would involve the design of a DNA probe spanning the predicted 
transcriptional start site. For example, the SfiIJPstI genomic DNA fragment from 439-
a23.fP containing the Group II sequence would be 32P-end labelled and hybridised to 
RNA from ES cells or foetal liver. The hybridisation products would then be digested 
with S 1 nuclease which will digest only single stranded nucleic acid. The digestion 
products would be denatured, separated by polyacryamide gel electrophoresis to 
determine the size of the protected end labelled DNA molecule. From the size of the 
DNA, the 5' end of the Group II transcript can be defined. 
Primer extension could also be used. A primer complementary to transcribed 
Group II sequence downstream of the predicted transcriptional start site would be 
designed, end labelled and hybridised to RNA. Extending from this primer, reverse 
transcriptase will duplicate the RNA molecule up to the 5' end of the transcript. The 
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products of this reaction would then be denatured and the radiolabelled DNA molecule 
sized on a polyacryamide gel to determine the start of the Group II transcript. 
The activity of the predicted promoter could be assessed by fusing it upstream 
of a reporter gene (e.g f3-geo). Conveniently, the 1.5Kb PstI genomic DNA fragment 
from PAC clone 439-a23 may contain sufficient promoter elements to drive reporter 
gene expression. The reporter expression pattern from such a construct could be 
monitored in vitro in ES cells and in vivo in chimaeric or transgenic animals to compare 
its expression with that of the gene trap integration event. 
A Liver Specific Protein Isoform? 
One of the most interesting aspects of the gtar gene trapped in the 1114 line is 
the potential function of the liver specific Group II sequence. The liver specific 
expression of this sequence as either an alternatively spliced internal exon or as an 
alternative 5 end of the endogenous gene is predicted to produce different protein 
isoforms (Figure 6.10). 
Expression of the Group II sequence as an internal exon is predicted to disrupt 
the ORF of the endogenous gene. This results in the production of a protein lacking the 
ANK repeats of the full length endogenous gene but retaining the novel repeat 
sequences and the hyperacidic cluster (Figure 6. lOBi). Consequently, the liver specific 
expression of the Group II transcript may serve to remove the protein binding ability of 
the endogenous gene but retain the function of the N-terminal region. 
The expression of the Group II sequence as an alternative first exon of the 
endogenous gene driven by a liver specific promoter is predicted to produce a protein 
with a different N-terminus which lacks the two novel tandem repeat sequences and the 
hyperacidic cluster (Figure 6. lOBii). The functional consequences of this will depend 
on the role of the absent motifs. The two tandem repeats and the hyperacidic cluster are 
potentially incorporated within two PEST sequences. PEST sequences consist of 
regions rich in proline, glutamic acid, serine, threonine and, to a lesser extent, aspartic 
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Figure 6.10: Summary of Group I and Group II sequence expression in gtar 
Splicing to the Group I fusion sequence 
The Group I sequence is ubiquitously expressed from the endogenous promoter producing 
the full length gtar transcript and predicted protein. 
Splicing of the Group II fusion sequence 
Group II sequence as an internal exon 
The Group I containing exon is ubiquitously expressed from the endogenous promoter. In 
the foetal liver, the Group II fusion sequence is alternatively spliced to downstream gtar 
sequences and the upstream Group I fusion sequence. The protein produced from this 
transcript will be initiated from the upstream start codon. This will place the gtar sequence 
downstream of the Group II sequence out-of-frame resulting in the production of a protein 
consisting of the N-terminus of predicted Gtar protein with no ANK repeats. 
Group II sequence expressed from an alternative promoter 
In the foetal liver, an alternative promoter drives expression of the Group II fusion 
sequence. In this transcript, the Group II sequence will be untranslated and a start codon 
within the gtar sequence used to initiate translation in the ORF predicted for the full length 
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acid. Ten proteins shown to contain PEST sequences have intra-cellular half-lives of 
less than two hours while of 35 proteins with half-lives of between 20 and 220 hours, 
only two contained PEST sequences (Rogers et al., 1986). If the N-terminus of the 
endogenous protein is functioning as a PEST sequence, then liver specific expression 
of the Group II sequence will remove this sequence resulting in a more stable ANK 
repeat protein whose expression is restricted to the foetal liver. Alternatively, the 
hyperacidic cluster may function, in the context of the full length gene, to modulate the 
binding specificity of the ANK repeats. A splice isoform of the Anki gene lacking an 
acidic portion of the regulatory domain shows enhanced binding of the ANK repeat 
domain to integral membrane proteins (Lux et al., 1990). Similarly, the absence of the 
hyperacidic cluster from the endogenous gene may enhance ANK repeat binding to 
target proteins in a liver specific manner. 
It would also be of interest to investigate if the different gtar splice isoforms are 
expressed in a tissue specific manner similar to other ankyrin splice isoforms (Bennett, 
1992; De Matteis and Morrow, 1998). Northern analysis, using probes specific to 
individual splice isoforms, or RT-PCR, using primers to amplify sequences which span 
the alternative splice sites used by the splice isoforms, will help to define their 
expression profile. The identification of a splice variant expressed exclusively in the 
foetal liver which is associated with the Group II sequence will help to further define a 
potential function of the liver specific gtar isoform. 
The predicted outcomes of Group II transcript expression would significantly 
alter the properties of the endogenous protein produced (Figure 6. lOB). The potential 
function of the liver specific Groupll transcript therefore could be to modulate the 
structure of the endogenous protein, either through the specificity of ANK repeat 
binding or protein stability, to perform a specific function necessary for hepatic 




The aim of this project was to characterise the 1114 gene trap cell line which 
shows restricted reporter activity in the foetal liver at mid-gestation. A detailed 
examination of the 1114 reporter activity identified one of the earliest markers of hepatic 
specification which, unlike all previously analysed liver specific markers, is restricted to 
the definitive endoderm lineage. The desire to identify the endogenous gene 
responsible for such an exquisite expression pattern dominated the decision to 
characterise a complex gene trap integration event which did not result in an obvious 
phenotype. From the molecular characterisation, the lack of a phenotype is potentially a 
consequence of splicing around the gene trap vector by the endogenous gene. The liver 
specific expression pattern is a result of the gene trap vector splicing to a sequence 
present in a ubiquitously expressed gene which is differentially expressed exclusively in 
the foetal liver, either as an alternatively spliced exon or as the first exon of a liver 
specific promoter . Characterisation of the 1114 integration does highlight certain 
aspects of gene trapping which contribute to the debate regarding the overall efficiency 
of gene trap vectors as a means of mutating the mouse genome. Moreover, it has 
identified a unique mechanism of gene trap vector action not previously identified which 
will facilitate the characterisation of future gene trap integrations. 
The most obvious shortcoming of gene trapping identified in the 1114 
integration was the failure of the gene trap vector to function as an effective mutagen. 
Consequently, the identification of a functional role for the trapped gtar gene is 
unresolved. Although there is no direct evidence that exon trap vectors are more 
efficient mutagens than gene trap vectors, gene trap vectors were used in all of the 
entrapment events which do not result in a null allele (Table 1.1). One can predict that 
eliminating the need for a splicing event for entrapment removes the possibility of 
splicing around the gene trap vector. In using exon trapping, therefore, the initial 
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efficiency of entrapment would be reduced (Friedrich and Soriano, 1991) but the 
likelihood that the cell lines produced are functionally disrupted will perhaps be 
increased. 
One of the most appealing aspects of gene trapping is the relative ease with 
which the trapped gene can be identified. In all the large scale gene trap screens carried 
out to date individual cell lines are prescreened to identify the trapped gene and complex 
integration events, such as multiple transcript production and intron containing lines 
(Hicks et al., 1997; Chowdhury et al., 1997; Townley et al., 1997; Zambrowicz et al., 
1998). In more focused gene trap screens aimed at identifying developmental 
expression patterns or phenotypes, the interest of the investigator is determined by 
criteria other than the ease with which the trapped gene can be characterised. Such is 
the case with the 1114 gene trap cell line. The extensive molecular characterisation of 
the 1114 gene trap integration has identified alternate splicing to the gene trap vector not 
previously reported in the context of gene trapping. 1114 therefore provides a model 
for the characterisation of multiple fusion transcript producing gene trap cell lines. 
One of the potential benefits of gene trapping is the identification of cell type or 
tissue specific markers with which to study development. Even without the molecular 
data gleaned from the 1114 line, the reporter activity provides an excellent marker for 
studying hepatic development which, due to the exclusivity of expression in the 
definitive endoderm, has benefits over existing hepatic markers. 
The 1114 gene trap integration presents an excellent opportunity for further 
study. The function of gtar could be assessed using gene targeting technology. It 
would be necessary to disrupt the function of the Group II liver specific transcript 
separately from the ubiquitously expressed Group I sequence to identify functional 
differences between the two proteins. If the Group II sequence is expressed from a 
liver specific promoter, then the isolation of this sequence would provide a useful tool 
for sudying liver develoment. The promoter itself could be used to identify and isolate 
the transcription factors driving the expression of the Group II transcript. Similar 
studies on the promoter elements of liver specific genes, such as transthyretin, resulted 
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in the isolation of the essential hepatic transcription factors HNF-3 and HNF-4 (Costa 
et al., 1989). Alternatively, the promoter could be used to drive the expression of 
specific molecules to the liver. For example, HNF-4 controls the expression of a 
number of liver specific factors. However, mice lacking HNF-4 die before the 
formation of the liver making it impossible to assess the role of HNF-4 in the liver 
(Chen et al., 1994a). The Group II promoter could be used to drive expression of Cre 
recombinase in a targeted mouse line containing HNF-4 flanked by loxP sites which 
could potentially disrupt the function of the gene specifically in the foetal liver. 
Despite the complex nature of the 1114 gene trap integration, its characterisation 
has defined a novel mechanism of gene trap vector action and potentially identified a 
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Appendix I: Sequence of 439-a23.fP 
Sequence of the 1.5Kb genomic PstI fragement from PAC 439-a23. The sequence 
in red corresponds to the Group I fusion sequence and the sequence in green the 
Group II fusion sequence. Positions 903 & 1379 are the splice donor sites used by 
the gene trap vector. The ATG highlighted at position 523 corresponds to the start 
codon of the endogenous gene. 
1320 
4Ir V 












BLAST/co I i 
BLAST/vector 
8E . 
Appendix II: NIX analysis of 439-a23.fP 
Diagrammatic output of the NIX suite of DNA analysis programs. The numbering corresponds to the nucleotide position on the positive strand 
of 439-a23.fP (same orientationas the fusion transcripts). Down the left hand side is listed the different DNA analysis programs run by NIX. 
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Appendix III: cDNA library clones 
Restriction maps and sequencing strategy of the endogenous cDNA clones used to identify the full length cDNA and splice variants. All 
inserts are cloned into the EcoRl site of pBluescript SK(-). The orientation within pBluescript SK(-) is indicated by the 0 and t7 primer sites. 
The different probes used for RFLP analysis derived from these clones are identified by a solid black line above the restriction fragment. 
Hatched area corresponds to region of -tubulin homology of hybrid cDNA clone p3Act-2 H, Hindill; P. PstI; Xb, XbaI; Xh, XhoI, E, EcoRI. 
Appendix IV 
Maps of the plasmid constructs used in the production of probes and riboprobes 
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All the plasmids isolated from the cDNA library screening are cloned into the EcoRI site 
of pBluescript SK(-). The cDNA inserts and the probes derived from them are shown 




alb serum albumin 
ANK ankyrin-like repeat 
AP alkaline phosphatase 
ATG translational start codon 
3-gal 3-galactosidase 
3-geo 3-ga1actosidase and neomycin fusion 
bp basepairs 
BSA bovine serum albumin 
cDNA complementary deoxyribonucleic acid 
C.P.M. counts per minute 
dATP deoxyadenosine triphosphate 
dCTP deoxycytidine triphosphate 
dGTP deoxyguanosine triphosphate 
dNTP deoxynucleoside triphosphate 
d.p.c. days post coitum 
dTTP deoxythymidine triphosphate 
DEN diethylnitrosaniine 
DEPC diethylpyrocarbonate 
DIA differentiation inhibiting activity 
DMSO dimethylsulfoxide 
DNA deoxyribonucleic acid 
DTT dithiothreitol 
EB embryoid body 
EDTA ethylenediaminetetraacetic acid 
en-2 mouse engrailed-2 
ENU ethylitrosourea 
ES cells embryonic stem cells 
EST expressed sequence tag 
ER endoplasmic reticulum 
FISH fluorescent in situ hybridisation 
FITC flourescein isothiocyanate 
GFP green flourescent protein 
gar gene trap ankyrin repeat gene 
HNF hepatocyte nuclear factor 
hsp heat shock protein 
147 
IRES internal ribosomal entry site 
kb kilobases 
LIF leukemia inhibiting factor 
LTR long terminal repeat 
mRNA messenger ribonucleic acid 
NLS nuclear localisation signal 
ORF open reading frame 
PAC p1 artificial chromosome 
PCR polymerase chain reaction 
PFGE pulse field gel electrophoresis 
PGK phophoglycerate kinase 
polyA polyadenylation 
RA retinoic acid 
RACE rapid amplification of cDNA ends 
RFLP restriction fragment length polymorphism 
RNA ribonucleic acid 
RPA RNase protection assay 
RT-PCR reverse transcription polymerase chain reaction 
SA splice acceptor 
SD splice donor 
SF!HGF scatter factor/ hepatocyte growth factor 
SV splice variant 
TESPA 3-aminopropyltriethoxysilane 
UTR untranslated region 
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